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                                                          Abstract 
The gut microbiota play a significant role in human health and nutrition, although the mechanisms these 
organisms use to survive in this densely populated environment are not well understood. Bacteroides 
thetaiotaomicron is a dominant member of the gut bacterial community whose genome sequence reveals large 
expansions in protein families involved in the sensing, acquisition and utilisation of complex carbohydrates, 
pointing to the ability to access a wide range of glycans as playing a significant role in becoming a successful 
resident of the human gut. Here we have characterised components of the B. thetaiotaomicron polysaccharide 
utilisation apparatus at molecular level, focusing mainly on fructan sensing, binding and degradation systems. 
Microarray data from our collaborators revealed that growth of B. thetaiotaomicron on inulin (β-2,1-linked 
fructan) specifically upregulated a locus of nine genes BT1757-BT1765 and an orphan gene BT3082, encoding a 
glycoside hydrolase from family 32 (GH32). The locus contains three other GH32s, two predicted polysaccharide 
binding outer membrane proteins (SusC and SusD homologues), a fructokinase, and an inner membrane 
monosaccharide transporter. Together these components form a polysaccharide utilisation locus (PUL). The 
nearest regulatory gene to the PUL is BT1754, a hybrid two component system. Here we show that the 
periplasmic sensor domain of BT1754 (BT1754peri) binds specifically to fructose, with a Kd of ~2 µM and a 
stoichiometry of 1:1, but not fructooligosaccharides or other monosaccharides. The crystal structure of 
BT1754peri revealed a two domain periplasmic binding protein (PBP)-fold with the ligand fructose sandwiched 
between the two domains. BT1754 is the first periplasmic sensor histidine kinase domain to display a non-PAS 
fold. The structure in combination with biophysical and site-directed mutagenesis studies also shows how the 
protein displays such specificity in ligand recognition and provides insights into the mechanism of signal 
transduction across the inner membrane. 
The four glycoside hydrolase family 32 members regulated by BT1754 were also biochemically and structurally 
characterised in this thesis. Three of four GH32 enzymes BT1759, BT1765 and BT3082, digest both β-2,1-linked 
(inulin) and β-2,6-linked (levan) fructans, indicating that levan is also utilised by the same locus. BT1759 and 
BT3082 are exo-acting enzymes releasing fructose from both long-chain and short-chain inulins and levans, while 
BT1765 is also exo-acting and produces fructose, but preferred short-chain sugars. BT1760 is unusual for GH32 
as it is specific for levan and has an endo-like activity, releasing a range of different size oligosaccharides from 
the polysaccharide. The crystal structures of wild type BT3082 and a nucleophile mutant in complex with 
substrate (kestose) were solved to 2.2 Å and revealed a typical GH32 β-propeller fold as the catalytic domain. 
Like all other GH32s solved to date, the enzyme has a C-terminal β-sheet domain of unknown function that was 
shown to be necessary for correct folding of the enzyme. BT3082 also has a unique N-terminal β-sheet domain 
that was shown to be essential for enzyme activity but not correct folding. Extensive site-directed mutagenesis 
was carried out to provide insight into the relative importance of different residues in substrate binding and 
catalysis in BT3082. The crystal structure of wild type BT1760 was solved to 2.6 Å, revealing a surprisingly 
similar structure to that of the exo-acting enzymes. A rationale for the endo-like activity of this enzyme and the 
role each of the four GH32s in fructan utilisation by B. thetaiotaomicron is discussed. 
The outer membrane SusD homologue BT1762 from the fructan locus was shown to bind preferentially to long 
chain levans, with no recognition of inulin. The crystal structure of BT1762 was solved to 1.9 Å and was shown 
to share the same novel α-helical fold as SusD. Site-directed mutagenesis of a number of residues in the same 
region as the SusD binding site showed that while the location of the ligand binding sites are conserved between 
these two proteins, the identity of the residues involved in polysaccharide recognition are not the same. A model is 
proposed for levan recognition in BT1762 and also its role in polysaccharide utilisation. 
B. thetaiotaomicron also has at least 12 ECF sigma/anti-sigma factor gene pairs likely involved in polysaccharide 
utilisation. Here we show that these systems form a trans-envelope signalling apparatus with their cognate SusC-
transducer homologue, but that there is no cross talk between different systems. The significance of this finding in 
relation to survival of this important gut bacterium is discussed.  
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Chapter 1 Introduction 
1.1 Carbohydrates and Nutrition 
Nutrition is the provision, to cells and organisms, of the materials necessary (in the form of food) to 
support life. Many common health problems can be prevented or alleviated with good nutrition. 
There are seven major classes of nutrients: carbohydrates, fats, fiber, minerals, proteins, vitamins, 
and water. Carbohydrates and proteins provide four kilocalories of energy per gram, while fats 
provide nine kilocalories per gram (Berg et al., 2002). 
 
More than 100 years ago, carbohydrate referred to natural chemical structures that have a 
composition of the formula (CH2O)n, where n is any number greater than two. However, many 
substances slightly different with this formula are also defined as carbohydrate, while many others 
agree with this formula are not carbohydrate. Nowadays, the definition of carbohydrate is a 
polyhydroxy aldehyde or ketone (Ajit et al., 1999). 
 
Carbohydrates may be classified as monosaccharides, disaccharides, oligosaccharides, and 
polysaccharides by the number of sugar units they contain. Simple carbohydrates are metabolized 
quickly and thus raise blood sugar levels more quickly resulting in rapid increases in blood insulin 
levels compared to complex carbohydrates (Henry, 2001). 
1.1.1 Monosaccharides 
Monosaccharides are the simplest carbohydrates, such as glucose, fructose, mannose, galactose, 
xylose, and ribose. They consist of one sugar and are usually colorless, water-soluble, crystalline 
solids. Some monosaccharides have a sweet taste. In 1888, Emil Fischer discovered chain-like 
conformations of glucose, fructose, and mannose. After that, Walter Haworth found that sugars have 
a ring-like, rather than just a straight-line, arrangement of their carbon atoms. Pyranose ring is a six-
membered ring of five carbons and one oxygen formed by the reaction of the OH- group with its 
aldehyde or ketone forming a hemiacetal or a hemiketal. A furanose is a five-membered furan-based 
ring structure formed by the reaction of the OH- group with its aldehyde or ketone forming a 
hemiacetal or a hemiketal. Both forms can exist in equilibrium (Figure 1. 1). The ratio of pyranose 
and furanose may shift with the change of solvent because of the variation of hydrogen bonds 
formed with solvent molecule, for example, water prefers pyranose, while dimethyl sulfoxide 
prefers furanose (Machie and Perlin.S.A, 1966). All monosaccharides are reducing sugars, which 
means its anomeric carbon is in the free form. 
 16
 
Figure 1. 1 Isomers of fructose. 
Monosaccharide can change the conformation from chain-like to ring-like. 
 
There are 4 different schemes to name a monosaccharide. According to the number of carbon atoms 
(3 to 10), monosaccharides are named into triose, tetrose, pentose, hexose, heptose, octose, nonose, 
and decose. According to the type of carbonyl group, monosaccharides are classified as aldose and 
ketose. Aldose has an aldehyde (CHO), while ketose has a ketone (C=O). According to the 
molecular configuration at the chiral carbon furthest from the aldehyde or ketone group, 
monosaccharides are classified as D and L. If the chirality at this carbon is equivalent to D-
glyceraldehyde's C2, the sugar is D; if it is equivalent to L-glyceraldehyde's C2, the sugar is L. 
Usually, the D form is found in nature. Unlike glyceraldehyde, D/L designation on more complex 
ugars is not associated with their direction of light rotation. According to the anomeric carbon, in 
an axial position, 
α-anomer 
ers are diastereomers 
ers to glucose on 
 
s
the chair configuration, the α-isomer has the OH- of the anomeric carbon in 
whereas the β-anomer has the OH- of the anomeric carbon in the equatorial position. The 
and β-anomer of one monosaccharide are always epimers and anomers. Epim
that differ in configuration of only one stereogenic center. Many sugars that are common in nature, 
such as galactose and mannose are epimers of glucose (Figure 1. 2). Mannose diff
OH- of C2, while galactose differs on OH- of C4. 
   
Figure 1. 2 Mannose, glucose, and galactose. 
All these monosaccharides are major sugars in nature. A: β-D-mannose, B: β-D-glucose, C: β-D-galactose. A and C are 
epimers of B. 
1.1.2 Disaccharides, oligosaccharides, and polysaccharides 
A B C
A disaccharide is composed of two monosaccharides via a dehydration reaction (also called a 
condensation reaction or dehydration synthesis) that leads to the loss of a molecule of water and 
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formation of a glycosidic bond. The glycosidic bond can be formed between any hydroxyl groups 
on the component monosaccharide. So, even if both component sugars are the same (e.g., glucose), 
different bond combinations regiochemistry (D/L) and stereochemistry (α/β) result in disaccharides 
that are diastereoisomers with different chemical and physical properties. 
There are two basic types of disaccharides: reducing disaccharides, in which the monosaccharide 
components are bonded by hydroxyl groups; and non-reducing disaccharides, in which the 
components bond through their anomeric centers (Matsuda, 1957). Most disaccharides are the 
reducing type, but a commonly occurring non-reducing disaccharide is sucrose, which is composed 
 fructose molecule linked by an α-1, 2 (from glucose) or -2, 1 (from fructose) 
 
of a glucose and a  β
bond.  
 
 
Figure 1. 3 Sucrose. 
Sucrose is non-reducing disaccharide formed by a glucose and a fructose. 
 
An oligosaccharide is a saccharide polymer containing a small number (typically three to ten) of 
olysaccharides are relatively complex carbohydrates. They are usually large, 
ks and 
nions, which are typically found in plants roots or rhizomes (Ritsema and Smeekens, 2003). Most 
component sugars. P
often branched, macromolecules. They tend to be amorphous, insoluble in water, and have no sweet 
taste. Unlike proteins which are formed by 23 different amino acid residues, polysaccharides 
seldom contain more than 3 different kinds of monosaccharides or linkages, normally only 1 or 2 
(Ajit et al., 1999). Examples include storage polysaccharides such as starch, fructan, and glycogen, 
and structural polysaccharides such as cellulose and chitin.  
1.1.3 Fructans 
Fructans are important storage energy sources, similar in function to starch, naturally occurring very 
widely in commercial plants such as wheat, chicory, artichokes, asparagus, green beans, lee
o
plants which synthesize and store inulin do not store other materials such as starch (Roberfroid, 
2005). Fructans have been shown to play a role in resistance to cold, and drought in plants (David 
and Cynthia, 1998; Pilon-Smits et al., 1995; Spollen and Nelson, 1994). The major mechanism is 
the fast polymerization/depolymerization of fructans on varying conditions offering a flexible and 
efficient osmoregulatory region (Ritsema and Smeekens, 2003). Fructans are also synthesised by a 
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number of bacteria where they are involved in dental biofilm formation (Rozen et al., 2001). 
 
Fructans are homopolymers of β-D-fructose with a single glucose at the chain end, which lead to 
rather different polymer behavior as compared with the pyranose ring-based glucans. Fructans 
occur in three main types: inulin (2→1 linkage), levan (2→6 linkage) and graminan (mixed 2→1 
linkage and 2→6 linkage (Ritsema and Smeekens, 2003). Inulins are only produced by plants 
hereas levans and graminins are produced mostly in monocots and bacteria (Ritsema and 
 from ~2-60 sugar units. 
(Kolida and 
ibson, 2007). 
 
There is a growing demand for fructan oligo and polysaccharides as health promoting prebiotics 
(Kolida and Gibson, 2007). Fructose itself is the sweetest of native saccharides and is added to a lot 
of food and drink as a sweetener. Fructose is often recommended for diabetics because it does not 
trigger the production of insulin (Sato et al., 1996). Inulin is also commonly used in low fat foods 
as a replacement for fat as it has a similar ‘mouth feel’, but very low calorific content. 
w
Smeekens, 2003). The difference between plant and bacterial levan appears mainly to be chain 
length; the average DP (degree of polymerisation) of bacterial levan is 105 to 106 fructose units, 
whereas plant levan is much shorter (only 6-42 fructose units) (Wack and Blaschek, 2006). The 
main reason is plants lack the key enzymes to produce high DP fructans, such as levansucrase 
(Hettwer et al., 1995). The average DP of inulin is ~12 for the polymer isolated from chicory, but 
the chains range
 
Despite their presence in a range of food crops, fructans are not utilised by our bodies (although we 
can readily metabolise fructose) due to the lack of the β-fructosidase enzymes required for their 
depolymerisation (Magnus et al., 2006). However our normal gut microbiota are able to utilise 
these polymers and thus fructans have been shown to act as prebiotic molecules, enabling our 
beneficial gut bacteria to outcompete pathogenic non-fructan metabolizing bacteria 
G
 
  
Figure 1. 4 Fructans. 
Left: Inulin, β-D-fructose-[(2→1)-β-D-fructose]n-(2→1)-α-D-gluc se, Right: Levan, β-D-fructose-[(2→6)-β-D-
fructose]
o
n-(2→1) α-D-glucose. Graminan is branched mixture of (2→1) and (2→6) linkages. Note the terminal glucose 
at each chain end. 
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1.2 Niche of the human gut 
The human body is home to a vast number of microbial cells that have coevolved with us and thus 
play a significant role in our normal biology. Of the various niches colonized by microbes, the gut is 
by far the most densly inhabited (Figure 1. 5). Indeed, 500-1000 species of gastrointestinal 
microbes (mostly bacterial) are present at densities of 1011 per gram of luminal contents, making it 
the most densly populated ecosystem on the planet (Berg, 1996). Most of these, up to 1014 microbial 
cells, are found in the large intestine, which is about 10 times of numbers of human cells (Backhed 
et al., 2005). From the process of birth, a sterile new baby is present with a large mixture of 
icrobes f ironm e of these organisms will colonize in the pristine host 
 et al., 2006). Only one archaeal 
e. Four major fungal phyla: 
icroflora, 
hich are mainly present in the intestinal microbial community. Most fungi are nonpathogenic to 
occus neoformans. Fungi produce immune-modulating 
m rom the env ent. Only som
leading to a complex ecosystem known as indigenous microbiota, while most of these bacteria will 
not be maintained in the human gastrointestinal tract (Savage, 1977). The composition of the 
microbiota can vary under some conditions, such as antibiotic treatment and dietary changes, but 
normally remains constant as defined by the cellular protein and fatty acid analysis as well as the 
16S rRNA gene fingerprinting (Moore and Moore, 1995; Zoetendal et al., 1998).  
 
The Bacteroidetes and the Firmicutes are the major divisions present and constitute >99 % of all 
phylotypes present in the colon with an approximate 50:50 split in the numbers of each based on 
16S rRNA (Backhed et al., 2005; Eckburg et al., 2005; Zoetendal
species Methanobrevibacter smithii was found, which produces methan
Ascomycota, Basidiomycota, Chytridiomycota and Zygomycota form ~ 2 % of the m
w
human and animals, except Cryptoc
compounds, which may alter immune system of host and take part in microbial immune 
homeostasis (Noverr et al., 2004; Scupham et al., 2006).  
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Figure 1. 5 The major indigenous bacterial species found in the human GI tract.  
The microflora found in the colon are listed in descending order of prominence .Cited from (Berg, 1996). 
 
 
1.2.1 The roles of gut bacteria 
Microbes in the gut play an important role in normal human health and nutrition. There are 
n genes are packed in the intestinal community, which will generate predicted 2 to 4 millio
metabolic functions beyond those of our own genome (Hooper and Gordon, 2001; Hooper et al., 
2002).  
1.2.1.1 In normal human health 
Gut bacteria produce antimicrobial substances termed bacteriocins to inhibit their competitors to 
grow (Lievin et al., 2000). Non-pathogenic bacteria adhere to the epithelial cells to prevent 
attachment of pathogenic enteroinvasive bacteria physically (Figure 1. 6) (Bernet et al., 1994). 
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Figure 1. 6 The Epithelium barrier. 
The epithelium has mucus layer as defensive barrier. But, GI bacteria are the important line outside of the surfactant to 
protect from exotic microbes from luminal environment. Cited from (Guarner and Malagelada, 2003). 
 
Gut microflora have been shown to enhance the threshold of tolerance of the immune system to 
microbial antigens (Braun-Fahrlander et al., 2002). GI bacteria can evade the immune response by 
changing their surface polysaccharide capsule, or precoating with IgA helps bacteria evade the 
human immune response (Krinos et al., 2001; Smith and Macfarlane, 1996; van der Waaij et al., 
1996). Gut bacteria have been shown to play a role in defence by producing anti cancer molecules 
such as butyrate (Kyriakidis et al., 2008; Mazmanian et al., 2005). 
 
Bacteria can improve human health as probiotics (Guarner and Schaafsma, 1998). Supplementation 
f Lactobacillus rhamnosus strain GG defends diarrhea in children (Oberhelman et al., 1999). Oral 
p the 
systemic and mucosal immunity (Isolauri et al., 2004). 
1.2.1.2 In nutrition 
dult colon, the daily substrate utilisation is about 20-60 g carbohydrates (Silvester et al., 
1995). Many members of the gut microflora (Finegold et al., 1983) obtain energy by hydrolysis of 
d glycolipids) in the colon (Prins, 1977; Roberfroid et al., 
995; Vercellotti et al., 1977). They also can utilise simple sugars when present, but 98 % of simple 
o
probiotics elevate IgA level against rotavirus infection of children (Majamaa et al., 1995). Actually, 
the newborn are predicted to need normal microbiota immediately after delivery to develo
Bacteria also play an important role in human nutrition, breaking down otherwise indigestable 
dietary polysaccharides, including resistant starches and pectins, to provide us with ~10-15 % of 
our daily calories from the fatty acid products of their fermentation (Backhed et al., 2005). In a 
human a
complex carbohydates of dietary, host polysaccharides (such as xylan, pectins, starch, and mucins) 
and glycoconjugates (glycoproteins an
1
sugars, such as glucose and sucrose, are absorbed in the small intestine (Hooper et al., 2001; 
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Salyers and Leedle., 1983).  
 
Colonic microorganisms have been shown to improve the absorption of metals such as iron, 
calcium, and magnesium and are known to synthesise several important vitamins (B12 and biotin) 
and help the absorption of others (e.g. vitamin K) (Conly et al., 1994; Roberfroid et al., 1995; 
Younes et al., 2001). Bacteria used in yoghurt improve lactose digestion and consumption and 
calcium intakes (Labayen et al., 2001). Furthermore, indigenous gut bacteria have been shown to 
stimulate the development of the epithelial blood vessels (Bons et al., 1997). 
1.2.1.3 Possible harmful effects of gut bacteria 
Diets with high fat and meat, and low vegetables increase the risk of colon cancer  possibly because 
such diets increase the amount of bacterial N-nitroso compounds in feces, which are well known 
promoters of colon cancer, inducing G→A transitions in codons 12 and 13 of K-ras (Bingham, 
1999; Hill, 1991; Hughes et al., 2001). Some intestinal bacteria can detoxify such substances 
whereas other bacteria, like Clostridium genera are thought to increase the growth of colonic 
mours (Horie et al., 1999; Wollowski et al., 2001). Also, some research pointed out that 
lthough we have co-evolved with our indigenous microflora, it is possible to live without these 
tu
overgrowth of gut bacteria may be harmful and can elicit gastritis, especially in the elderly 
(Husebye, 2005). Gut microbiota could be an extra contributor to the formation of obesity by small 
alteration in energy harvest from the diet (Flegal and Troiano, 2000; Turnbaugh et al., 2006). 
Hopefully, the balance of benefit and harm will be achieved by controlling the diet (Rastall, 2004). 
 
A
microbes as evidenced by the existence of germfree animals in research labs (Luckey, 1972). 
1.2.2 Bacteroides thetaiotaomicron 
Bacteroides thetaiotaomicron is a Gram-negative anaerobic bacterium (Figure 1. 7) that is a 
prominent member of the normal human gut microflora, 13 % of Bacteroidetes and 6 % of total 
bacteria detected by 16S rRNA analysis (Eckburg et al., 2005). Its 6.26 Mbp genome has been 
sequenced (ATCC 29148; originally isolated from the feces of a healthy adult human) (Xu et al., 
2003).  
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 Figure 1. 7 Electron microscope pictures of Bacteroides thetaiotaomicron.  
B. thetaiotaomicron embedded in the mucus layer overlying the epithelium in a monoassociated mouse gut. Scale bar is 
0.5 µm. Cited from (Sonnenburg et al., 2005). 
 
 
The most striking feature is large expansions in groups of proteins involved in the sensing, 
acquisition and degradation of carbohydrates. These include 209 homologues of outer membrane 
26 glycoside 
 transporters, and 21 
, 2003). Coevolution of human glycan diversity 
dly respond to changes in the 
y B. thetaiotaomicron showed that in the suckling 
polysaccharide-binding and transport proteins SusC (107) and SusD (102), 2
hydrolases (GH), as well as 15 polysaccharides lyases (PL), 20 sugar-specific
permease subunits of ATP-binding cassette (ABC) transporters (Magnus et al., 2006; Shipman et al., 
2000). The number of predicted GH genes in the proteome exceeds that in any other sequenced 
bacterium, including other human gut symbionts. In comparison, the human 2.85-Gb genome only 
contains 98 GH genes. The human genome is deficient in enzymes required to degrade of xylan-, 
pectin-, and arabinose-containing polysaccharides which are common components of dietary fiber 
while B. thetaiotaomicron has 64 corresponding enzymes and appears capable of cleaving most 
glycosidic bonds found in nature (Xu and Gordon
and a large group of microbial GH ensures the community can rapi
diet. Research on germ-free mice colonized b
period, gut B. thetaiotaomicron prefers host-derived polysaccharides and mono- and 
oligosaccharides from mother’s milk. After weaning, B. thetaiotaomicron starts to utilise plant-
derived dietary polysaccharides (Magnus et al., 2006). 
 
B. thetaiotaomicron also contains a large number of inner membrane spanning environmental 
sensors and regulators including 50 extracytoplasmic function sigma factors (ECF-σ), 26  anti-
sigma (anti-σ) factors (typically found downstream of a co-transcribed sigma), 79 classic two-
component systems (TCS) and 32 novel ‘hybrid’ two-component systems (HTCS), which comprise 
all components of a classical TCS in a single peptide (Magnus et al., 2006; Xu et al., 2003).  
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Many of these regulatory genes appear to be involved in controlling carbohydrate utilisation in B. 
thetaiotaomicron, as they are positioned adjacent to SusC and SusD homologues as well one or 
more catabolic genes such as GHs (Martens et al., 2008). These gene clusters are named 
polysaccharide utilisation loci (PULs) (Figure 1. 8). The arrangement in close proximity of 
environmental sensors-regulators with the outer membrane polysaccharide binding and transport 
proteins (SusC and SusD) and glycoside hydrolases suggests the co-regulation of these components 
to enable B. thetaiotaomicron to sense and respond to different types of carbohydrates depending on 
their availability in its local environment with high efficiency. Indeed recent data have shown that 
this is the case (Martens et al., 2008). 
 
 
 
Figure 1. 8 Typical PUL organization in B. thetaiotaomicron.  
locus in B. thetaiotaomicron composed of a membrane associated transcriptional 
gulator (TCS, HTCS or ECF-sigma/anti sigma factor), a SusC homologue (β barrel porin), a SusD homologue (outer 
embrane lipoprotein) and several catabolic genes, commonly glycoside hydrolases or polysaccharide lyases. These 
enes are closely linked on the genome, but are not always present as operons. 
ironment. In bacteria this is commonly achieved using multidomain proteins that span the 
Typical polysaccharide utilisation 
re
m
g
 
 
The extensive number of environmental sensor regulators coupled with the availability of genetic 
systems for manipulating B. thetaiotaomicron, the relative ease of culturing this aero-tolerant 
anaerobe and a complete genome sequence makes B. thetaiotaomicron an outstanding model 
system for increasing our understanding of the mechanisms of extracellular signal perception and 
transduction in bacteria, furthermore, for a more thorough understanding of the relationship 
between humans and their intestinal microflora (Hooper et al., 2003; Hooper et al., 2001; Hooper et 
al., 1999).  
1.2.3 Bacterial extracellular sensing and signalling systems 
Survival in the microbial world depends on the ability of the cell to sense and respond to changes in 
its env
cytoplasmic membrane and contain and extracellular ‘input’ domain that senses the environmental 
condition, linked to a cytoplasmic ‘output’ domain that is able to mediate the appropriate cellular 
response, either at the transcriptional or post translational level (Hughes and Mathee, 1998). The 
main classes of extracellular sensor regulators are extracytoplasmic function (ECF) sigma/anti-
sigma factors and two component systems (TCS).  
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1.2.3.1 ECF sigma/anti-sigma factors 
Bacterial sigma factors can be divided into two large families: the σ70 and σ54 (Helmann and 
Chamberlin, 1988). The description of sigma factors reflects their molecular mass in kDa. 
Extracytoplasmic function (ECF) sigma factors are a subfamily of σ70. 
ifferent sigma factors regulate different sets of genes to adjust metabolism with cues from outside 
and inside cells (Brinkman et al., 1999; Engels et al., 2004; Gunesekere et al., 2006). Sigma factors 
activate the transcription of genes by binding to specific promoters while associated with RNA 
polymerase (RNAP) (Carter et al., 2002; Horsburgh and Moir, 1999; Newman et al., 1999; Sun et 
al., 2004; Wilson and Lamont, 2000; Yeoman et al., 1999; Yeoman et al., 2003). Sigma factors can 
not bind DNA in the absence of RNAP (Malhotra et al., 1996). These sigma factors recognize 
promoters with similar elements around 10 and 35 bp upstream of the transcription initiation site.  
 
σ70 could be classed as four groups according to gene structure and function (Helmann, 2002; Paget 
and Helmann, 2003). Group 1 belongs to the essential primary sigma factors, which are classed into 
al., 1996; Murakami et al., 2002; Vassylyev et al., 2002). The region 2 of 
igma factors is the highest conserved region, in which subregions 2.3 and 2.4 are the promoter 
elting and recognition region (Malhotra et al. s σ factors, 
but is dispens Group 3 is ondary sigma factors, which are significantly 
smaller than gr regio is absent.  
 
 
 
D
4 sequence-conserved regions (σ1, σ2, σ3, σ4, with subregions 1.1, 1.2, 2.1, 2.2, 2.3, 2.4, 3.0, 3.1, 3.2, 
4.1 and 4.2)  (Figure 1. 9) that fold into separate structural domains connected by linkers (Gross et 
al., 1998; Malhotra et 
s
m , 1996). Group 2 i close to the primary 
able to cell growth. sec
oup 1 and 2. In many cases, n 3 
 
Figure 1. 9 The s
Cited from (Moon
 
 
gnals from the extracytoplasmic 
, pH, 
ubregions of σ .  
ey et al., 2005). 
70
Group 4 contains ECF sigma factors which respond to si
environment including osmotic and oxidative stress, iron and haem uptake, temperature
detergents, salt, and phage (Alvarez et al., 2007; Arraiz et al., 2001; Biville et al., 2004; Burger et 
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al., 2000; Dona et al., 2008; Horsburgh and Moir, 1999; Manganelli et al., 2001; Maunsell et al., 
2006; Ryu et al., 2006). ECF σ factors are more varied in sequence than other sigma factors. In 
many cases, they equal or exceed the number of other sigma factors found (Table 1. 1) (Helmann, 
2002). Bacteria in poor environments and frequent variation of nutrients are especially rich in ECF 
sigma factors (Braun et al., 2003b). Generally, the ECF sigma factors have several common 
characteristics (Helmann, 2002). They do not have a conserved subregion 3 which interacts with 
DNA -10 promoter element; instead they identify similar promoter elements with an ‘AAC’ motif in 
ECF σ factor can target the same promoter for regulation, 
 of 
ese proteins with specific molecules in the periplasm (Helmann, 2002). The ECF anti-sigma 
ctors are sometimes also controlled by an anti-anti-sigma factor, which locates to membrane 
(Masuda et al., 20
 
 
the -35 region. Finally, more than one 
especially in bacteria containing many ECF σ factors (Huang and Helmann, 1998). 
 
Normally, sigma factors are inhibited by anti-sigma factors (Anthony et al., 2004; Brown and 
Hughes, 1995; Brutsche and Braun, 1997; Gorham et al., 1996; Hughes and Mathee, 1998; Rowen 
and Deretic, 2000). The non-ECF anti-sigma factors are all cytoplasmic proteins, while the ECF 
anti-sigma factors are transmembrane proteins spanning the cytoplasmic membrane with a 
periplasmic sensor domain and a cytoplasmic domain that holds the sigma factor in an inactive 
form until the appropriate extracellular signal is received (Figure 1. 10) (Browning et al., 2003). 
The activity of ECF anti-sigma factors is controlled by the interaction of the periplasmic domain
th
fa
04). 
 
Figure 1. 10 ECF Sigma/anti-sigma factor complex. 
Anti-sigma factor is colored in red, while sigma factor is colored in green, in both location diagram (A), and in cartoon 
representation (B). This sigma/anti-sigma factor is sigma 28/FilM complex in E. coli (PDB ID 1SC5) (Sorenson et al., 
2004). When signal is released to anti-sigma factor, the conformational change of FilM will liberate sigma factor to 
initiate gene transcription. 
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Organism Total Sigma factors ECF sigma factors 
Streptomyces coelicolor 65 41 
Bacteroides thetaiotaomicron 54 50 
Pseudomonas aeruginosa PAO1 24 19 
Bacillus halodurans C-125 19 11 
Caulobacter crescentus 17 13 
Bacillus subtilis 168 17 7 
Escherichia.coli K12 MG1655 15 3 
Mycobacterium tuberculosis H37Rv 13 10 
Clostridium perfringens 12 3 
Vibrio cholerae El Tor N16961 8 3 
Porphyromonas gingivalis 7 5 
Enterococcus faecalis V583 6 2 
Haemophilus influenza 5 2 
Mycobacterium leprae TN 4 2 
Table 1. 1 Distribution of sigma/anti-sigma factor complex in organisms. 
Based on the genome sequences at TIGR (www.tigr.org). See references (Helmann, 2002) and (Xu et al., 2003). 
 
 
ECF sigma/anti-sigma factors are often involved in trans-envelope signalling, a process that also 
involves a TonB-dependent outer membrane transducer protein. These outer membrane transducers 
are β-barrel porins that couple import of specific molecules with signalling via a periplasmic tail 
that contacts the cognate anti-sigma factor. In B. thetaiotaomicron many of the ECF-sigma/anti-
sigma factor gene pairs are in PULS that contain SusC homologues with an N-terminal extension 
and are predicted to be TonB dependent transducers. More details of this trans envelope signalling 
system are present in chapter 6. 
1.2.3.2 Two component systems 
Two-component systems (TCS) are one of the most commonly encountered means of extracellular 
sensing and signalling in both Gram-positive and Gram-negative bacteria (Table 1. 2, and Figure 1. 
11). TCS are also found in archea, fungi, and some plants, but not in animals. The number of TCS 
in different bacteria varies considerably depending on the environmental niche of the organism 
(Chang and Stewart, 1998; Loomis et al., 1997; Perraud et al., 1999; Wurgler-Murphy and Saito, 
1997). Most sequenced bacteria have more than one TCS, except Mycoplasma species which are 
parasites and very stable environments, so do not need many sensors. Organisms with constantly 
changing or poor environments will need more sensors. TCSs may share the same ancestor as heat-
shock protein Hsp90, which indicated TCSs are conserved sensing proteins (Dutta et al., 1999). 
 
 
Aquifex aeolicus VF5 4 0 
Bifidobacterium longum 3 1 
Mycoplasma genitalium G-37 1 0 
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Histidine 
Kinase (HK) 
Organism Response 
typical hybrid 
Regulator 
(RR) 
Escherichia .coli 24 5 32 
Streptococcus pneumoniae 13 0 14 
Synechocystis sp. 25 16 38 
Methanobacterium thermoautotrophicum 14 1 9 
Dictyostelium discoideum 0 11 1 
Saccharomyces cerevisiae 0 1 2 
Arabidopsis thaliana 2 9 16 
Bacteroides thetaiotaomicron 48 41 31 
Pseudomonas aeruginosa 50 16 58 
Streptomyces coelicolor 64 1 70 
Table 1. 2 TCSs distribution in organisms.  
Based on (West and Stock, 2001) and (Zhang and Shi, 2005).  
 
TCSs regulate a wide range of bacterial responses to environmental variations, including oxidative 
stress, pH, temperature, and the presence of nutrients and harmful compounds  (Adams et al., 1999; 
Chen et al., 2008; Gottschalk et al., 2008; Griffitts et al., 2008; Krzeslak et al., 2008; Lee et al., 
2008b; Li et al., 2008; Marutani et al., 2008; Nes and Eijsink, 1999; Putrins et al., 2008; Sebert et 
al., 2005; Shanks et al., 2008; Williamson et al., 2008; Zoetendal et al., 2008).  
 
Signal transduction in TCS is via a phosphorelay and the minimal TCS, as the name suggests, is 
composed of two components, a membrane associated sensor histidine kinase (HK) and a 
ic response regulator (RR) (Figure 1. 11). The minimal HK is composed of three distinct 
ains; an extracellular or membrane embedded sensor or cytoplasmic domain that senses a 
specific environmental signal, a cytoplasmic phosphoacceptor domain and an ATP-dependent 
histidine kinase domain. The RR is a free cytoplasmic protein composed of a receiver domain and 
an output domain that once activated usually binds DNA to affect transcription and to elicit the 
appropriate cellular response (Lee et al., 2008b; Stock et al., 2000). Typically, the genes for the HK 
and the cognate RR are close to each other. But some bacteria show an orphan gene organization of 
TCS pairs, especially Myxococcus xanthus which contains 146 HKs and more than half are 
separated by two or more genes from RR genes (Mascher et al., 2006). 
cytoplasm
dom
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Figure 1. 11 A classical TCS. 
TCS comprises a membrane associated sensor and a cytoplasmic response regulator. In the sensor there is an N-terminal 
extracellular sensing domain (blue arrow) and a C-terminal cytoplasmic kinase domain (green rectangles). In the 
response regulator, there is an N-terminal receiver domain (green circles) and a C-terminal output domain (orange 
The H in the kinase domain represents the conserved His residue that is phosphorylated, while the D in receiver 
omain of RR presents the Asp residue that receives the phosphate from the HK. The output domain can regulate at the 
r with in t e membrane, such as turgor or solute gradients. 
arrow). 
d
level of transcription or post translation. The pathway is ATP dependent.   
 
 
Based on the biological function of signal transduction, >18,000 sensor kinases in the SMART 
database (http://smart.embl-heidelberg.de/) are classified so far into three major groups: 
periplasmic-sensing HKs, transmembrane-sensing HKs (TMHK), and cytoplasmic-sensing HKs 
(Figure 1. 12) (Mascher et al., 2006). The biggest group is periplasmic-sensing HKs including 
gram-positive bacteria which have no periplasm (extracellular HKs here are classified as 
periplasmic for simplicity). TMHK is the smallest group, which has high diversity, possessing 2 to 
20 transmembrane regions connected with very short intra- or extracellular loops (20-50 residues). 
TMHK lacks the obvious extracellular sensing domain of the first group (50-300 residues). Their 
stimuli are either membrane associated o h
Most sensors of gram-positive bacteria belong to this class. Cytoplasmic-sensing group are either 
free or with membrane-anchor proteins in cytoplasm. They detect the stimuli inside the cell, such as 
cell cycle, and cell development.  Some HKs are mixed periplasmic/cytoplasmic-sensing HK to 
detect additional stimuli. 
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Figure 1. 12 Three major groups of TCSs. 
A: Periplasmic-sensing HKs. B: Transmembrane-sensing HKs, with 2-20 transmembrane regions, either with short 
extracellular loops. C: Cytoplasmic-sensing HKs, either free or with membrane-anchor. The red arrow or red star 
presents the stimulus. The gray protein with Asp presents the RR. Cited from (Mascher et al., 2006). 
 
Periplasmic-sensing HKs comprise two regions: an N-terminal periplasmic sensing domain linked 
by TM helices on both sides (TM1 and TM2) and a C-terminal cytoplasmic transmitter domain 
(Figure 1. 11 and Figure 1. 12A). Usually, the binding of the sensor domain to a small extracellular 
ignalling molecule or interaction with a physical stimulus causes the activation of the HK, which 
arries out an ATP-dependent autophosphorylation of a special conserved histidine residue on the 
phosophoacceptor (Belcheva and Golemi-Kotra, 2008; Filippou et al., 2008). The phosphate is then 
transferred from the histidine to a conserved aspartate of the receiver domain of the RR. This 
phosphorylation event activates the output domain of the RR, usually via a conformational change 
(Whitworth et al., 2008).  This basic modular scheme allows adaption to a huge range of 
environmental signals by simply varying the sensory input domain, while the rest of the 
phosphorelay system remains highly conserved.  
 
This kind of classical organization can vary in the nature of the cytoplasmic linker region between 
 domain, or presence of an additional phosp orylation domain after the 
 prokaryotes and eukaryotes 
ly a result of gene duplication from the original TCS (Zhang and 
s
c
TM2 and the transmitter h
transmitter domain.  The latter complex systems involve multiple His-donors and Asp-receivers and 
form complex multistep phosphorylation pathways (Figure 1. 13). Both
have these complex TCS, although as expected they are more common in the latter (Appleby et al., 
1996). A phylogenetic study revealed that there was no common ancestor for complex TCS and that 
the additional domains were like
Shi, 2005). Normally, in gram-negative bacteria, components of complex HKs are in one peptide, 
while in gram-positive bacteria, such as B. subtilis, these components are individual (Figure 1. 13b). 
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Figure 1. 13 The diversity of TCS pathways.  
The HK and RR receiver are shown as green rectangles and green circles marked with His and Asp respectively, while 
the sensing input domains are blue arrows. Black arrows show the phosphate flow. Membranes are indicated as grey 
bars. Orange arrows represent the output domain of the RR. (a) The osmoregulatory EnvZ/OmpR system of E. coli is 
an example of ‘classical’ TCS. In such systems, phosphotransfer to the RR occurs in a single step (Si
Goulian, 2008). (b) The sporulation control system of Bacillus subtilis has two sensor HKs, one of which i
ryaporn and 
s free in the 
cy asm,, a cytoplasmic Asp containing phosphotransfer protein (APt) and a cytoplasmic cytoplasmic His containing 
, leading to a His–Asp–His–Asp relay. In this case, all domains form independent proteins 
topl
phosphotransfer protein (HPt)
(Weinrauch et al., 1990). (c) The osmoregulatory SLN1-YPD1-SSK1 system from yeast Saccharomyces cerevisiae has 
a three-step phosphorylation via a cytoplasmic HPt (Maeda et al., 1994). (d) The BvgAS/EvgAs system of Bordetella 
pertussis/E. coli has three-step phosophorylation as well, but the HPt is part of the same polypeptide as the membrane. 
associated HK (Beier et al., 1995).  (e) The TodST system of Pseudomonas putida has two HK domains and two Asp 
receiver domains, with the sensing domain after the first receiver domain. Cited from (Perraud et al., 1999). 
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1.2.3.2.1 Periplasmic-sensing HK sensor domains 
anism of periplasmic-sensing HKs is direct 
ical molecule (Janausch et al., 2002). In 
nd to, but functionally, they can be 
rouped as PAS, GAF, PBPb, CAHCHE and Reg_prop domains according to sequence alignment 
ascher et al., 2006).  
PAS domains were initially identified in the PER, ARNT, and STM proteins, which are very 
common sensory folds used in a lot of proteins, such as CitA, DcuS, and PhoQ (Cheung and 
Hendrickson, 2008; Sevvana et al., 2008; Tu et al., 2006). PASs sense light, redox potential, energy, 
oxygen, voltage, and small ligands and involve in protein-protein interactions (Ayers and Moffat, 
2008; Taylor and Zhulin, 1999; Zhulin et al., 1997). PAS domains are known to bind metal ions, 
heme, flavin, C4 dicarboxylates, and adenine, which are often duplicated. Generally, PAS domain 
has a β-scaffold and several α-helices and loops (Figure 1. 14). PAS may appear in the linker region 
between TM2 and HK as well. 
 
In the simplest cases, the signal detection mech
interaction between the sensor domain and a small chem
other cases, chemical stimuli interact with a periplasmic binding protein, which release or associate 
with the sensor of HKs to activate the systems such as VirA and PhoQ (Dathe and Wieprecht, 1999; 
Shimoda et al., 1993). When binding the stimulus, the conformational changes of sensor domain 
may be propagated into the TM helices, transducing the signal across the membrane. 
    
The sensor domains of periplasmic-sensing HKs have low sequence similarity among different 
systems, as expected due to the diversity of signals they respo
g
(M
 
 
 
Figure 1. 14 PAS structures 
The periplasmic domain PAS sensor histidine kinase CitA with the absence (left) and presence (right) of citrate shown 
as a monomer. This PAS sensor has a β-scaffold and several α-helices and loops around it. While ligand citrate bound, 
the scaffold and loops fold up to hold the citrate. Cited from (Sevvana et al., 2008).   
 33
GAF is a large family of small molecule binding domain, predicted to bind cyclic nucleotides, such 
onting, 1997; Ho et al., 2000). GAF could 
e looked as a subgroup of PAS. 
BPb is periplasmic binding protein (about 250 residues), which is periplasmic binding protein 
pp. and E. coli  respectively (Bantscheff et al., 
ononucleotide, and flavin adenine 
inucleotide in redox potential sensors, even though some PASs can function independently 
(Borgstahl et al., 1995; Christie et al., 1999; Gong et al., 1998; Soderback et al., 1998; Watts et al., 
2006). PAS could sense light, oxygen, and redox potential, and regulate many effectors: kinases, 
phosphodiesterases, and transcription factors (Crosson et al., 2003).  
 
1.2.3.2.2 Role of transmembrane region in signal transduction 
Little is known about the signal transduction mechanism via transmembrane helices mainly because 
of the constraints of a lipid bilayer (Matthews et al., 2006). α-helices are hard to compress and 
extend, so they could make a small change in the conformation of a long distance. Generally, there 
are five postulated models for transmembrane signalling: association, piston, rotation, scissor model, 
and see saw model (Ottemann et al., 1999) (Figure 1. 15A). A recent research revealed that the 2 
igure 1. 14B). 
as cGMP/cAMP. GAF has PAS-like fold (Aravind and P
b
 
P
homolog, such as BvgS and Evgs in Bordetella s
2000). PBPb are specific for polar amino acids and opines, which are normally found up to three 
repeats side by side in a single sensor domain of HKs (Tam and Saier, 1993).  
 
CACHE domains (Ca2+ channels, chemotaxis receptors; 150-300 residues) have been shown to be 
involved in small-molecule binding, such as amino acids in methylation, carbohydrates in 
phosphotransferase system, and dicarboxylates in nitrogen fixation (Garrity et al., 1998; Hanlon 
and Ordal, 1994; Reid and Poole, 1998).  
 
Reg_prop is a group of novel sensors found in B. thetaiotaomicron, which has more than 1000 
residues to form 14 tandem Reg_prop repeats which are predicted to be two seven-bladed β-
propellers (Pons et al., 2003). The function of these domains is unknown to date. 
 
So far all structurally resolved sensor domains belong to the PAS superfamily (Miyatake et al., 
2000; Pappalardo et al., 2003; Rajagopal and Moffat, 2003; Reinelt et al., 2003). The functional 
specificity of a PAS is associated with the cofactor, such as 4'-hydroxycinnamic acid in the bacterial 
photoactive yellow protein, a heme in the oxygen sensor, flavin m
d
transmembrane helices of a histidine kinase YycG from Bacillus subtilis form into piston model to 
complete the signalling process through a subtle alteration (Figure 1. 15B) (Szurmant et al., 2008). 
The piston model is predicted to happen in histidine kinase CitA as well (F
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Figure 1. 15 TM structure. 
A: The five postulated models for transmembrane signalling. The black lines are present α-helices in transmembrane 
domain from the side angle, while the cycles are present single helices from the angle of the top. The letters a, b, c, 
represent amino acids. Cited from (Ottemann et al., 1999). B: The TM structure complex YycG/H/I of Bacillus subtilis.  
The 4 transmembrane helices of two homodimer histidine kinase YycG (gray) were associated with two other 
transmembrane proteins YycH (yellow) and YycI (red-green-blue) to transducer the signal. The residues in YycI 
contacting with YycG are in orange sticks, while these contacting with YycH are in blue, and these free residues are in 
green. The signal stimuli from the extracellular domain to the TM complex YycG/H/I will be transmitted through by the 
subtle alteration of these proteins (Szurmant et al., 2008). 
 
1.2.3.2.3 Cytoplasmic domains of sensor HKs 
ytoplasmic transmitter domain 
f the HK is highly conserved and has two sub domains: the His-containing phosphoacceptor 
omain, which usually forms a homodimer, and catalytic (kinase) domain which carries out trans-
uto phosphorylation of the opposing monomer (Figure 1. 16). 
 
Sensor HKs belong to an ancient enzyme family which uses ATP as the phosphate donor (Saier, 
1993). The closest relatives are serine/threonine/tyrosine protein kinases, such as MAP kinase 
(Bourret et al., 1991). In a small group of HKs, the phosphorylated residue is Tyr or Ser instead of 
His (Elich and Chory, 1997; Wu et al., 1999; Yeh et al., 1997). The c
o
d
a
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Figure 1. 16 The structure of the cytoplasmic domains of a sensor HK.  
The cytoplasmic region of CheA sensor HK from Thermotoga maritima. PDB ID is 1B3Q (Bilwes et al., 1999). The 
monomer A rotates 90 degrees around monomer B to form a homodimer by a central four-helix bundle (yellow from 
monomer A and orange from B), which has a conserved histidine (purple sticks) separately. This is the His-containing 
phosphoacceptor domain. The ATP-dependent catalytic (kinase) domains are present in limegreen for monomer A and 
green for monomer B with ATP binding sites colored hotpink for A, and red for B.  
 
 
Some HK are bifunctional and play a role as a phosphatase as well. This kind of HK controls the 
phosphorylation level of its cognate RR which means it controls the signalling flow. The linker 
region between the TM2 and transmitter domain varies a lot in size, extent and function. HAMP or 
PAS domains are sometimes present as linkers. HAMP is helical domain of around 50 residues, 
originally found in histidine kinases, adenylyl cyclases, methyl-accepting chemotaxis proteins, and 
phosphatases (Aravind and Ponting, 1999; Fulop and Jones, 1999) (Figure 1. 17). The HAMP 
domain may be involved in signal transduction, possibly via rotation of its four α-helices (Hulko et 
al., 2006; Inouye, 2006). 
 
Figure 1. 17 HAMP structure. 
HAMP is usually about 50 residues, formed into four helices and acts a linker domain between the membrane and the 
cytoplasmic domains of the HK. PDB ID is 2ASW (Inouye, 2006). 
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1.2.3.2.4 Response Regulator (RR) domains 
Response regulators (RR) are usually free cytoplasmic proteins with two distinct domains; the N-
terminal receiver domain and the C-terminal output domain. The receiver domain accepts the 
phosphate from the HK on a conserved Asp. This event activates the associated output domain, 
usually by a conformational change, to elicit the appropriate cellular response, either at the 
transcriptional or post-translational level. RRs are analogous to Ras family members of eukaryotic 
small GTPases (Artymiuk et al., 1990). The structure of the N-terminal receiver domain is 
conserved due to its conserved function (Figure 1. 18) (Robinson et al., 2000). Phosphorylation 
changes the electrostatic effect of the conserved Asp less than other residues, and phosphor-Asp is 
the most stable phosphorylated residue, which has a half life of hours. This high energy bond 
between Asp and phospho group changes the conformation to the active form of the RR. The 
structure of C-terminal regulatory output domain varies according to the function (Galperin, 2006). 
Regulatory domains can bind DNA, RNA, protein, and even have enzyme activity. If the regulatory 
domain is a DNA binder, it normally has a helix-turn-helix (HTH) structure (Figure 1. 18b). In 
some cases, RRs have no attached regulatory domain, their mode of action may be different and 
involve more complex phosphorelay events (Stock et al., 1989). 
 
 
Figure 1. 18 TCS RR multidomains. 
The conformational changed area of receiver domain are colored blue, the unaltered regions are green. An Asp residue 
showing the ph
CheB (PDB I
osphorylation site is colored purple. The Output domain is yellow. A: The structure of methylesterase 
D 1A2O) (Djordjevic et al., 1998). B: The structure of nitrate response NarL (PDB ID 1A04) (Baikalov et 
al., 1998). The output domain is to bind to DNA, which has a helix-turn-helix structure. 
 
 
TCSs sometimes act in concert with sigma factors to co-regulate gene expression as a positive and  
negative switch (Yan et al., 2008).  The processes mediated by TCS make them a novel intervention 
in antimicrobial therapy (Filippou et al., 2008). TCSs can be used as drug targets because they are 
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not found in animals and often regulate important processes including virulence (Beier and Gross, 
2006). 
1.2.3.3 Hybrid two component systems 
As mentioned earlier B. thetaiotaomicron has large number of novel hybrid two component systems 
(HTCS) that comprise all of the domains of  a classical two component system in a single peptide 
(Figure 1. 19) (Sonnenburg et al., 2006). In all known HTCS the output domain is an AraC-type 
helix–turn–helix DNA-binding domain (HTH_AraC) (Figure 1. 19). HTH_AraC domains are 
usually involved in the activation of transcription of the genes under their control. The independent 
C-terminal domain of an HTCS could bind DNA, which suggests the HTCS may release the 
HTH_AraC to regulate the gene expression (Miyazaki et al., 2003). But the mechanism of how to 
terminate this regulation is unknown. 
 
B. thetaiotaomicron has 32 HTCS, which is more than any other sequenced organism. In B. 
thetaiotaomicron, the genes for many of these HTCS are linked to PULs containing SusC/D 
homologues as well as glycoside hydrolases and lyases. Therefore it is likely that the HTCS are 
rganism. involved in regulation of polysaccharide utilisation in this o
 
 
 
 
Figure 1. 19 Hybrid two component system. 
Cartoon representation shows the sub-domains of HTCS. The N-terminal periplasmic sensor domain displays the most 
sequence variation and is anchored in the inner membrane via two transmembrane regions (TM) that flank it’s N and C-
terminus (Sonnenburg et al., 2006). The other four domains, HisKA, HATPase_C, Response_reg, and HTH_AraC are 
conserved, and located in the cytoplasm. Cited from (Xu et al., 2004). 
 
 
Genome sequencing has revealed that HTCS occurs in a range of different species including  
Bacteroidetes, Proteobacteria, and Chloroflexi (Miyazaki et al., 2003; Sonnenburg et al., 2006). 
Bacteroidetes as the major organisms of HTCS are located in gut habitats and niches, which  
usually contain a lot of sensor regulators so they seem to be an adaption to minimise cross 
interaction. 
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1.2.4 Polysaccharide utilisation in Bacteroides thetaiotaomicron 
The only previously studied PUL is the starch utilisation system (sus) of B. thetaiotaomicron. The 
sus is composed of seven genes susABCDEFG controlled by a membrane associated transcriptional 
regulator known as SusR (Figure 1. 20) (D'Elia and Salyers, 1996; Hooper et al., 1999; Reeves et 
al., 1996; Reeves et al., 1997). SusR is a maltose dependent regulator which has an N-terminal 
sDEFG are thought to 
form an OMP complex to bind and degrade long-chain starch molecules, which are then transported 
sF are unclear, but they may also be involved in polysaccharide 
periplasmic input domain and a C-terminal helix-turn-helix DNA binding output domain, similar to 
any TCS-RR output domains. The susR gene is not regulated itself, but its product activates the m
expression of downstream sus genes in the presence of maltose or any higher oligomers. The susA 
gene belongs to a single transcriptional unit, while other members belong to a downstream operon, 
which suggested that the regulation of susA is different to other proteins. Indeed, the expression of 
susA is less than susB/C, and sensitive to the gene amount of susR (D'Elia and Salyers, 1996). SusA, 
SusB, and SusG display neopullulanase, α-glycosidase and α-amylase activities, respectively 
(Reeves et al., 1996). SusG is an extracellular lipoprotein that associates with the outer membrane, 
whereas SusA and SusB are periplasmic enzymes (Shipman et al., 1999). Su
via SusC. The roles of SusE and Su
binding in the complex as they are both found associated with the outer membrane (Shipman et al., 
2000). Interestingly, although SusC and SusD homologues are very common in the B. 
thetaiotaomicron genome, there are no SusE or SusF homologues, suggesting the role of these 
proteins is specific to starch utilisation. 
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Figure 1. 20 The relative locations of the sus genes of the B. thetaiotaomicron.  
ane complex that binds and actively transports starch binding into the cell. The 
nctions of SusE/F are unclear, but appear to be part of the SusC/D complex. Cited from (Koropatkin et al., 2008). 
SusR is the regulator of sus genes of B. thetaiotaomicron. SusA, SusB, and SusG are glycoside hydrolases that digest 
starch. SusC/D form an outer membr
fu
 
1.2.4.1 SusC 
The outer membrane provides a semi permeable layer that protects Gram negative bacteria from 
many environmental insults. Porins are β-barrel proteins that span the outer membrane and enable 
molecules to pass back and forth across this barrier (Figure 1. 21).  While small molecules (<~ 
600Da) can diffuse across passively, large molecules have to be actively transported, usually by 
utilising the energy provided by the inner membrane TonB complex (Braun et al., 2003a; Koebnik 
et al., 2000; Walzer et al., 2008). SusC is an energy dependent β-barrel porin that is thought to 
actively transport the polysaccharide across the outer membrane (Koropatkin et al., 2008; Reeves et 
al., 1996). 
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Figure 1. 21 Some known structures of β-barrel membrane proteins. 
Cited from (Kleinschmidt, 2005). 
 
Based on the protein database, an alignment of SusC to other OMPs revealed that SusC has high 
sequence similarity to a group of OMPs at a region of 60 amino acids, which is believed to be a 
domain to stabilize OMPs in the outer membrane (Figure 1. 22) (Reeves et al., 1996). These OMPs 
function into energy-dependent iron or vitamin uptake, such as the ferrichrome receptor FhuA of E. 
coli.  
 
Figure 1. 22 Conserved domain alignment of SusC to other OMPs. 
The alignment shows the conserved region of 60 amino acid of a group of OMPs including SusC. The similarity to 
SusC is: 1) 82 % to CsuF (OMP of B. thetaiotaomicron for chondroitin sulfate utilisation) (Cheng et al., 1995); 2) 60 % 
to IrgA (iron-regulated OMP of Vibrio cholerae (Goldberg et al., 1992); 3) 66 % to BtuB (the vitamin B12 receptor of E. 
coli.) (Heller and Kadner, 1985), 4) 62 % to FepA  (enterochelin receptor of E. coli) (Rutz et al., 1992), 5) 59 % to CirA 
(the colicin I receptor of E. coli) (Nau and Konisky, 1989), 6) 62 % to IutA (the ferric-aerobactin receptor of E. coli) 
(Thomas and Valvano, 1992), 7) 61 % to FhuA (the ferrichrome receptor of E. coli) (Coulton et al., 1988), 8); 63 % to 
) (Dean and Poole, 1993). Cited from (Reeves et al., PfeA (the ferric enterobactin receptor of Pseudomonas aeruginosa
1996). 
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1.2.4.2 SusD 
SusD is an outer membrane lipoprotein that is anchored in the membrane via a lipid linker 
covalently attached to an N-terminal cysteine. Recent data have shown that SusD is a novel form of 
carbohydrate-binding protein that binds directly to starch and maltooligosaccharides (Koropatkin et 
l., 2008). The structure of SusD reveals that it forms a novel, mainly α-helical fold (Figure 1.25). 
, an inner 
embrane protein from Pseudomonas aeruginosa involved in pilus formation that also consists of a 
number of TPR motifs (Kim et al., 2006). The carbohydrate binding site is composed of a number 
urface of the protein that matches 
e helical fold of starch. Thus the protein seems to specifically recognise the three-dimensional 
h the 
a
Eight of these helices pack together a four tetratricopeptide repeat (TPR: a versatile all-helical 
structural motif) units even though SusD was not predicted to have any TPR motifs as it does not 
contain the amino acid signature of W4-L7-G8-Y11-A20-F24-A27-P32 (D'Andrea and Regan, 2003). 
TPRs are most commonly involved in protein-protein interactions, a fact that has significance with 
SusD as it is suspected to form a complex with SusC. The closest homolog of SusD is PilF
m
of exposed aromatic residues that form a curved pocket on the s
th
structure of the polysaccharide rather than its component sugar molecules. It is thought that SusD 
initially binds the polysaccharide and somehow targets it to the SusC porin, althoug
mechanistic details of this interaction are unknown. The gene knockout analysis of SusD revealed 
the essential role in growth on maltooligosaccharides >5 glucose units, such as maltohexaose 
(Sonnenburg et al., 2006).  
 
Figure 1. 23 SusD structure. 
SusD has 22 α-helices (cyan) and 3 sets of two-antiparallel β shee
ligand maltoheptaose is colored blue. PDB ID is 3CK9 (Koropatk
ts (purple). Calcium is shown as green ball, while the 
in et al., 2008). 
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 B. thetaiotaomicron possesses 101 pairs of SusC/SusD (Xu et al., 2003). Four other human gut-
associated sequenced Bacteroides species, B. distasonis ATCC 8503, B. vulgatus ATCC 8482 B. 
fragilis NCTC9343, and B. fragilis YCH46 have an additional 269 pairs (Xu et al., 2007). These 
pairs also are present in soil and marine Bacteroidetes, such as Cytophaga hutchinsonii, 
Croceibacter atlanticus, Gramella forsetii, and Leeuwnhoekiella blandensis (Bauer et al., 2006; 
Cho and Giovannoni, 2003; Pinhassi et al., 2006). These pairs are linked to glycoside hydrolases 
and polysaccharide lyase to form PULs that target specific polysaccharides.  
1.2.5 Glycoside hydrolases 
Glycoside hydrolases (GHs) are enzymes which hydrolyse the glycosidic bond. The International 
Union of Biochemistry and Molecular Biology (IUBMB) Enzyme nomenclature of GHs (EC 3.2.1.-) 
is mainly based on the substrate classification which could not reflect the structural specificity and 
mechanism of these enzymes (Bairoch, 2000). A different classification of GHs based on amino 
acid sequence similarities has been established, which describes more details of the structural 
features of GHs, evolutionary relationships and mechanisms (Henrissat and Bairoch, 1993). The 
Carbohydrate-Active Enzymes database (CAZy: www.cazy.org) provides the list of the GH families. 
There are presently 114 families in CAZy database. Because the folds of enzymes are conserved, 
some families present similar fold configuration, which are grouped in larger superfamilies known 
as clans. For example families 1, 2, 5, 10, 17, 26, 30, 35, 39, 42, 50, 51, 53, 59, 72, 79, 86, and 113 
belong to clan GH-A, because they all adopt the (β/α)8 fold. There are currently a total of 14 clans 
(A-N) (Figure 1. 24). 
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Figure 1. 24 R of GH cl
res ydrol β stra n in yellow, α 
helices in red a
sually GHs hydrolyse the glycosidic bond using two catalytic residues: a general acid (proton 
donor) and a nucleophile/base, com  A u. Hydrol rs with either overall 
retention or inversion of the config ion at t
(Figure 1. 25). In both mechanisms proton hyd nding distance of the 
glycosidic oxyg h is proton by this reta s, the nucleophile is 
close to the sugar anomeric carbon.  distanc n do nucleophile/base is ~ 
5.5 Å. The nucleophile/base binds to the anome rm a glycosyl-enzyme intermediate. 
The sugar is released from  by a sec olecule 
and the anomer esents the same ster s befo  inverting GHs, 
 are ~ 10 Å, which must harbor a water molecular between 
olecule mediates the protonation and nucleophilic 
pposite stereochemistry of the anomeric carbon. 
ibbon representation shows example structures 
entations show the diversity of folds of glycoside h
nd loops are in green.  
ans. 
ases clans A-N. Cartoon rep nds are show
 
 
U
monly an sp or a Gl ysis occu
urat he anomeric carbon (Davies and Henrissat, 1995) 
, the  donor is within rogen-bo
en, whic ated acid catalyst. In ining GH
 The e between proto nor and 
ric carbon to fo
 the enzyme ond nucleophilic substitution of a water m
ic carbon pr eochemistry a re cleavage. In
the distance of the two catalytic residues
the base and the anomeric carbon. This water m
substitution to achieve an o
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Figure 1. 25 Mechanism of retaining and inverting. 
A: The retaining mechanism. The glycosidic oxygen is protonated by the acid catalyst AH, while the anomeric carbon 
is nucleophilic substituted by a nucleophile/base B-. This anomeric carbon is then nucleophilic substituted by a water 
molecule. Finally, this anomeric carbon keeps the same stereochemistry as before cleavage. B: The inverting 
mechanism. The protonation of the glycosidic oxygen and nucleophilic substitution of the anomeric carbon are 
achieved by the attack of a water molecule and change the stereochemistry of the anomeric carbon. Cited from (Davies 
and Henrissat, 1995). 
 
 
Glycoside hydrolases ac r a de nerally, endo-acting GHs 
contain an open groove w  r ha ains and cuts to release a mixture 
 G monly bind the terminal sugar 
residues of oligo and polysaccharides via a pocket-like active site and only release a single product 
 (Hovel et al., 2003; Pell et al., 2004) (Figure 1. 26). 
sivity 
(Figure 1. 26C) (Divne et al., 1998). These exo-processive enzymes release cellobiose from the 
ose chains while remaining firmly bound the substrate (Davies et al., 1997; 
t via eithe n endo or exo mo  of action. Ge
hich binds andomly to the sacc ride ch
of different size oligosaccharides, while the exo-acting Hs com
from the chain end - usually a monosaccharide
A variation on the pocket topology for exo activity is provided by cellulases from families 6 and 7 
bind polymeric substrates threaded through a tunnel, which provides the conditions for proces
reducing ends of cellul
Rouvinen et al., 1990). Processivity may be the key mechanism for the biological digestion of 
insoluble microcrystalline cellulose (Davies and Henrissat, 1995). 
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Figure 1. 26 Structural features of endo and exo-acting GHs. 
A: Endo-acting 
Enzyme shown i
GH with open cleft active site enabling the enzyme to bind randomly to the polysaccharide chain. 
s Xylanase10C mutant E385A from Cellvibrio japonicus in complex with xylopentaose. PDB ID is 
1US2 (Pell et al., 2004). B: Exo-acting GH which binds sugar in a pocket like active site and releases monosaccharide 
rabinofuranosidase (GH family 51) 
8 (Hovel et al., 2003). C: Exo-
This 
in the densely populated niche of the large intestine. 
 
from the chain end of polysaccharides and other glycans. The enzyme shown is α-L-a
from Bacillus stearothermophilus in complex with Ara-α1, 3-Xyl. PDB ID is 1QW
processive enzyme with tunnel-like active site. The enzyme shown is cellobiohydrolase I from Trichoderma reesei in 
complex with a cellulose chain. PDB ID is 5CEL (Divne et al., 1998). 
 
 
 
B. thetaiotaomicron contains 226 glycoside hydrolases which belong to 42 families in the Cazy 
database and encode a wide range of different activities (Figure 1. 27). This number of GH genes 
exceeds that found in any other sequenced bacterium, and any other human gut habitants. 
capacity enables B. thetaiotaomicron to digest a range of plant and host derived glycans and likely 
contributes to its ability to dominate 
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Figure 1. 27 B. thetaiotaomicron glycoside hydrolase family distribution.  
Cited from www.cazy.org/geno/226186.html.  
 
1.2.6 Other systems employed by bacteria for carbohydrate utilisation 
There are other ways for bacteria to obtain and degrade polysaccharides mainly from plant cell wall. 
The aerobic soil saprophyte Cellvibrio japonicus secretes complex modular enzymes into the 
nvironment (DeBoy et al., 2008). Anaerobic bacteria such as Clostridium thermocellum could 
produce multi modular e o the outside of the cell 
(Bayer et al., 2004). Both these two mechanism  use enzymes containing multiple carbohydrate 
 CBM families 
entified to date contain bacterial proteins, which may be because they are required to access the 
Specifically these are:  
ransmembrane signalling systems from B. 
thetaiotaomicron; 
f B. thetaiotaomicron activated 
y fructans: BT1759, BT1760, BT1765, and BT3082; 
e
nzyme complex (cellulosomes) to secrete or attach t
s
binding modules (CBM) belonging to the same or different families. 40 of 52
id
recalcitrant celluloses and hemicelluloses of the plant cell wall. B. thetaiotaomicron has just 25 
CBMs suggesting that it does not access the same polysaccharides. 
1.3 Objectives of this study 
The main objectives of this project are to structurally and functionally characterise components of 
the polysaccharide utilisation system of B. thetaiotaomicron. 
1. Study the level of interaction amongst several t
2. Understand the mechanism of signal perception in BT1754 HTCS and identify the signalling 
molecule that activates this system; 
3. Characterise the enzymic activities of the four GH32 members o
b
4. Characterise recognition of polysaccharides by the SusD homolog BT1762. 
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 Chapter 2 Materials and Methods 
2. cterial
Th terial stra  study are listed in Table 2.1 and Table 2.2. 
 
Str Use Reference 
1 Ba  strains and plasmids 
e bac ins and plasmids used in this
ain Description 
BL21(DE3) F’ ompT, hsdSB (rB-mB), gal.dcm. (DE3) Protein expression  (Studier and Moffatt, 1986) 
XL1-Blue recA1,endA1,gyrA96,thi1,hsdR17, supE44,relA1,lac,[F’proABlacqZ∆15,Tn10,(tetr)] 
DNA 
manipulation  Stratagene 
Tuner(DE3) F’ompT, hsdSB (rB-mB), gal, dcm, lacY1(DE3) Protein expression Novagen 
B834 F¯ompT hsdSB (rB¯mB¯), gal dcm met (DE3) Protein expression Novagen 
Origami™ 
B 
F- ompT hsdSB(rB- mB-) gal dcm lacY1 ahpC 
gor522:: Tn10 trxB (KanR, TetR) Protein expression Novagen 
Origami 2 
(DE3) 
(ara-leu)7697 l
ahpC galE galK r
acX74 phoA PvuII phoR araD139 
psL F′[lac+ lacIq pro] (DE3) 
gor522::Tn10 trxB (StrR, TetR) 
Protein expression Novagen 
C41 
Protease deficient strain of BL21 (DE3) lysogen with 
a tighter c n prot n BL21 
(DE3), pe e exp xic oteins 
under con  T7 p h IP
Protein expression 
and DNA 
pulation 
(Miroux and Walker, 1996) ontrol ormits th
ein expression tha
ression of more to pr
TG. manitrol of a romoter wit
JM83(DE3) recA-,(DE3)ara, ∆(lac-proAB), rspL, φ xpression  80, lac∆M15 Protein e
TOP-10 
F- mcrA ∆(mrr-hsdRMS-mcrBC) ±80l
∆lacX74 recA1 endA1 ara 39 ∆(ara 697
galU galK L nu manipulation 
Invitrogen 
acZ∆M15 
, leu)7  DNA D1
pG tonA hsdR   ∆λ- rps
Table 2. 1 E. coli strains in this study
) Genotype Supplier 
. 
 
 
Plasmid Size (kb
pET21a 5.5 Ampr T7 lac laclq Novagen 
pET22b 5.5 Ampr T7 lac laclq Novagen 
pET28b 5.37 Kanr, T7 lac laclq Novagen 
pET32b 5.9 Ampr T7 lac laclq Novagen 
pET39b 6.1 Kanr T7 lac laclq Novagen 
pCR® Blunt 3.5 Kanr, Znr, ccdB Invitrogen 
minipRSET-A 2.9 Ampr N-His Invitrogen 
minipRSET-Trx 3.2 Ampr N-His-Trx Invitrogen 
pGEX_6P_1 4.9 Ampr N-GST GE Healthcare 
Table 2. 2 List of plasmids used in this study. 
More details about plasmids are in Appendix C. 
2.2 Growth media 
Two differe
TM
nt media were used in this study, LB with or without agar, and Se-Met medium from 
thenaES  for crystallization using selenomethionine (se-met) instead of methionine in proteins 
when expressed in B834 cell strain (Table 2. 3). 
A
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Medium Composition for 1 litre 
10 g acto®tryptoneB  
5 g cto®yeast exBa tract 
10 g aCl N
Lurie-Bertani 
medium 
The as adjusted to 7 he final volume was made up to 1 litre before 
autoclavi g. 
pH w .4 with NaOH and t
n
LB solid medium In L ertani Medium,  final concentration 1.5 % and autoclave at 121 oC for 20 
min. 25 ml into a φ90 h until setting. Keep at 4 oC. 
urie-B add agar to
 Pour  mm sterilized Petri dish and put on benc
Se-Met medium Commercial medium, used for B834 cell strain. 
Table 2. 3 Growth media used in this study. 
ective media 
The β-lactam antibiotics  am  inhibiting the formation of peptidoglycan 
cross-links in the bacterial cell wall, while kanamycin works by affecting the 30S ribosomal subunit 
and preventing the translation of RNA re used at 1000 
fold dilution of stock solutions as given in Table 2. 4; they were added to the sterilized growth 
oC. 
2.3 Sel
(such as picillin) work by
 (Garrod and al., 1981). These antibiotics we
medium once it had cooled to ~50 
 
Antibiotic Stock concentration Storage details 
Ampicillin 50 mg ml-1 in water -20 oC 
Kanamycin 50 mg ml-1 in water -20 oC 
Table 2. 4 Antibiotics used in growth media. 
2.4 Chemicals, enzymes and kits 
Chemicals, enzymes and kits are listed in Appendix A. The water used in this study was double 
distilled and purified to 18.2 Ω with a Millipore Milli-RO 10 Plus Water Purification System. 
2.5 Sterilisation 
er an Astell Hearson 
000 Series Autoclave or a Prestige® Medical series 2100 Clinical Autoclave at 121 oC, 15l b in-
sterilized using an 0.25 µm pore Millipore 
lter disc (Supor® Acrodisc® 3.2, Gelman Sciences) and a suitable sterile syringe 
(Plastipak®,Becton Dickinson). 
2.6 Storage of D d bacteria 
Bacterial cells were stored at -80 oC in 25 % (v/v vials. Bacterial colonies on agar 
plates were stored at 4 C for a maximum of four w oC in Elution 
Buffer (EB, 10 mM Tris/HCl buffer, pH 8.5). 
Solutions, media, and glassware were usually sterilized by autoclaving in eith
2
2(psi) for 20 min. When necessary, solutions were filter 
fi
NA an
) glycerol in cryo-
o eeks. DNA was stored frozen at -20 
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2.7 Centrifugation 
2.8 Chemical competent E. coli 
E. coli strains were made competent for uptake of plasmid DNA using calcium chloride in a 
f LB (without antibiotic) in a 1-litre non-baffled flask. The culture was 
tating at 180 rpm until log phase was 
600 ted by centrifugation 
 
2.9 Transformation of chemical competent E. coli 
Transformation was carried out as follows: 100-500 ng of the plasmid DNA to be transformed was 
mixed with 50 µl chemically competent E. coli cells in 1.5 ml Eppendorf tubes by gentle swirling 
and incubated on ice for 10 min. The cells were heat shocked by incubation in 42 oC for 2 min and 
immediately returned to the ice for 2 min. The cell was then added 0.3 ml LB Medium and incubate 
at 37 oC for 1 h with 180 rpm shaking. The transformed cells were spread onto LB agar plates 
containing the appropriate antibiotics. Plates were inverted and incubated at 37 oC for 16 h. 
2.10 Purification of DNA 
DNA was replicated by transformation of the plasmids into XL1-Blue cells or TOP10 cells and 
selective LB agar plates (Clark, 1968; Joseleau-Petit et al., 1987; 
 was purified from a small scale (5-10 ml LB) culture 
Harvesting of bacterial cells from cultures of 50-1000 ml was carried out by centrifugation at 5, 000 
g for 10 min in 500 ml centrifuge tubes (Nalgene) using a Beckman J2-21 centrifuge with a JA-10 
rotor. Bacterial cells from culture volumes 5-10 ml were harvested in 30 ml Sterilin universal 
container at 3, 000 g in a MSE Mistral 3000i bench centrifuge with a swing out rotor. 
Centrifugation of small volumes was carried out in 1.5 ml tubes (Treff) at 13, 000 g in a Haraeus 
Instruments Biofuge pico. 
variation of the method described by Cohen (Cohen et al., 1972). 
 
A 1 ml aliquot of a 10 ml culture of E. coli grown overnight in LB with appropriate antibiotic was 
used to inoculate 100 ml o
incubated at 37 oC with aeration in a shaking incubator ro
reached (OD  -0.4). After incubating for 10 min on ice, the cells were harves
at 5, 000 g at 4 oC for 5 min. The supernatant was removed and the cells were gently resuspended 
with a pipette in 8 ml of ice cold 100 mM MgCl2.The cells were harvested again and resuspended in 
4 ml ice-cold 100 mM CaCl2. After keeping on ice for 2 h, the cells were available to be used 
immediately or stored at -80 oC in 100 µl aliquots with 15 % (v/v) glycerol in 1.5 ml cryovials 
(Eppendorf).
growth of colonies on 
Khachatourians and Huzyk, 1974). The DNA
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using Qiagen® Plasmid mini kit according the manufacturer’s instructions. 
ere produced using oligo 2000 synthesis technology and purified using HPSF® 
purification (MWG-Biotech AG, Germany). Oligonucleotide primers were designed such that 
lly 20 - 40 bases in length having a G/C content of 
o o
2.11 Primers  
All primers used w
complementary sequences were norma
approximately 40 % and a melting temperature (Tm) of ≥45 C and within 5 C for the primer pair. 
Tms were calculated using the “Oligonucleotide Properties Calculator” at the 
http://www.basic.northwestern.edu/biotools/oligocalc.html which uses the following calculation: 
 
Tm=64.9 + 41*(yG +zC -16.4)/(wA +xT +yG +zC) 
 
Where w, x, y, z are the number of the bases A,T,G,C in the sequence, respectively. 
 
If possible, primers were also designed such that one or two G or C bases at both ends of the 
primers, so that the primers termini anneal well to the template strand. When required restriction 
site sequences were added to 5’-ends of primers with the addition of the sequence CTC at the 
extreme 5’-end to allow for cutting of the PCR product for ligation into appropriate vectors. Primers 
double distilled water to 100 µM, freeze-thawed to ensure full 
-1
PCR requires two oligonucleotide primers, one complementary to each strand of the DNA molecule, 
NA to be amplified. A thermostable DNA polymerase catalyses the 
were dissolved in sterile 
solubilization and then an aliquot was diluted to 125 ng µl . 
2.12 Polymerase chain reaction (PCR) 
The polymerase chain reaction (PCR) developed by Mullis and Faloona (Mullis and Faloona, 1987) 
was used throughout this study to amplify specific regions of B. thetaiotaomicron VPI-5482 
genome DNA (125 mg/ml), and to introduce amino acid mutations. 
 
at sites that flank the region of D
synthesis of the complementary DNA strand in the presence of dNTPs. 
 
PCRs were performed in sterile 0.2 ml or 0.5 ml Eppendorf tubes with a final 25 µl or 50 µl volume 
as Table 2. 5. 
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 e active 
e is high enough. The KOD polymerase prevents 
PX2 (Hybaid). The standard PCR 
 was as Table 2. 6. 
Table 2. 5 General PCR working system. 
 
The PCR enzyme was KOD Hot Start DNA polymerase, which has an antibody bound at th
site which would be displaced when the temperatur
DNA synthesis before the primers are annealed. It also moves fast (106-138 bases/s) with low 
mutation frequency. The PCR machine utilised in this study is 
program
 
Step 1 95 oC for 1 min 
1. 95 oC for 30 sec 
2. 50 oC for 40 seconds 
Step 2 32 cycles 
3. 68 oC for 1 min/kb in each cycle 
Step 3 68 oC for 10 min 
Step 4 5 oC for 24 h 
Table 2. 6 General PCR programme. 
2.13 Site directed mutagenesis 
e) allows site-specific mutation in 
anufacturer’s instructions 
fully complemented the DNA template. A high fidelity proof reading DNA 
polymerase PfuTurbo was u i ked plasmid containing the 
 ml Eppendorf tubes to a final volume of 40 
or site-directed mutagenesis was described in 
1 µl TP mixdN  (100 mM) 
1 µl 50 µM fo
1 µl 0 µM re
~60 n A tem
1 µl DNA poly
5 µl eacti  8.8, 20
1 mg ml
rward oligonucleotide primer 
5 verse oligonucleotide primer 
g DN plate 
merase (2.5 U  µl-1) 
10x r on buffer (200 mM Tris/HCl, pH
on® X-100, 
 mM MgSO4, 100 mM KCl,  
-1100 mM (NH4)2SO4, 1 % Trit  BSA) 
                            Add sterilized ddH2O to 50 µl 
QuickChangeTM Site-Directed Mutagenesis Kit (Stratagen
virtually any double-stranded plasmid and was used according the m
(Kunkel, 1985; Sugimoto et al., 1989; Taylor et al., 1985). 
 
The site-directed mutagenesis method utilised an appropriate double-stranded recombinant plasmid 
DNA and two synthetic oligonucleotide primers containing the designed mutation flanked by 10-15 
nucleotides that 
sed to extend the pr mers generating a nic
desire mutation. Reactions were made up in sterile 0.2
µl as shown in Table 2. 7. The amplification program f
Table 2. 8. 
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20 ng  dsDNA template 
125 ng Oligonucleotide primer #1 
125 ng Oligonucleotide primer #2 
5 µl 10x reaction buffer 
1 µl dNTP mix 
1 µl PfuTurbo DNA polymerase (2.5U µl-1) 
                                    Add sterilized ddH2O to 50 µl 
Table 2. 7 Mutation PCR reactio
 
n system. 
Step 1 95 oC for 1 min 
1. 95 oC for 30 sec Step 2 16 cycles 
2. 50 oC for 1 min 
3. 68 oC for 2 min/kb of plasmid length in each cycle 
Step 3 68 oC for 10 min 
Step 4 5 oC for 24 h 
Table 2. 8 Mutation PCR programme.  
 
After completion of the amplification reaction, 1 µl of DpnI (10 U) was added to each tube and 
n down briefly and incubated at 37 
C for 1 h. The DpnI digested the methylated template dsDNA specifically, not the unmethylated 
A before and after DpnI digestion was analysed by agarose gel 
rried out by 
electrophoresis through submerged horizontal agarose gels (Meyers, 1975).  
mixed gently by flicking several times. The mixtures were spu
o
amplified DNA. An aliquot of DN
electrophoresis to determine the quality of DNA produced. Digested reactions were then 
transformed into E. coli competent cell TOP10. The in vivo plasmid replication resulted in a closed 
plasmid. 
2.14 Agarose gel electrophoresis of DNA 
The separation and determination of the sizes of DNA molecules were ca
 
The related buffers and reagents are given in Table 2. 9. 
 
Buffer Ingredient 
8.9 mM  Tris base 
8.9 mM  Boric acid 
Electrophresis Buffer-TBE 
(pH 8.3) 
2 mM EDTA pH 8.0 
0.25 % (w/v) Bromophenol Blue 
50 % (v/v) Glycerol 
DNA loading buffer 
10x TBE 
Table 2. 9 DNA agarose gel running buffer and loading buffer.  
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Agarose (1 % w/v) was boiled in 50 ml 1x TBE buffer until fully dissolved. After cooling to ~60 oC, 
the gel was mixed with 5 µl 0.5 µg/ml ethidium bromide solution and then poured into a mini gel 
 and end-plates inserted. After setting, 50 ml 1x TBE buffer was 
comb and end-plates removed. The DNA samples were loaded with 
2.15 Visualisation of DNA and photography of agarose gels 
 to visualise the DNA under UV light. DNA gel photographs 
ular Analyst™/PC 
.16 Determination of DNA fragment size 
in
apparatus with a suitable comb
poured on top of the gel and the 
1/10th volume DNA loading buffer. Electrophoresis was conducted with a constant voltage 60 V 
(LKB Bromma 2197 Power Supply) for approximately 45 min, when a 500 bp fragment would 
migrate the 4/5 full length of the gel. 
Ethidium bromide staining was used
were produced using a gel documentation system (Bio-Rad Gel Doc 1000, Molec
Windows Software and were printed by Mitsubishi Video Copy Processor (Model P68B) with 
Mitsubishi thermal paper. 
2
The size of lineal double stranded DNA molecules can be determ ed because the rate of migration 
through gel matrices is in effect inversely proportional to the log10 of the size of the nucleic acid. 
Therefore, the sizes of DNA fragments were determined by comparing their electrophoretic 
mobility with that of the DNA standards of known sizes. The standard markers used are shown in 
Figure 2. 1. 
 
Figure 2. 1 DNA standards. 
The DNA markers are from 10 kb to 200 bp. 
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2.17 DNA extraction from agarose gels 
DNA was isolated from agarose gels with a razor blade and purified using the Perfectprep® Gel 
Cleanup Kit (Eppendorf) following the manufacture’s protocol (Downey, 2003; Matitashvili and 
Zavizion, 1997).  
2.18 DNA digestion, ligation 
Digestion of double strand DNA with restriction endonucleases was carried out as directed by the 
manufacturers (MBI Fermentas). Endonuclease restriction sites were identified using the tool on-
line at http://rna.lundberg.gu.se/cgi-bin/cutter2/cutter (Bulow and Mosbach, 1982). 
 
The required amount of DNA was mixed with the appropriate volume of 10 x concentrated reaction 
buffer. Endonuclease was then added at 5 -10 units µg-1 DNA and the digest incubated at 37 oC for 
2 h (one unit is the amount of enzyme sufficient to digest 1 µg DNA in 1 h). For double digestions 
where both enzymes retained activity and specificity in the same reaction buffer the reactions were 
carried out simultaneously. When the reaction conditions for two restriction enzymes were 
 the 
 
l 
, and 
ormed to competent 
incompatible the DNA was digested with one endonuclease, the buffer removed with
Perfectprep® Gel Cleanup Kit (Eppendorf), and DNA was then digested with the other 
endonuclease. Controls of undigested and single endonuclease-digested DNA were also carried out. 
 
DNA fragments with cohesive ends were mixed to a final 3:1 insert:vector ratio, while for DNA
molecules with blunt-ended termini, the ratio was at least 10:1. The reaction mixture included 1 µl 
5X ligation buffer (250 mM Tris/HCl, pH 7.6, 50 mM MgCl2, 25 µM ATP, 25 mM dithiothreito
(DTT), 25 % (w/v) polyethylene glycol 8000), 1 µl 5U T4 ligase (Invitrogen), insert, vector
water up to 5 µl. Ligation was performed at 16 oC for 2 h before 2 µl was transf
XL1-Blue E. coli cells (Stratagene) or TOP10 E. coli cells (Invitrogen) following the 
manufacturer’s instructions.  
2.19 DNA Sequencing 
DNA sequencing was conducted using the Value Read service from MWG Biotech AG, Ebersberg, 
Munich, Germany using ABI 3700 sequencers and Big dye technology (Applied Biosystems) 
(Hagemann and Kwan, 1999), each clone was sequenced in both the forward and reverse direction. 
Plasmid DNA (5 µl) was dried by vacuum lyophilization at room temperature in 1.5 ml tube. 
Plasmids were then sequenced with appropriate primers listed as Table 2. 10. 
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Plasmid type Forward primer Reverse primer 
pET plasmids T7:  
TAATACGACTCACTATAGGG 
T7 Term: 
CTAGTTATTGCTCAGCGGT 
pCR® Blunt M13 uni (-21): M13 reverse (-29): 
TGTAAAACGACGGCCAGT CAGGAAACAGCTATGACC 
pGEX-6p-1 pGEX forward: 
ATAGCATGGCCTTTGCAGG 
pGEX reverse: 
GAGCTGCATGTGTCAGAGG 
minipRSETA T7:  T7 Term: 
TAATACGACTCACTATAGGG CTAGTTATTGCTCAGCGGT 
minipRSET-Trx T7:  
TAATACGACTCACTATAGGG 
T7 Term: 
CTAGTTATTGCTCAGCGGT 
Table 2. 10 Commercial primers for sequencing. 
The sequencing results were analysed using the DNAStar software (section 2.42.8). Configurations of multiple 
sequencing reactions, combining both sense and anti-sense directions, were generated and aligned with the wild type 
sequence using the CLUSTALW2 (section 2.42.9). Conflicts were resolved by reference to the sequencing trace. 
Nucleotide sequence was translated into amino acid sequence to ascertain the effect on the primary structure.  
2.20 Purification of DNA by phenol 
The removal of any impurities from DNA solutions was carried out when necessary by extraction 
ith phenol and chloroform (Bewsey et al., 1991). 
r 5 min, 
with an equal volume of chloroform. DNA was precipitated from the aqueous layer by the addition 
M sodium acetate, pH 5.2, and 2.5 volumes of ethanol (100 % v/v), followed by 
l-1 gives an A260 = 1.0 
2.22 Protein over expression in E. coli 
Fresh colonies of E. coli containing expression plasmids were picked from plates and inoculated 
into 5-10 ml LB containing appropriate antibiotics and grown at 37 oC for ~16 h with 180 rpm 
shaking. The resultant cultures were then diluted 100-fold into 1 l fresh LB with appropriate 
w
 
An equal volume of phenol/chloroform (1:1) mixture was added to the DNA solution and mixed by 
vortexing. The organic and aqueous phases were separated by centrifugation at 13, 200 g fo
and the upper DNA-containing aqueous phase was transferred to a fresh tube then extracted again 
of 0.1 volumes of 3 
incubation at -20 oC for approximately 16 h. After centrifugation, the DNA pellet was washed in 70 
% (v/v) ethanol, allowed to air-dry and resuspended in an appropriate volume of sterile double 
distilled water.  
2.21 Determination of DNA concentration 
DNA concentration was determined either by estimation from comparison of band size /intensity 
compared to quantified DNA ladders when electrophoresed on agarose gels or by scanning the 
absorbance of the appropriately diluted DNA (in MQ water) between 230 nm and 340 nm using a 
spectrophotometer (GE Ultrospec 4000 and 4300) (Hirschman and Felsenfeld, 1966; Skidmore and 
Duggan, 1966): 
dsDNA at 50 µg m
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antibiotics in 2 l baffled flasks and cultured at 37 oC to OD600 ~0.6-0.8. The cultures then were 
transferred to an incubator at the appropriate temperature and induced with required amount of 
isopropyl- toside (IPTG) for protein expression (Golomb and Chamberlin, 1974; 
Studier an d at this temperature for the necessary length 
of time before the cells were harvested by centrifugation at 5, 000 g at 4 C for 10 m
 
Recombin  was prepared from either the periplasmic, cell free extract or insoluble 
fractions as detailed below.  
2.23 Pr
The cell p  20 ml per l of culture of ice-cold 20 mM Tris/HCl buffer, 
pH 8.0, containing 25 % (w/v) sucrose on ice and centrifuged at 5, 000 g for 10 min at 4 oC to 
remove cell debris. The supernatant comprises the periplasm. An aliquot of the periplasm, 
supernatan  SDS-PAGE to deter  the success of the 
protein expression and the purity of the protein in the periplasmic fraction ( l., 1998).  
2.24 Pr l free extracts (CFEs) 
2.24.1 H
 mM Tris, 300 mM NaCl, pH 8.0) 
nd stored in Sterilin tubes for 16 h at -20 oC. After thawing, the cell suspension was sonicated for 2 
8 M urea. 
2.24.2 GST tagged protein 
2.7 mM KCl, 10 mM Na2HPO4, 
s for storing at -20 oC. After thawing, the 
cell suspension was sonicated as His tagged protein. The cell debris pelleted at 30, 000 g for 30 min 
β-D-thiogalac
d Moffatt, 1986). The flasks were incubate
o in.   
ant protein
eparation of periplasm protein 
ellets were gently resuspended in
t and cell debris pellet was analysed by mine
Guisez et a
eparation of cel
is tagged protein 
The cell pellet was resuspended with 15 ml Talon™ buffer (20
a
min using a B. Braun Labsonic U sonicator set at low intensity ~42 watts and 0.5 second cycling on 
ice then transferred to a 50 ml centrifuge tube (Nalgene). The cell debris pelleted at 30, 000 g for 30 
min at 4 oC, and the supernatant comprising the CFE, was used for further study. The pellet 
(insoluble fraction) was resuspended in 10 ml Talon™ buffer denatured by 
The cell pellet was resuspended with 15 ml PBS (140 mM NaCl, 
1.8 mM KH2PO4, pH 7.2) and transferred in Sterilin tube
at 4 oC, and the supernatant comprising the CFE, was used for further study. The pellet contained 
insoluble fraction. 
2.24.3 Untagged protein 
The cell pellet was resuspended with 15 ml Talon™ buffer and transferred in Sterilin tubes for 
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storing at -20 oC. After thawing, the cell suspension was sonicated as for His tagged protein. The 
cell debris pelleted at 30, 000 g for 30 min at 4 oC, and the supernatant comprising the CFE, was 
used for further study. The pellet contained insoluble fraction. 
2.25 Insoluble Protein 
Proteins expressed as inclusion bodies (IB) were resuspended in with 2 8.0 buffer 
containin  NaCl and 8 M urea and incubated at 37 oC for 30 m r ation at 
30, 000 g for 30 m
conditio
2.26 P
2.26.1  Metal Affinity Chromatography (IMAC) 
Proteins fused to a thioredoxin-His6-tag (Trx-His) or His6-tag were purified using metal affinity 
matrix T sin (Clontech Laboratories Inc) (Hansen and Lindeberg
 
n resin was loaded onto a FastflowTM column. The column was then 
 or solubilised IB was loaded to the column and allowed to flow through by 
gravity. The column was then washed with 30 ml Talon buffer and the bound protein eluted with 5 
.26.2 Ion Exchange Chromatography (IEC) 
a flow rate 2 
0 mM Tris, pH 
g 300 mM in. Afte centrifug
in, the supernatant was collected for further purification under denaturing 
ns. 
rotein Purification 
Immobilised
alonTM re , 1995). 
A 2 ml bed volume of Talo
equilibrated with at least 10 column volumes of Talon buffer (20 mM Tris, pH 8.0 buffer containing 
300 mM NaCl). CFE
ml Talon buffer containing 10 mM imidazole followed by 5 ml Talon buffer containing 100 mM 
imidazole. These fractions were collected separately and aliquots of 13 µl of each fraction were 
analyzed by SDS-PAGE. 
 
Proteins fused to a GST-tag were purified using glutathione sepharose 4B resin (GE Healthcare). 
CFE was prepared in PBS buffer and loaded onto a 1 ml bed volume glutathione sepharose column 
which had been equilibrated with at least 10 column volumes of PBS buffer. The column was 
washed with 30 ml PBS buffer and the fusion protein was eluted with 10 ml elution buffer (20 mM 
reduced glutathione in 50 mM Tris/HCl, pH 8.0). Aliquots (13 µl) of each fraction were taken for 
SDS-PAGE analysis. 
2
IEC was used to purify proteins fused to a His-tag after thrombin digestion. Proteins were 
concentrated to 4.5 ml using a centrifugal concentrator. A Q-12 anion exchange (Bio-Rad) column 
was equilibrated with 100 ml Talon buffer using a Bio-Rad HR workstation with 
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ml/min. The protein was loaded using a 4 ml static loop and then washed with 60 ml Talon buffer to 
remove unbound protein. Finally, a 200 ml linear gradient Talon buffer containing 0-500 mM NaCl 
was carried out. Protein elution was detected by UV-absorbance and fractions were collected above 
a threshold of 0.05 AU at 280 nm. Fractions were then checked by SDS-PAGE. Fractions 
containing pure protein were pooled together and stored at 4 oC. 
2.26.3 Gel Filtration Chromatography (GFC) 
GFC was used to purify proteins by size. The protein was dialysed into buffer A (10 mM Tris, 150 
mM NaCl, pH 8.0) and concentrated to 4.5 ml. The protein was loaded on a HiLoad 26/60 Superdex 
75PG column connected to an AKTAprime low pressure system (GE Healthcare). The column was 
equilibrated with 400 ml buffer A at 3 ml/min flow rate before the protein was loaded onto the 
column using a 4 ml static loop. Proteins were eluted from the column using Buffer A at 3 ml/min 
0.05 AU at 280 nm. 
actions were then checked by SDS-PAGE. Fractions containing protein were pooled together and 
tored at 4 oC. 
y spectrophotometer 
flow rate. Proteins were collected by UV-absorbance above a threshold of 
Fr
s
2.27 Determination of protein concentration b
Protein concentration was determined using published methods based on the tyrosine and 
tryptophan content (Gill and von Hippel, 1989; Pace et al., 1995). The absorbance difference 
between 280 nm and 320 nm of the appropriately diluted pure proteins was measured with a 
spectrophotometer and the data were used to calculate protein concentrations, using the formula:  
A=εCID 
Where A = absorbance 280 nm-absorbance 320 nm, ε = molar extinction coefficient, I = length of 
light path (cm), D = dilution factor, and C = molar concentration of sample. 
 
The molar extinction coefficient value was calculated using ProtParam online software 
(http://ca.expasy.org/tools/protparam.html). The length of the light path was always 1 cm. 
2.28 Protease Digestion 
Proteins used in this study fused to a Trx-His or His-tag have a thrombin cleavage site between 
g(s) and the start code of target proteins, which can be digested by thrombin to remove tags. The 
purified protein fusions were transfer membrane clipped at both terminals 
and dialysed into 2 l thrombin cut buffer (20 mM Tris, 150 mM NaCl, 2.5 mM CaCl2, pH 8.4) at 
4 oC overnight with slow stirring. Proteins were then transferred into a sterile tube with 1U 
thrombin (Novagen) per mg fusion protein to digest at room temperature overnight. The digested 
ta
red to a semi-permeable 
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proteins were then loaded onto Talon resin and the flow though containing the cleaved untagged 
protein collected.  
 
Proteins fused to a GST-tag were digested by PreScission Protease in a cleavage buffer (50 mM 
Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, pH 7.5) following the manufacturer’s 
instructions.  
 
Proteins fused to pET32b have an enterokinase (rEK) cleavage site between N-terminal His-tag and 
the start code of target proteins which can be digested by rEK to remove the N-terminal extra 
fragments. The fusion proteins were concentrated and dialysed into rEK cut buffer (same as 
 rEK was added, to digest at 37 oC overnight. The 
digested solution was filtered for further purification by Ion Exchange. 
 
Less specific proteases, such as protease K, trypsin and chymotrypsin, were used in this study to 
check the protein stability. The buffer for these protease digestions was the same as for thrombin. 
Digestions were performed for different time periods and different protease concentrations. 
2.29 Sodium Dodecylsulphate Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) 
The gel consists of two parts, the resolving gel and the stacking gel (Table 2. 11). The system used 
was the AE-6450 apparatus from ATTO Corporation, Genetic Research Instruments that has 10 cm 
x 10 cm glass plates that are clipped together with a rubber seal between them. The resolving gel 
was poured into the plates covered with water and allowed to polymerize. The water was then 
removed and the stacking gel poured on top of the resolving gel. This was allowed to polymerize 
with a 14-well comb in place. The comb and the rubber seal around the glass plated were removed 
when the gel was set. Protein samples were prepared by taking 13 µl of appropriately diluted 
protein solution, mixed with 7 µl of loading buffer and boiled for 3 min. The plates were placed in 
the gel tank that was filled with running buffer. An aliquot 20 µl of protein standards (SigmaTM) of 
known moledular weight was loaded beside protein samples into the well of the gel which was then 
electrophoresed at a current of 30 mA per gel. 
 
thrombin cut buffer), the appropriate content of
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 Volume/Amount Component 
Resolving gel 12.5 % 15 % 
0.75 M Tris/HCl buffer, pH 8.8 with 0.2 % SDS 9.4 ml 9.4 ml 
40 % Acrylamide (BDH Electran acrylamide, 3 % (w/v) bisacrylamide) 5.8 ml 7.1 ml 
d.d. H2O 3.5 ml 2.2 ml 
10 % (w/v) Ammonium persulphate 90 µl 90 µl 
TEMED 30 µl 30 µl 
Stacking gel 
0.25 M Tris/HCl buffer, pH 8.8 with 0.2 % SDS 3.75 ml 
40 % Acrylamide (BDH Electran acrylamide, 3 % (w/v) bisacrylamide) 0.75 ml 
d.d. H2O 3.0 ml 
10 % (w/v) Ammonium persulphate 60 µl 
TEMED 20 µl 
Loading buffer 
SDS 10 % (w/v) 
0.25 M Tris/HCl buffer, pH 8.8 with 0.2 % SDS 5 ml 
Glycerol 25 % (w/v) 
β-mercaptoethanol 2.5 ml 
Bromophenol blue dye 0.1 % 
Running buffer 
32 mM Tris/190 mM glycine, pH 8.3 350 ml 
SDS 0.1 % 
Table 2. 11 SDS-PAGE gel solutions, loading buffer and running buffer. 
 
 
After electrophoresis the gel was soaked in the Stain Buffer (0.4 % commassie brilliant blue R, 40 
% (v/v) methanol, 10 % (v/v) glacial acid) for 30 min with gentle shaking or used for blotting 
directly. The Mr of proteins separated by SDS-PAGE were estimated by the comparing their 
electrophoretic mobility with protein standards of known Mr (Figure 2. 2). 
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Figure 2. 2 Protein markers used for SDS-PAGE. 
Lane 1: Low molecular weight marker, Lane 2: High molecular weight marker. 
2.30 Affinity Gel Electrophoresis (AGE) 
Native polyacrylamide gels (7.5 % w/v acrylamide) were used in the same gel apparatus (ATTO 
Corporation) for SDS-PAGE to detect the affinity of proteins with soluble polysaccharides based on 
the methods described by Takeo (Takeo, 1984) (Table 2. 12). The gel was poured into the glass 
plates and allowed to polymerize with a 14-well comb in place. The comb and the rubber seal 
around the glass plated were removed when the gel was set. Gels with and without ligand (0.1 %) 
were run in the same gel tank with running buffer. A 10 µl of protein sample was mixed with 10 µl 
ell. BSA (10 µg) was used as a marker. Native gels were 
ectrophoresed at 10 mA/gel at room temperature for 1.5 h. Gels were stained and destained as 
SDS-PAGE gels.   
 
Component Volume/Amount  
of loading buffer before loading into a w
el
Native gel Control Ligands 
250 mM Tris, 2.5 M glycine pH 8.3 2 ml 2 ml 
40 % Acrylamide (BDH Electran acrylamide, 3 % (w/v) bisacrylamide) 3.75 ml 3.75 ml 
d.d. H2O 12.13 ml 10.13 ml
1 % ligand (w/v)  nil 2 ml 
10 % (w/v) Ammonium persulphate 100 µl 100 µl 
TEMED 20 µl 20 µl 
Running Buffer 
25 mM Tris, 250 mM glycine pH 8.3 350 ml  
Loading Buffer 
Glycerol 25 % (w/v) 
Bromophenol blue dye 0.0025 % 
Table 2. 12 AGE gel solutions.  
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2.31 Protein N-terminal Sequencing and molecular weight 
measurement 
ich was constructed comprising 
of two pieces of dampened filter paper, a PVDF membrane, an SDS-PAGE gel, and another two 
as then run at 10 V for 1 h to transfer the protein to 
I-TOF is ± 0.1 %. 
The SDS-PAGE gel after electrophoresis was incubated in blotting buffer (10 mM CAPS containing 
10 % methanol, pH 11.0) for 15 min. Four pieces of 3 mm filter paper (Whatman™) cut to the same 
size as the gel were soaked in blotting buffer. One piece of PVDF membrane was dampened in 
methanol before being moved into blotting buffer. The proteins were then blotted onto the PVDF 
membrane using a Bio-Rad semi-dry transfer cell in which a sandw
pieces dampened filter paper. The transfer cell w
the PVDF membrane. After blotting, the protein was visualized by staining for 2 min in Stain Buffer, 
destained in 40 % v/v methanol/10 % v/v glacial acid and washed in ultra pure water to remove 
excess dye. The protein band was then cut from the membrane and the N-terminal sequenced at the 
Pinnacle Lab at Newcastle University. 
 
The same protein band was cut from an SDS gel and sent to the Pinnacle Lab for molecular mass 
analysis by MALDI (Matrix-Assisted Laser Desorption Ionization)-TOF (Time Of Flight) mass 
spectroscopy with two standards (Figure 2. 3).  The error of MALD
 
 
Figure 2. 3 MALDI-TOF mass spectrum standards. 
The error value of MALDI-TOF mass spectrum for molecular weight measurement is 0.1 %. 
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2.32 Isothermal Titration Calorimetry (ITC) 
Isothermal titration calorimetry was used to measure binding affinity of different molecules (Fisher 
and Singh, 1995; Leavitt and Freire, 2001; Wiseman et al., 1989). ITC was carried out at 25 oC 
using a MicroCal Omega titration calorimeter (Figure 2. 4). All solutions were dialyzed in same 
buffer to minimize the noise. All solutions were thoroughly treated by vacuum stirring before 
loading into the syringe and the cell of the calorimeter. The samples for the cell were ~1.8 ml with 
lower concentration of protein while the ones for the syringe were about 0.6 ml with higher 
n. The machine was setted to inject successive aliquots of 10 µl 
samples from the syringe with a 200-350 seconds interval into the cell under continuous stirring at 
300 rpm. The binding data were collected according to the heat effects and analysed by non-linear 
regression using a simple one-site binding model. The fitted data yield the association constant (KA), 
number of binding sites on the protein (N), the enthalpy of binding (∆H) and the entropy of binding 
(∆S) by Origin software (version 7.0). In these titrations, T is 298 oC. Other thermodynamic 
parameters (∆G, T∆S) were calculated using the standard thermodynamic equation as below: 
concentration of another protei
 
-RTlnKA=∆G=∆H-T∆S 
 
Figure 2. 4 ITC instrument used in this study. 
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2.33 Circular Dichroism (CD) 
py based on the differential absorption of left- and 
t (Figure 2. 5). It can be used to help determine the structure of 
red using the Jasco J-815 CD. The 
00 µl 10 µM protein in 20 mM Tris pH 8.0 were loaded in the 0.2 mm two-slide cuvettes and put 
Circular dichroism (CD) is a form of spectrosco
right-handed circularly polarized ligh
macromolecules (including the secondary structure of proteins and the handedness of DNA) (Kelly 
et al., 2005). The secondary structures of proteins were measu
2
into the detector with temperature controlled at 20 oC. The scan was carried out from 250 nm to 190 
nm. The data were collected and analysed using the manufacturer’s software. 
 
 
Figure 2. 5 Circular di
 
chroism instrument used in this study. 
y 
0 nm at 20 oC. Samples were corrected by substraction of a buffer 
blank. The concentration of ligand varied between 0.5 mM to 50 mM. 
2.34 Fluorescence Spectroscop
Fluorescence spectroscopy was used to determine the binding of ligands to proteins, based on the 
intrinsic fluorescence of tryptophan and tyrosine residues. Fluorescence spectroscopy was 
performed using a SLM100 8100 spectrometer operating in ratio mode with an 8 nm excitation and 
4 nm emission bandwidths. Proteins were diluted in 20 mM Tris buffer, pH 8.0 to a final 
concentration of 1 µM. Samples were excited at 280 nm, and the emission spectra of the proteins 
recorded between 300 nm and 45
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2.35 Differential Scanning Calorimetry (DSC) 
Differential Scanning Calorimetry (DSC) measures the function of temperature against target 
proteins by measuring the heat changes during controlled increase (or decrease) in temperature. In 
this study, DSC was used to measure the difference of protein with the presence and absence of 
ligands. One ml of 0.5 mg/ml protein in 20 mM Tris pH 8.0 buffer was degassed at 25 oC and then 
injected into sample cell of MicroCal Differential Scanning Calorimeter VP-DSC (Figure 2. 6). The 
control cell holds the same buffer. The solution was heated at a constant rate of 1 oC per min from 
15 oC to 70 oC. The Tm measured indicated the heat changes. The transition midpoint Tm is the 
temperature where 50 % of the protein is in its native conformation and the other 50 % is denatured. 
The higher the Tm, the more stable the molecule.  
 
F
 
igure 2. 6 DSC instrument used in this study. 
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2.36 Protein Crystallization 
Proteins for crystallization were required at >95 % homogeneity as assessed by SDS-PAGE. 
Proteins were concentrated to at least 12 mg/ml in ultra pure water. Crystallization of proteins was 
carried out initially using the sitting drop vapour diffusion technique. Drops were viewed using a 
Nikon SM21000 stereo zoom microscope each day in the first week. After the first week, trays were 
assessed periodically. The successful conditions of sitting drop experiments were then modified in 
hanging drop vapour diffusion technique to achieve better crystals. 
2.36.1 Sitting drop vapour diffusion 
For initial small scale screening, crystallization was conducted using a Mosquito™ (TTP Labtech) 
or JSCG screen, see Appendix B) was 
dispensed into each well of the plates, and 7 µl of protein was dispensed into each of the 8 sample 
on shelves. The 100 
nanolitre pipetting robot with 96-well crystallization plates (Greiner) (Figure 2. 7). Crystallization 
mother liquor (50 µl) (Newcastle, Classics, PACT, AmSO4, 
reservoirs before 100 nl was aliquoted by the robot onto each of the crystallizati
nl of protein was then mixed with the same or half amount of crystallizing mother liquor in each 
two eyes of a well of a 96-well plate. The tray was then sealed using sealing film with contact 
adhesive and crystal conditions were viewed as described before.  
 
  
Figure 2. 7 Robot crystallization instrument and its sitting drop method. 
Diffusion due to loss of water from sitting drop in vapour phase causes equilibrium to occur between drop and reservoir. 
 
he hanging drop technique for crystal growth requires that a small aliquot of protein or 
2.36.2 Hanging drop vapour diffusion 
T
protein/ligand mix (0.7-2 µl) is mixed with an amount of crystallizing mother liquor (0.7-2 µl) on a 
siliconized cover slip. Cover slips (18 × 18 mm, Scientific laboratory supplies) were pretreated with 
Aqua Sil™ (Hampton Research), dried according to manufacturer’s instructions and polished with a 
silk scarf prior to dispensing of protein or crystallization liquor. Cellstar, 24-well tissue culture, 
polystyrene, non-pyrogenic, DNase and RNase free plates (Greiner, Bio-one) were prepared by 
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applying High Vacuum Grease (Dow Corning) to the rim of each well using a 10 ml syringe with a 
00 µl Gilson tip, trimmed to allow flow of the grease. Typically 0.5 ml of mother liquor was 
pipetted into each well, although different well volumes cou e used for altera fusion 
rate. O ce co  were immediately inverted and 
sealed above the corresponding m
vacuu grea ystallization trays were incubated at 20 oC and/or 4 oC in a 
Sanyo IR-1
2
ld b tion of dif
n ver slips were setup, as previously described, they
other liquor by firmly pressing down the cover slip against the 
m se as in Figure 2. 8. Cr
 M 53 incubator.  
 
 
Figure 2. 8 Hanging drop crystallization method. 
of water from hanging drop in vapour phase causes equilibrium to occur between drop and 
tion of protein is also increased as water diffuses away from drop (adapted from Hampton 
2.36.3 Collection of crystal diffraction data and structure refinement 
a suitable form were harvested on rayon fibre loop and flash frozen in liquid 
rbank, Newcastle University. Potentially useful crystals 
were screened on an in-house source (Rigaku rotating RU-200 X-ray generator, with a Cu 1.5418 Å 
0 kV and 100 mA with focusing X-ray optics from Osmics), utilising a Rigaku 
ted and reflections 
indexed using DENZO (Otwinowski and Minor, 1997) to determine space group and quality of 
ction on home source were taken to Diamond 
ngth optimized for the f’’ signal of the selenium or by molecular replacement. 
Prior to refinement, 5 % of the observations were immediately set aside for cross-validation 
992) and were used to monitor various refinement strategies. The programs 
Diffusion due to loss 
reservoir. Over satura
Research). 
 
Unique crystals of 
nitrogen with appropriate cryoprotectant. Crystal harvesting, data collection, and structure 
refinement were carried out by Dr Susan Fi
target operating at 5
RAXIS IIC or a RAXIS-IV image plate detector. Typically, two images per crystal at 0° and 90°, 
with an oscillation range of 0.5°/image to a resolution of 2.2 Å, were collec
crystals. Crystals with good diffra
(www.diamond.ac.uk) for synchrotron diffraction. 
 
Structures shown in this thesis were solved by using the single-wavelength anomalous dispersion 
method at a wavele
analysis (Brünger, 1
MOSFLM, REFMAC5, and SCALA used are part of the CCP4 software package (Project, 1994). 
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Models were completed with manual correction using COOT (Emsley and Cowtan, 2004) and 
refinement with REFMAC5. 
2.37 Protein cross linking 
µg protein in 50 mM NaPO4 pH 7.6 was incubated 10 min at room 
 µl 25 % gluteraldehyde was added and incubated for 2 min at room 
oom temperature. A 1.5 µl aliquot of 10 % deoxycholate was added, then 22.5 µl 
ed slowly and incubated on ice for 5 min before centrifuging at 13, 200 g at 
pernatant was then discarded and the pellet washed with 600 µl ice-cold 
2.38 Carbohydrate Digestion 
igested into a range of smaller oligosaccharides by acid hydrolysis. 
 digestion. The sugar fractions were purified with a BioRad P2 column or 
n using degassed water at flow rate 1 ml/min. The sugar fractions were collected 
 
ent systems to separate chemicals in a horizontal direction in a wide range 
of temperatures and can be developed for a visualized image (Demirci, 2008; Meyers and Meyers, 
d drawn a faint pencil line 1 cm from the bottom edge. 
ples (2-16 µl) were loaded at 0.8 cm intervals on the line using a 2 µl pipette 
and allowed to dry using a hair drier after each loading of 2 µl. After loading, the plate was placed 
2
samples migrates through the adsorbent layer of 
A crosslinking protocol was used to investigate changes in the oligomeric state of proteins in the 
presense and absence of ligand (Jaenicke and Rudolph, 1986).  
 
A 0.5 ml solution containing 50 
temperature. Then 20
temperature. This was quenched by addition of 25 µl 2 M NaBH4 and incubated for a further 20 
min at r
trichloroacetic acid add
4 oC for 20 min. The su
acetone, dispersing pellet using vortex or pipette tip, then centrifuging at 13, 200 g at 4 oC for 10 
min. The supernatant was the removed and discarded and the pellet resuspended in 20-40 µl SDS-
PAGE loading buffer. Molecular weight differences resulting from cross linking were assessed 
using SDS-PAGE. 
Polysaccharides were partially d
HCl was added to the polysaccharide solution (1 % w/v in dH2O) to a final concentration of 1 M. 
The samples were vortexed and kept at room temperature for 20 min to 1 h. NaOH was added to 
neutralize the pH and stop
a BioRad P4 colum
and freeze-dried for further use. 
2.39 Thin Layer Chromatography (TLC) 
TLC uses different solv
2008; Tie-xin and Hong, 2008; Waksmundzka-Hajnos, 2008). A piece of 25 x 25 cm foil backed 
silica TLC was cut to an appropriate size an
Oligosaccharide sam
in a 1 l prolate glass tank containing butanol/acetic acid/H O in a ratio of 2:2:1, to a depth of 0.5 cm 
and sealed with greased glass plate. The mixture of 
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TLC. As the process runs, the sugars move different distances, depending on their relative affinities 
r and immersed for a few seconds in an orcinol 
ater 3:70:20 v/v, orcinol 1 ‰), dried carefully and 
heated until sugars were revealed, at 120 oC (5 -10 min). In this study, sugar fractions were digested 
from fructans by acid hydrolysis. Their relative affinities are predicted same. So the movement of 
sugars on TLC mainly depends on the size of fractions. A group of known oligosaccharides was 
used as size marker. Figure 2. 9 shows the separation of hydrolyzed levan on TLC as an example. 
Figure 2. 9 TLC shows the isolated fragments of digested levan. 
M: The size markers made by Dr. James Flint included L2 to L5, and fructose. Numbers below the pencil line were the 
collection tubes’ numbers. Finally, No. 86-89 were identified as L2, No. 74-82 were L3, No. 63-69 were L4, No. 56-58 
were L5, No. 47-51 were L6, No. 39-45 were L7. 
2.40 DNSA assay 
The reducing sugar content of solutions was determined by the methods of Miller (Miller, 1959). 
All reactions were carried out at 25 oC in 20 mM Tris buffer (pH 8.0) plus 1 mg/ml BSA. The 
DNSA reagent (Table 2. 13) was boiled with the sugar containing samples with a ratio of 1:1 or 3:1 
depending on the volume of samples for 20 min, while the colour changed from light orange to dark 
red indicating the contents of reducing sugars which can be measured by a spectrophotometer at 
575 nm. 
 
Component Concentration Note 
for the adsorbent. When the running buffer reached ~1 cm to the top of the plate, the plate was 
taken out and dried carefully using a hair drie
sulphuric acid reagent (sulphuric acid/ethanol/w
 
3, 5-Dinitrosalicylic acid (DNSA) 1 % (w/v)  
Phenol 0.2 % (w/v)  
Sodium hydroxide 1 % (w/v)  
Glucose 0.002 % (w/v) added on the day of use 
Na2SO3 0.05 % (w/v) added on the day of use 
Table 2. 13 DNSA solution. 
 
A series of acceptable absorbency (from 0.1 to 1.5) on at least 5 different time points were collected 
for final analysis. By comparing with a standard curve of reducing sugars (in a reasonable range: 0-
1000 µg ml-1), the enzyme activities against different sugars were calculated using the Michaelis-
Menten model of nonlinear regression analysis of Prism (Version 4.0.3, GraphPad™). R2 values 
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were checked to be higher than 95 % in each set to guarantee the quality of the nonlinear regression 
c  
mean. The Kca
Kcat= F[con]/E[con] 
al concentration of enzyme in the reaction solution.  
 
urves. At least two repeats were performed with acceptable R2 values to achieve the variation of
t is calculated according the equation: 
Here E[con] means the fin
Figure 2. 10 presents a graph made by Prism as an example to show how DNSA data were analysed. 
 
 
Figure 2. 10 DNSA assay example. 
This nonlinear regression graph shows the change in enzymic rate within different concentration of substrate. Data were 
fit to a single site model to obtain Vmax and Km using Graphpad Prism.  
 
2.41 High performance liquid chromatography (HPLC) 
High performance liquid chromatography (HPLC) was used to determine the products made by the 
glycoside hydrolases (Kang et al., 1990; Lohmander, 1986; Nishiura et al., 1990; Parente et al., 
akeuchi et al., 1987). The HPLC machines (Dionex DX500 and ICS3000) are fully 
automated and have a sample size of 215 µl, flow rate of 1 ml min-1 and run at a pressure of ~2100 
psi (lb in-2). The sugars were detected by pulsed amperometric detection (PAD) with settings 
E1=0.05V, E2=0.6V, E3= -0.6V (Hardy et al., 1988; Lee, 1990; Townsend and Hardy, 1991; 
Townsend et al., 1988). The column is a CARBOPAC™ PA-100 anion exchange column equipped 
with a guard column (Dionex). Samples were prepared by removing the denatured protein from 
boiled enzyme assays by centrifugation (13, 200 g for 5 min) and carefully decanting the 
supernatant. At least two separate standards (containing glucose, fructose, and sucrose at the 
concentration of 10 µg/ml for each) were used in each run, one is at the beginning and another one 
is at the end to control the variation in the elution times of the sugars through the run (Figure 2. 11). 
1984; T
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Figure 2. 11 Fructose, glucose, and sucrose as standard of HPLC. 
Fructose comes out at 6.80 min, glucose comes out at 5.67 min, and sucrose comes out at 11.47min. The sugar signals 
are different even all their concentrations were 10 µg/ml respectively.  
 
All the buffers used in HPLC were degassed over 30 min before poured into the tank. Each pipe 
linked to buffer tanks was primed ~5 min till no air bubbles came out. Prior to the first run of each 
batch of samples, the column was equilibrated with 66 mM sodium hydroxide at flow rate 1 ml/min 
for ~20 min until the baseline was flat. The programme for each sample is 65 min as described 
below (Table 2. 14). The gradient in step 2 varied depending on the difference of each samples. All 
data were analyzed through Prism. 
 
% Time (min) Step Solution 
1 66 mM sodium hydroxide 100 10 
2 500 mM sodium acetate in 66 mM sodium hydroxide 0-15/0-25/0-35/0-50 25 
3 500 mM sodium acetate in 66 mM sodium hydroxide 100 10 
4 500 mM sodium hydroxide 100 10 
5 66 mM sodium hydroxide 100 10 
Table 2. 14 HPLC buffers and programme. 
 
 
2.42 Bioinformatics Softwares 
2.42.1 NTI vector  
The local software NTI vector (Version 10.0.1) was used to map any potential restriction cleavage 
sites of reconstructed plasmids. 
2.42.2 PyMol  
The local software PyMol (Version 0.99) was used to present protein structures and the 
ccomplished ligands at three-dimensional level. a
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2.42.3 Tcoffee 
The online software Tcoffee (http://tcoffee.vital-it.ch/cgi-bin/Tcoffee/tcoffee_cgi/index.cgi) was 
used r protein sequence alignments.  to colo
2.42.4 SignalP 
The online software SignalP (Version 3.0) (http://www.cbs.dtu.dk/services/SignalP/) predicts the 
presence and location of signal peptide cleavage sites in amino acid sequences. 
2.42.5 TMHMM and TMpred 
The online software Prediction of transmembrane helices in proteins (TMHMM) Server (Version 
2.0) (http://www.cbs.dtu.dk/services/TMHMM-2.0/) and TMPred 
(www.ch.embnet.org/software/TMPRED_form.html) were used for Prediction of transmembrane 
helices in proteins. 
2.42.6 SMART 
The online software SMART (Simple Modular Architecture Research Tool) (http://smart.embl-
heidelberg.de/smart/set_mode.cgi?NORMAL=1) was used to analyse the domain structue of 
proteins. Only domains in the SMART database are recognised by the software. 
.42.7 Swiss Model 2
The online software Swiss Model 
(http://swissmodel.expasy.org/workspace/index.php?func=modelling_simple1) was used to predict 
the protein three-dimensional structures according the alignment with structure-known proteins. 
2.42.8 DNAstar 
re DNAstar was used to look through gene and protein sequences and to design 
primers. 
The local softwa
2.42.9 ClustalW2 
ClustalW2 is general purpose multiple sequence alignment program for DNA or proteins 
(Jeanmougin et al., 1998). It produces biologically meaningful multiple sequence alignments of 
divergent sequences. It calculates the best match for the selected sequences, and lines them up so 
that the identities, similarities and differences can be seen. Evolutionary relationships can be seen 
via viewing Cladograms or Phylograms. 
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2.42.10 BLAST 
This online software the Basic Local Alignment Search Tool Blast 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) was used to analyse the similarity of proteins and genes 
among different sources. 
2.42.11 DALI 
The online software DALI (http://ekhidna.biocenter.helsinki.fi/dali_server/) was used to search the 
.42.12 SWEET2 
The online software SWEET (http://www.dkfz-heidelberg.de/spec/sweet2/doc/index.php
similar secondary structures through PDB database (Holm and Park, 2000).  
2
) was used 
to predicte the 3D structure of saccharides. 
2.42.13 LipoP 
The online software LipoP (http://www.cbs.dtu.dk/services/LipoP/) was used to predicte the 
presence of lipoproteins in gram negative bacteria. 
2.42.14 Multalin 
Multalin (http://bioinfo.genotoul.fr/multalin/multalin.html) is an online multiple sequence 
alignment software with hierarchical clustering. 
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Chapter 3 Characterisation of the periplasmic sensor domain 
 respond to their environment to survive. In this study we want 
to investigate the identity of the signalling molecule and the mechanism of signal perception in 
bacterial sensory systems and also further our understanding of bacterial survival in the human gut, 
as our normal microbiota play an important role in health and nutrition (section 1.2.1). To do this 
we are using B. thetaiotaomicron as a model system as it’s a dominant member of the normal 
microbiota and the genome sequence indicates it contains a large number of extracellular sensor-
regulators (section 1.2.2). These are linked to polysaccharide utilisation genes (susC/D homologues 
and glycoside hydrolases), so it is likely that they are coregulated to sense and respond to different 
complex carbohydrates present in the niche of the large intestine. These carbohydrates are likely to 
be mainly plant polysaccharides from our diet or host mucins found in the gut. Initial tests revealed 
that B. thetaiotaomicron could grow on a range of purified polysaccharides, such as pectins, storage 
polysaccharides (starch and fructan) and host polysaccharides (chondroitin sulphate and heparin), 
but not hemicelluloses (xylans and mannans; D. Bolam, unpublished data). Custom genechips 
(work carried out by Dr Eric Martens, Washington University, St Louis, USA) were run and the 
results showed that each polysaccharide activated one or more loci containing susC and susD genes 
of the BT1754 hybrid two-component system 
3.1 Introduction 
All cells need to be able to sense and
as well as a number of catabolic enzymes and sugar transporters (Figure 3. 1). 
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Figure 3. 1 Polysaccharide utilisation loci of B. thetaiotaomicron.  
Heat map of unique upregulated loci containing SusC/D gene pairs linked to glycoside hydrolase and lyase genes. Cells 
were grown in minimal media + polysaccharide and harvested mid-log phase for GeneChip analysis. Red indicates 
higher levels and green lower levels of gene expression compared with the mean value for all conditions. The 
experiments were carried out by Dr Eric Martens (Centre for Genome Sciences, Washington University, St Louis, USA). 
The PUL outlined in red cycle is the unique locus activated in the presence of the fructan inulin. The numbers down the 
right hand side are the locus tags of the genes. 
 
 
The closest regulatory protein in almost all GeneChip analysis (except pullulan) is an Hybrid two-
component system (HTCS). B. thetaiotaomicron has 32 hybrid two-component systems (HTCS) 
that incorporate all parts of classical two-component systems into one peptide. Most have a 
conserved domain architecture with a very large predicted N-terminal periplasmic domain made up 
of 10 or more Regulatory-propeller repeats (likely form a beta-propeller fold) (Mascher et al., 2006) 
(Table 3. 1). However, one of the HTCS (BT1754; adjacent to the inulin activated locus, Table 3. 1 
and Figure 3. 2) has a shorter periplasmic domain that displays homology to periplasmic binding 
proteins. Periplasmic binding proteins are components of ABC transport systems that bind small 
molecules like amino acids and sugars (see section 1.2.3.2.1). 
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Locus tag HTCS domain architecture Polysaccharide 
BT1754 Inulin 
BT4663 Heparin 
BT3049 Arabinan 
Table 3. 1 HTCSs of B. thetaiotaomicron. 
The domain structures of 3 different Bacteroides HTCS as predicted by SMART are shown. The polysaccharide that 
activated the PUL to which each is closet is also shown. The red bar at the end of N-terminal is an uncleaved signal 
peptide, followed by either a PBPb periplasmic sensor domain or several β-propellor repeats. The blue bar indicates a 
transmembrane region (in BT3049 this is a pink box representing a region of low complexity as the prediction is not as 
strong), and then the cytoplasmic domains that make up the phosphorelay; HisKA (His Kinase A phosphoacceptor 
domain), HATPase (Histidine kinase-like ATPase domain), REC (cheY-homologous phosphoreceiver domain), and 
HTH_AraC, (helix_turn_helix, arabinose operon control DNA binding domain). 
 
The unique locus upregulated in cells grown with inulin as carbon source comprises nine genes 
with the following predicted functions: a fructokinase, an inner membrane sugar transporter, a SusC 
homologue, a SusD homologue, four GH32 proteins, and a hypothetical protein of unknown 
function (Figure 3. 2) (Dr Eric Martens, unpublished data). 
 
 
Figure 3. 2 The inulin utilisation locus regulated by BT1754. 
he genes activated during growth on inulin are BT1757 (fructokinase), BT1758 (inner membrane fructose transporter), 
T1759 (GH32), BT1760 (GH32), BT1761 (hypothetical protein of unknown function), BT1762 (SusD homologue), 
T1763 (SusC homologue), and BT1765 (GH32). Also upregulated, but not in the locus, was the only other GH32 in B. 
thetaiotaomicron, BT3082. The arrows point in the direction of transcription. 
 
The prediction that the periplasmic domain of BT1754 was a PBP, a class of proteins known to bind 
small molecules including carbohydrates, and the fact that fructans are relatively simple 
homopolymers initiates the study to identify the activating signal molecule and further our 
understanding of signal perception and transduction in these important prokaryotic regulatory 
systems. 
3.2 Results 
3.2.1 Cloning of the predicted periplasmic domain of BT1754 
SMART domain prediction of the BT1754 HTCS revealed an N-terminal domain of approximately 
300 amino acids flanked by two transmembrane (TM) regions (Table 3. 1 and Figure 3. 3). The C-
terminus of the protein after the second TM domain contains all the domains required for 
phosphorelay and signal output indicating that this region is cytoplasmic and thus that the N-
terminal domain is located in the periplasm (Figure 3. 4). To test this hypothesis the predicted 
T
B
B
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periplasmic region of BT1754 (residues 29-343, hereafter known as BT1754peri) was amplified by 
CR from B. thetaiotaomicron genomic DNA using the following primers: BT1754-1: 5’-
CTCCCATGGAT
P
GATACACCCCATTTTCGTATTG-3’ and BT1754-2: 5’-
CCGCTCGAGGA TTGTGTAGCTAC-3’. The amplified DNA fragment was digested with 
Nco and Xho (unique sites introduced at the 5’ er) and cloned into similarly 
e protein to the E. coli 
CCTG
 end of each prim
digested pET22b (Novagen; encodes an N-terminal pelB leader that targets th
periplasm and a C-terminal His6 tag).  
 
Figure 3. 3 The prediction of transmembrane regions and orientation of BT175
TMPred was used to confirm the SMART prediction of the transmembrane regions
4.  
 in BT1754. Anything above zero is 
on the scale is considered to be a possible TM. The first peak (aa 1-28) indicates the uncleaved signal peptide (TM1). 
The second TM that flanks the periplasmic domain is indicated by the large peak at ~350 aa. 
 
 
Figure 3. 4 BT1754 amino acid sequence. 
This fused protein has 921 amino acids, the molecular weight is 103821.24 Dalton, and the theoretical pI is 5.82. The 
domain prediction is made by SMART (see Table 3. 1). The first transmembrane domain (residues: 1-28) is colored in 
red with underline, while the second one (residues: 343-362) is blue with underline. The periplasmic domain of BT1754 
is colored in black and bolded (29-343), which is used for cloning. The HisKA means the Histidine kinase (cyan square, 
residues: 410-476), while the HATPase_c means the histidine kinase-like ATPase (cyan triangle, residues: 523-635). 
The last orange triangle presents the helix_turn_helix, arabinose operon control protein (HTH-ARAC, residues: 834-
917). The links of each domain are presented as black. The double-lipid layer (gray) presents the inner membrane. 
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3.2.1.1 Expression and purification of BT1754peri 
BT1754peri was over expressed in E. coli C41 by induction with 1mM IPTG. The soluble CFE 
fraction was purified by IMAC method (Figure 3. 5). The eluate from the column was then dialysed 
into 20 mM Tris-HCL, pH 8.0 buffer and stored at 4 oC until required. 
  
 
Figure 3. 5 Purification of BT1754peri. 
Lane 1: CFE, Lane 2: Flow through, Lane 3: Eluate, Lane 4: Marker. The calculated MW of the protein expressed from 
ET22b is 36.1 kD, although this runs at ~43 kDp  on the SDS-PAGE gel. The pI is 5.5. 
molecule this protein could recognize is inulin or one of its enzymatic breakdown products. Initial 
binding tests were carried out with BT1754peri against inulin and commercially available β-2,1 
linked fructooligosaccharides (sucrose, kestose, kestotetraose, and kestopentaose), but no binding 
was observed by ITC (Figure 3. 6). 
 
3.2.1.2 Carbohydrate binding studies with BT1754peri 
BT1754 is involved in the control of inulin degradation and therefore the most likely signalling 
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Figure 3. 6 BT1754peri does not bind inulin or fructooligosaccharides with a terminal glucose.  
Sucrose, kestose (K3), and kestopentaose (K5) as oligosaccharides of inulin, none of them could bind BT1754peri. 
Kestotetraose (K4, G-F-F-F) was presumed that could not bind BT1754peri, because K3 and K5 could not, and K4 is 
longer than K3 and shorter than K5. 
 
As the major component of fructans is β-D-fructose this monosaccharide was tested for binding and 
was shown to interact with BT1754peri with a Kd of ~0.5 µM and a stoichiometry of 1:1. This 
binding event was metal independent as the affinity was unchanged in the presence of 5 mM EDTA 
(Figure 3. 7 and Table 3. 2). The reaction is driven by a favourable change in enthalpy (-∆H) with 
an unfavourable entropic contribution (-T∆S). This thermodynamic signature is common to sugar 
binding proteins and is thought to arise due to the desolvation of the hydroxyls and formation of 
new hydrogen bonds with the protein. 
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 ractions is fructose alone rather than any of the oligosaccharides present (Figure 3. 8).   
β-D-fructose  β-D-fructose + 5mM EDTA
Figure 3. 7 BT1754peri binds fructose. 
BT1754peri bound fructose is metal independent.  
 
 
It is possible that the terminal Glc present on inulin or the commercially available 
kestooligosaccharides interferes with binding to BT1754peri and therefore binding was assessed 
against fructooligosaccharides produced by partial acid hydrolysis of inulin and separation of the 
mixture on a P2 bio-gel size exclusion column. No binding was observed with higher MW fractions 
from fractions 9-25, but fractions from 27 onwards were shown to interact with BT1754peri. As 
these fractions all contain monomeric fructose and the ITC data looks identical to fructose alone 
when n is set to 1 in the fits, it is most likely that the ligand BT1754peri is recognising in the 
hydrolysed f
 
Figure 3. 8 TLC showing purification of inulin oligosaccharides produced by partial acid hydrolysis. 
is of positive fractions by TLC. Left: Lane 0 is 
Total hydrolysate was applied to a Bio-gel P2 size exclusion column in water and fractions collected. These were 
initially assayed for reducing sugar using DNSA reagent before analys
the inulin after digestion and before isolation. Lanes 6-38 are the collection tube numbers. Each tube has 4 ml collection.  
Samples (2 µl) from each tube were applied to the TLC plate for separation. Inulin fraction 27# is same size as fructose 
from the TLC result though a bit shift because of side-effect. Right: ITC of BT1754peri with fraction 27# at 1 mg/ml. 
As the molar concentration of ligand is unknown, the n-value was iteratively fitted to as close as possible to one, by 
adjusting the molar concentration of the ligand. 
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To further examine the specificity of BT1754peri, interaction of this protein with a range of small 
fructose containing sugars, fructose epimers and other monosaccharides was assessed by ITC 
igure 3. 9). Only sorbose showed any binding to BT1754peri, but the affinity was too low to fit 
curately to a single site model in Origin (ITC data not shown). These data reveal that the 
ing 
(F
ac
periplasmic domain of BT1754 bound specifically to β-D-fructose, but not fructose contain
disaccharides, oligosaccharides, polysaccharides, or analogues of fructose. 
 
 
 
Figure 3. 9 Structures of sugars tested for binding to BT1754peri. 
The top panel: Raffinose is α-D-galactose-(1→6) α-D-glucose-(1→2) β-D-fructose, Lactulose is β-D-galactose-(1→4) 
β-D-fructose, Turanose is α-D-glucose-(1→3)-α-D-fructose, and levanbiose is β-D-fructose-[(2→6)-β-D-fructose, the 
disaccharide of levan without the glucose at the end. The middle panel: fructose analogs: compared with fructose, 
xylulose lost the C6, while psicose, tagatose, and sorbose are epimers of fructose, different on C3, C4, and C6 
separately. The bottom panel: glucose is the end unit of fructans; ribose is a five carbon sugar. Only sorbose could bind 
fructose, albeit very weakly.  
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Ligand Ka × 105 (M-1) ∆H (kcal mol-1) T∆S (kcal mol-1) n*
Fructose 2.6 ± 0.2 -13.9 ± 0.1 -6.5 ± 0.5 1.0 ± 0.0 
Inulin-27# 3.4 ± 0.6 -11.9 ± 0.3 -4.3 0.9 ± 0.0 
Frc + EDTA 4.0 ± 0.1 -12.5 ± 0.4 -4.8 0.9 ± 0.0 
Table 3. 2 ITC data show the binding ability of BT1754peri against a group of ligands. 
*: The ITC data were fitted to a single site binding model for all ligands. ITC was carried out in 10 mM Tris/HCl pH 8.0 
at 25 oC. BT1754peri was 0.05 to 0.1 mM. Mon saccharides, glucose, xylulose, fructose, psicose, tagatose, and sorbose, 
were with a molar concentration of 1 mM respectively. Oligosaccharides: raffinose, lactulose, turanose, sucrose, kestose, 
 a molar concentration of 1 mM, 1 mM, 1 mM, 1 mM, 5 mM, 5 mM, and 0.5 
.2.1.3 Biophysical studies on BT1754peri 
3.2.1.3.1 BT1754peri oligomeric state in the presence and absence of fructose. 
To assess the oligomeric state of BT1754peri in the presence and absence of fructose, the likely 
activating molecule, gel filtration on a Sephadex S200 column was carried out. Fructose was added 
to the protein sample as well as gel filtration buffer at a concentration of 5 mM. The protein ran as a 
monomer in the absence and in the presence of ligand (Figure 3. 10). 
o
kestopentaose, and levanbiose, were with
mM, respectively. Inulin fractions were at 1 mg/ml.  
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Figure 3. 10 BT1754peri is a monomer in the absence and presence of ligand as assessed by gel filtration. 
BT1754peri eluted from gel filtration column at the same time point while the conditions were different. A: 0.115 mM 
BT1754peri in 10 mM Tris run in normal gel filtration buffer. B: 0.115 mM BT1754peri in 10 mM Tris buffer plus 1.6 
mM fructose run in normal gel filtration buffer. C: 0.115 mM BT1754peri in 10 mM Tris buffer plus 1.6 mM fructose 
run in gel filtration buffer plus 5 mM fructose. 
 
 
To present the possible oligomeric difference with presence and absence of fructose, the 
crosslinking analysis (section 2.37) was carried out. The results indicated that in both conditions, 
BT1754peri is a monomer, which supports the gel filtration results (Figure 3. 11). 
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Figure 3. 11 Crosslinking analysis with BT1754p resence nd absence of fructose. 
SDS-PAGE gel of crosslinked BT17 i. Lan l weight marker. Lane 2: BT1754peri before 
crosslinking treatment (see arrow). This otein is ed  elution, so there are a few minor bands smaller 
than BT1754peri. Lane 3: Crosslinking treated BT1 in ab f fructose. Lane 4: Crosslinking treated 
BT1754peri with presence of 5 mM fructose. Lane e erence, which indicates that in both conditions, 
BT1754peri is a monomer. 
 
3.2.1.3.2 BT1754peri is thermally sta  th esence of fructose 
Diffrential scanning calorimetry (DSC) was carried out to check the thermal stability of BT1754peri 
in the presence and absence of f se. T dic hat the thermal stability of BT1754peri 
increased in the presence of fructose, whil d tabilize the protein (Figure 3. 12). 
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Figure 3. 12 DSC data showing the melt peaks of BT1754peri.  
The 0.5 mg/ml protein was in 20 mM Tris pH 8.0 buffer. Ligand concentrations were 5 mM. The BT1754peri with the 
absence of fructose half unfolded at 42.55708 oC, while in the presence of fructose, it increased the half unfolding 
temperature to 48.76591 oC, and BT1754peri in the presence of glucose half unfolded at 43.03393 oC, which is almost 
no donation to the change of thermal stability. 
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 3.2.1.3.3 BT1754peri is resistant to protease digestion in the presence of fructose 
To further assess the ability of fructose to stabilize the structure of BT1754peri, the protein was 
incubated with protease K in the presence and absence of the monosaccharide. The data show that 
BT1754peri is rapidly degraded to a stable ~31 kD fragment in the presence and absence of fructose, 
hich remains in the former sample after 19 h digestion (Figure 3. 13). However, after 19 h in the 
bsence of fructose the protein has been almost totally digested. These results show that fructose 
t 17 sti  a
w
a
pro ects BT 54peri from dige on by prote se K.  
 
 
Figure 3. 13 BT1754peri protease K digestion.  
160 µl BT1754peri (1.2 mg/ml) was digested with 10 µl 0.01 mg/ml protease K at different time points with or without 
5 mM fructose. Lane 1: Marker, Lane 2: BT1754peri only, Lanes 3-6: BT1754peri digested by protease K for 10 min, 1 
, 2 h, and 19 h respectively, Lanes 7-10: BT1754peri plus 5mM fructose digested by prh otease K for 10 min, 1 h, 2 h, 
nd 19 h respectively. The arrow shows the position of the stable band that was subjected to MALDI-TOF and N-
rminal sequencing. 
fter the overnight digestion was blotted for MALDI-TOF analysis and 
for N-terminal sequencing to identify the stable core structure. The MALDI-TOF shows that the 
remaining fragment has a molecular weight of 31944.12 Da. The N-terminal sequencing shows that 
this fragment starts from the 41st amino acid, serine, so the full length of this fragment could be 
calculated. It’s from amino acid 41 to 329 (Figure 3. 14). 
 
a
te
 
 
 
 
The stable band at ~31 kD a
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Figure 3. 14 The MALDI-TOF map of digested fragment of BT1754.  
This protease K digested fragment of BT1754peri was 31944.12 Dalton.   
 
3.2.2 BT1754peri crystallization  
BT1754peri was purified by IMAC and then by ion exchange method (Q12). The purity is higher 
than 95 % according to the bands on SDS-PAGE gel (Figure 3. 15). Final BT1754peri concentration 
was 10 mg/ml in water. Four screens (PACT, JCSG, Classical, NCL, see Appendix B) were used 
with or without the accompaniment of 5 mM DTT or 5 mM fructose for sitting-drop crystallization. 
.0 M Lithium sulfate. Further modification for hanging-drop crystallization was based on these 
tion 0.1 M HEPES sodium salt pH 7.5, 0.8 
M Sodium phosphate, and 0.8 M Potassium phosphate 15 days after setting up (Figure 3. 15).  
Tiny crystals formed in condition: 0.1 M HEPES sodium salt, pH 7.5, 0.8 M Sodium phosphate, 0.8 
M Potassium phosphate and condition: 0.5 M Ammonium sulfate, 0.1 M tri-Sodium citrate, pH 5.6, 
1
two conditions. A single crystal formed in screen condi
 
 
 
 
Figure 3. 15 BT1754peri for crystallization. 
Left: Lane 1: Marker, Lanes 2-14: BT1754 fractions collected from ion exchange column Q12. Right: Crystal of 
T1754peri fused in pET22b with a C-His tag formed in Classical-46. B
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This cryst t u n o . Susan 
Firbank. Molecular replacemen ve the st sed on the 
tein from aerobacter 
ngcongensis (PDB ID: 2IOY) which displays ~35 % sequence similarity (Figure 3. 16) (Cuneo, 
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3.2.3 BT1754peri fold and ligand binding site 
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Figure 3. 17 BT1754peri structure. 
Left: This cartoon representation shows the protein N to C-terminal from blue to red. The two sub-domains form into a 
pocket that sandwiches one molecule of fructose. This protein has 10 α-helixes and 12 β-sheets. The last α helix spans 
from one sub domain to another. The protein has a C-terminal His-tag, but the tag is not visible in the structure. Right: 
Two BT1754peri structures (orange and marine) are present in symmetry dimer form. 
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All the hydroxyls of fructose are involved in the hydrogen bond formation with 9 residues from 
both the N and C-terminal domains, especially O1, O4, and O6, which form 4 hydrogen bonds each. 
In addition two tryptophans (Trp45 and Trp196) from each domain, stack against each face of the 
sugar. Other two residues Pro168 and Tyr271 are close to one edge of the fructose and may be 
involved in hydrophobic interactions with the sugar (Figure 3. 18 and Table 3. 3). 
 
 
 
 
 
Figure 3. 18 BT1754peri binding site. 
Bound fructose is shown in the binding pocket of BT1754peri. All oxygens of fructose donate to the hydrogen bond 
formation with residues of BT1754peri. Several –OH groups (O1, O4, and O6) make 4 Hydrogen bonds respectively. 
Totally, 18 hydrogen bonds are formed. The 9 residues bound fructose are Ser41, Asp43, Arg46, Asp120, Arg121, 
Arg172, Asn222, Arg224, and Asp248. Trp45, Pro168, Trp196, His221, Ile247, and Tyr271 are very close to fructose. 
Trp45 and Trp196 stack against opposite faces of the fructose molecule. 
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 Fructose BT1754peri Distance (Å) 
Ser41-O 3.56 
Arg46-N1 3.43 
Arg46-N2 2.56 
O1 
Asp43-O 2.89 
C1 Trp45-C 3.68 
Arg224-N1 3.04 
Arg224-N2 3.38 
O2 
Trp196-C 4.14 
Arg224-N2 2.84 
Asp248-O1 2.55 
O3 
Asn222-N 2.80 
Asp248-O1 3.35 
Asp248-O2 2.56 
Arg172-N1 3.15 
Arg172-N2 3.20 
Ile247-O 5.03 
Tyr271-C 3.49 
O4 
 
His221 4.69 
O5 Arg46-N1 3.07 
Arg46-N1 3.35 
Asp120-O1 2.55 
Asp120-O2 3.19 
Arg121-N 3.14 
O6 
Pro168-C 3.57 
Table 3. 3 Hydrogen bonding and close contacts between BT1754peri residues and fructose. 
ly. The hydrogen bound residues atoms are bolded.  O1, O4, and O6 form four hydrogen bonds respective
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DALI analysis was used for comparing protein structures in 3D. Figure 3. 19 shows the DALI 
1 2ioy-A 38.0   1.3   271 274 30 PERIPLASMIC SUGAR-BINDING PROTEIN 
results for BT1754peri and reveals that the most similar ten structures are periplasmic binding 
proteins that bind small sugars such as ribose (No. 1 and 2), glucose (No. 3 and 6), lactose (No. 4), 
galactose (No. 5 and 6), (2R, 4S)-2-methyl-2, 3, 3, 4-tetrahydroxytetrahydrofuran (R-THMF) (No. 
7 and 8), and arabinose (No. 9).  
 
 
 
 
No Chain Z rmsd lali nres %id Description 
2 2fn8-A 34.9 1.7 273 292 24 RIBOSE ABC TRANSPORTER, PERIPLASMIC RIBOSE 
3 2h3h-A 32.9 2.0 281 313 23 SUGAR ABC TRANSPORTER, PERIPLASMIC SUGAR-
GALACTOSE 
jy-A 29.5 2.0 274 316 17 SUGAR TRANSPORT PROTEIN 
w-A 29.3 2.1 275 315 17 SMLSRB 
2.74 305 16 L-ARABINOSE-BINDING PROTEIN COMPLEX WITH L-
ARABINOSE    
10 3d02-A 28.5 2.3 273 300 15 PUTATIVE LACI-TYPE TRANSCRIPTIONAL 
n the protein. %id: percentage of identical amino acids over all 
T. tengcongensis (Cuneo, 2008). No. 2 is ribose binding protein 
from Thermotoga maritima msb8 (Cuneo et al., 2008). No. 3 is glucose binding transporter from T. maritima (Tian et 
al., 2007), No. 4 is lactose binding transporter from Clostridium phytofermentans (unpublished), No. 5 is galactose 
binding protein from Burkholderia phytofirmans (unpublished), No. 6 is glucose/galactose binding protein from 
Salmonella typhimurium (Zou et al., 1993). No. 7 is (2R,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran (R-THMF) 
binding protein from S. typhimurium (Miller et al., 2004). No. 8 is SMLSRB from Sinorhizobium meliloti binds R-
THMF as well (Pereira et al., 2008).  No. 9 is L-arabinose binding protein from E. coli (Quiocho et al., 1974). No.10 is 
predicted to be a LacI-type regulator from Klebsiella pneumoniae subsp. (unpublished). 
 
 
 
 
 
Alignment of these 10 protein sequences against BT1754peri indicates that the sequence similarity 
 35 % against 2ioy 
BINDING 
4 3brs-A 32.1 1.6 261 271 19 PERIPLASMIC BINDING PROTEIN/LACI 
TRANSCRIPTIONAL 
5 2rjo-A 31.6 2.3 280 322 24 TWIN-ARGININE TRANSLOCATION PATHWAY SIGNAL 
6 1gca 31.3 2.2 275 309 25 GLUCOSE/GALACTOSE-BINDING PROTEIN WITH 
7 1t
8 3ej
9 1abe 28.5 2.6 
REGULATOR 
Figure 3. 19 DALI analysis of BT1754peri. 
Dali matches the top 10 structures sorted by Z-score. Chain: PDB entry code plus chain identifier. Z: normalized Z-
score that depends on the size of the structures. The program optimises a weighted sum of similarities of intramolecular 
distances. rmsd: root-mean-square deviation of C-alpha atoms in the least-squares superimposition of the structurally 
equivalent C-alpha atoms. nres: number of amino acids i
structurally equivalent residues. No. 1 is RBP from 
is low (Figure 3. 20). The identity of BT1754peri to other sequences is from
(RBP) to 10 % against 1tjy. 
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e 3. 20 Tcoffee alignments of BT1754peri homologs from DALI. 
 protein sequences are from PDB website according to their PDB IDs from DALI analysis above without the
ags. The proteins are sorted according Z score. The sequences vary a lot while the secondary structures a
ed. The identity of BT1754peri to other sequences is from 35 % against 2ioy (RBP) to 10 % against 1tjy. 
The deletion analysis of BT1754peri 
In an attempt to obtain better crystals to solve the structure to a higher resolution, several C-
inal deletion constructs of BT1754peri were made. The first was cut off the whole of the C-
inal helix (α10); and the second was to remove the extra residues after α10 that have no density 
tructure. 
Figur
The  fused 
His t re 
conserv
 
3.2.4 
term
term
in the s
 
as BT1754peri with same restriction sites 
in the presence of 5 mM fructose. The long-slim needle crystals of these two proteins 
annot diffract on X-ray to achieve structures (data not shown).  
 ( 5’---------------------- ----
Both deletions were cloned into same vector pET22b 
(Nco I and Xho I) using the primers in Table 3. 4. The 2 fragments were over expressed as soluble 
proteins (data not shown), and the ITC data indicated that they kept the binding ability against 
fructose (data not shown). They were then purified for crystallization in the same condition as for 
BT1754peri 
c
 
Primer ID Sequence ------- --------------->3’) Note 
BT1754-23 CCGCTCGAGTGCG TACGGTC To 307st aa TTGG
BT1754-33 CCGCTCGAGGAGCGTTTCAATC To 327st aa 
Table 3. 4 etion.  
5 M  s  
 o nalysis of BT1754peri (F 3 roup of residue 
nts ere made to understand the relative impo  o  each of these residues in ligand binding. 
 Primers for BT1754peri del
 
3.2. utation of residues involved in ugar binding in BT1754peri 
Based n the structure a igure . 18 and Table 3. 3), a g
muta w rtance f
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All the r ed into hydrogen bonds with f e 43, Arg46, Asp120, Arg121, 
72, Asn222, Arg224, and Asp248 were site-directed mutated respectively. A further four 
yr271) that are 
interactions with the sugar rings were mutated separately to alanine as well.  
Primer ID Sequence ( 5’---------------------------------------------------------->3’) Note 
esidues form ructos : Ser41, Asp
Arg1  
residues (Trp45, Pro168, Trp196, and T close to fructose and may form hydrophobic 
 
Based on the BT1754peri fusion in vector pET22b as template, a group of subclones was carried 
out using mutagenesis PCR program with the following primer pairs separately (Table 3. 5).  
 
 
 
BT1754-6 CGATGATTCATGGGCACATAAGATGAATGATG R46A F 
BT1754-7 CATCATTCATCTTATGTGCCCATGAATCATCG R46A R 
BT1754-10 GTTATTCTTGTAGCCCGGAAGATTCTTTC D120A F 
BT1754-11 GAAAGAATCTTCCGGGCTACAAGAATAAC D120A R 
BT1754-12 GTTATTCTTGTAGACGCGAAGATTCTTTCG R121A F 
BT1754-13 CGAAAGAATCTTCGCGTCTACAAGAATAAC R121A R 
BT1754-14 CCTGCAATGGAAGCGCATCAGGGATTTATG R172A F 
BT1754-15 CATAAATCCCTGATGCGCTTCCATTGCAGG R172A R 
BT1754-16 GCGGATGCTGCGGCGGAACGTGGTCCG W196A  F 
BT1754-17 CGGACCACGTTCCGCCGCAGCATCCGC W196A  R 
BT1754-18 GTGTATGCCCATGCTGACCGTATCGCTC N222A F 
BT1754-19 GAGCGATACGGTCAGCATGGGCATACAC N222A R 
BT1754-20 GATTTTTGTCGGCATAGCTGCCTTGCCGGGTAAG D248A F 
BT1754-21 CTTACCCGGCAAGGCAGCTATGCCGACAAAAATC D248A R 
BT1754-25 CAATGCAGCGATGCTTCATGGCGACATAAG D43A F 
BT1754-26 CTTATGTCGCCATGAAGCATCGCTGCATTG D43A R 
BT1754-27 CAGCGATGATTCAGCGCGACATAAGATG W45A F 
BT1754-28 CATCTTATGTCGCGCTGAATCATCGCTG W45A R 
BT1754-29 GCCCATAATGACGCTATCGCTCCGGGTG R224A F 
BT1754-30 CACCCGGAGCGATAGCGTCATTATGGGC R224A R 
BT1754-34 GTGGCTCAATGCGCCGATGATTCATGG S41A F 
BT1754-35 CCATGAATCATCGGCGCATTGAGCCAC S41A R 
BT1754-36 GAGCGGTTCGACTGCTGCAATGGAACGG P168A F 
BT1754-37 CCGTTCCATTGCAGCAGTCGAACCGCTC P168A R 
BT1754-38 GCCACCTTTATCGCTCCGACCAATGGC Y271A F 
BT1754-39 GCCATTGGTCGGAGCGATAAAGGTGGC Y271A R 
Table 3. 5 Primers for mutations of BT1754peri 
F: Forward primers, R: Reverse primers. 
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3.2.5.1 Mutated proteins expression 
of BT1754peri were expressed in C41 cell strain and purified by IMAC. 
A, R121A, P168A, and R224A) are 
soluble while other 5 (R172A, W196A, N222A, D248A, and Y271A) are insoluble. The insoluble 
Site-directed mutations 
Among the 13 mutants, 8 (S41A, D43A, W45A, R46A, D120
mutants were dissolved in TalonTM buffer containing 8M urea from inclusion bodies and then 
refolded in TalonTM buffer while bound to the Talon resin. The insoluble form of the WT (present in 
cells at lower levels to soluble BT1754peri) was used as a control (Figure 3. 21). Multiple protein 
bands are evidence of some degradation of both WT and refolded WT, which could not be inhibited 
in the presence of fructose (data not shown).  
 
 
 
Figure 3. 21 The mutants of BT1754peri.  
Lane 1: WT, Lane 2: R46A, Lane 3: D120A, Lane 4: R121A, Lane 5: D43A, Lane 6: W45A, Lane 7: R
S41A, Lane 9: P168A. Lane 10: Marker, Lane 11: BT1754peri WT (IB), Lane 12: R172A, Lane 13: W
224A, Lane 8: 
196A, Lane 14: 
222A, Lane 15: D248A, Lane 16: Y271A. 
ctose is abolished (Figure 3. 22 and Figure 3. 23). Only S41A and P168A 
tain some affinity for the sugar, although the affinity of S41A for fructose was too low to 
N
 
 
3.2.5.2 ITC analysis of mutants 
The ITC analysis was carried out to determine the binding ability of each mutant of BT1754peri 
with the WT as control for soluble mutants and refolded WT as control for refolded insoluble 
mutants, except for W45A (see Section 3.2.5.3 below). The ITC data show that for most of the 
mutants binding to fru
re
accurately quantify by Origin software (Table 3. 6).  
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Figure 3. 22 ITC data hint the binding ability of BT1754peri soluble mutants against fructose.  
68A, G: R224A. H: WT.  
B C D A 
E G F H 
A: S41A, B: D43A, C: R46A, D: D120A, E: R121A, F: P1
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Figure 3. 23 ITC data hint the binding ability of BT1754peri insoluble mutants against fructose. 
A: R172A, B: W196A, C: N222A, D: D248A, E: Y271A. F: WT. Use the refolded insoluble BT1754peri WT as control, 
which still has the full binding ability to fructose. 
 
 
 
 
Protein Ka × 105 (M-1) ∆H (kcal mol-1) T∆S (kcal mol-1) n*
A B C 
D E F 
WT 2.6 ± 0.2 -13.9 ± 0.1 -6.5 ± 0.5 1.0 ± 0.0 a
P168A 0.3 ± 0.0 -11.4 ± 0.5 -5.4 0.7 ± 0.0 
WT (IB) 2.8 ± 0.1 -15.0 ± 0.1 -7.3 1.0 ± 0.0 
Table 3. 6 ITC data for binding of WT BT1754peri and P168A mutant to fructose. 
The ITC data were fitted to a single site binding model. ITC was carried out in 10 mM Tris/HCl pH 8.0 at 25 oC. WT is 
soluble BT1754peri, WT (IB) is refolded BT1754peri from inclusion bodies. The S41A affinity is not high enough to be 
fitted by Origin. aThe parameters for WT are average values from 5 repeats, while other titrations are single. 
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3.2.5.3 Analysis of ligand binding by fluorescence 
W45A was only expressed at very low levels in an insoluble form and therefore its binding could 
not be assessed by ITC. Instead, binding of refolded W45A to fructose was analysed using 
fluorescence spectroscopy with the refolded WT as control as this technique requires much less 
protein than ITC. Protein, either alone or in the presence of fructose, was excited at 290 nm and the 
emission spectra recorded from 300-450 nm. Compared with WT, W45A shows no change in the 
position of the emission maxima, even at 2500-fold molar excess of fructose (Figure 3. 24), 
indicating that the mutant protein had lost the ability to bind the monosaccharide. 
 
 
Figure 3. 24 Fluorescence spectroscopy to assess the binding of refolded WT BT1754peri and W45A to fructose. 
The emission peak for BT1754peri WT in the presence of fructose shifts to left and down compared to protein in the 
absence of ligand, indicating an interaction with the sugar. The protein is saturated at a 250-fold molar excess of sugar. 
For the mutant W45A, there is no shift in the emission maxima in the presence of up to 2500-fold molar excess of 
fructose. 
 
 
3.2.5.4 CD analysis 
CD experiments were carried out to confirm that these mutants kept the secondary structure while 
they are abolished binding ability to fructose no matter they are soluble or refolded from inclusion 
bodies (Figure 3. 25 and Figure 3. 26). These data suggest the lack of binding observed with most 
of the mutants is not because of misfolding. 
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Figure 3. 25 CD data showing the secondary structures of soluble BT1754peri mutants.  
The curves in the diagram from 250 nm to 200 nm showed the soluble mutants and WT of BT1754peri have similar 
secondary structures. The voltages of these proteins were less than 600 V (data not shown). 
 
 
 
Figure 3. 26 CD data showing the secondary structures of insoluble BT1754peri mutants. 
All insoluble mutants and WT of BT1754peri were refolded during purification. The curves in the diagram from 250 
nm to 200 nm showed the soluble mutants and WT of BT1754peri have similar secondary structures. The voltages of 
these proteins were less than 600 V (data not shown). 
 
 
 
3.2.6 Structure comparisons   
The ribose binding protein (RBP) from Thermoanaerobacter tengcongensis is structurally the most 
similar protein to BT1754peri (Cuneo, 2008). It was compared with BT1754peri to further 
understand the ligand specificity in both proteins. RBP has 9 α-helices, and 12 β-sheets formed into 
two sub domains, with one ribose in pyranose form inside (Figure 3. 27A). There are 14 residues 
close to the ribose molecule, of which 7 residues formed 12 hydrogen bonds with all 5 oxygens of 
ribose (Figure 3. 27B). O2, O3, and O4 each form 3 hydrogen bonds against residues. There is no 
oxygen forming 4 hydrogen bonds as fructose.  
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F
A
igure 3. 27 The crystal structure of ribose binding protein from Thermoanaerobacter tengcongensis.   
: The RBP structure is shown as cartoon, bound ribose is shown in stick form. The resolution of this protein is 1.9 Å 
uneo, 2008). The PDB ID is 2ioy. This protein has 9 α-helixes and 12 β-sheets formed two sub domains holding the 
bose molecule in the middle. The BT1754peri was modeled on this structure using SWISS-Model to enable 
identification of putative ligand binding residues.  B: The 7 residues of RBP bound directly to ribose. They are N13, 
D89, R90, R141, N191, D216, and Q236. 
 
 
 
 
Generally, the structures of BT1754peri and RBP are identical, although RBP, in common with all 
other (non-sensing) PBPs solved to date is missing the C-terminal helix of BT1754 (Figure 3. 28). 
When BT1754peri was overlaid with RBP to show the relationship of residues close to ligands, 13 
nd Table 3. 7).  
(C
ri
of 14 residues of RBP are found at the same positions as BT1754peri (Figure 3. 29 a
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Figure 3. 28 The structures overlap of BT1754peri and RBP. 
Green is BT1754peri. Blue is RBP. BT1754peri has an extra helix at the C-terminal compared to RBP. 
 
 
Of the 13 residues surrounding the ligand binding site, 5 are conserved between BT1754peri and 
RBP: 2 Asp, 2 Arg, and one Asn. These 5 residues make 9 hydrogen bonds against O3, O4, O6 of 
fructose, and 10 hydrogen bonds against O1-5 of ribose, which indicate that these 5 residues are 
highly important for ligand binding of PBP superfamily (Figure 3. 29). Two Phe residues are facing 
the ring of ribose from both sides, while for fructose two Trp residues take the place of Phe (Table 3. 
7). Only Ala135 of RBP is unmatchable, which is far from ribose and predicted no donation for the 
binding activity. 
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Figure 3. 29 The binding sites overlay of BT1754peri and RBP. 
nds 
 BT1754peri, and Ala135 in 
BP) are present in lines. There are 13 pairs in this overlay. 5 of them are same residues in both proteins. They are 
sp248, Arg172, Asn222, Arg121, and Asp120 in BT1754peri matching Asp216, Arg141, Asn191, Arg90, and Asp89 
spectively.   
BT1754peri: Green, RBP: Blue. Fructose: Green and Red. Ribose: Light blue and Red. Dashes present hydrogen bo
between residues and ligand (green in BT1754peri and blue in RBP). When residues from one protein are at the same 
positions as in another protein, they form into pairs. When at least one residue of a pair has a ring-like side-chain, the 
pair is present in sticks, whilst other pairs and unmatched residues (Ser41 and Arg224 in
R
A
re
 
 
BT1754 Interacts with Frc at: RBP Interacts with Ribose at: 
D43 OD1 and OD2 with O1 N13 ND2 with O4 
W45 Face-to-face stack F15 Stacks with one face of Rib. 
R46 NH2 with O1 F16 Contributes to one side of aromatic sandwich 
formed by F15, F16 and F165  
D120 OD1 with O6, OD2 with O6 D89 OD2 with O1, OD1 with O2 
R121 NH2 with ring O, NE with O6 R90 NH2 with ring O, NE with O1 
P168 Forms hydrophobic part of binding site near C6 A137 Forms hydrophobic part of binding site near C1 
R172 NH1 with O4, NH2 with O4 R141 NH1 with O3, NH2 with O2 
W196 Face-to-face stack F165 Stacks with one face of Rib. 
H221  Q190  
N222 ND2 with O3 N191 ND2 with O4 
I247  F215  
D248 OD2 with O3, OD1 with O4 D216 OD2 with O3 and O4, OD1 with O3 
Y271 Forms hydrophobic part of binding site near C4-
C5 
Q236 NE2 with O2 and O3 
Table 3. 7 The 13 paired residues of BT1754peri and RBP around ligands. 
The 13 pairs are sorted according BT1754peri. The 5 identical pairs are bolded. 
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All oxygens of both sugars are involved into the formation of hydrogen bonds. When overlay the 
fructose and ribose, four oxygens are found in the similar locations: O3, O4, O5, and O6 in fructose 
against O4, O3, O1, and O5 in ribose respectively (Figure 3. 30). But O1 and O2 in fructose form 
extra hydrogen bonds which do not exist in the same location of ribose case, which may explain 
why BT1754peri could not bind ribose. 
 
 
 
 
Figure 3. 30 Ribose and fructose overlay. 
The black numbers O1 to O6 are labeled for fructose (green and red sticks), while the blue O1 to O5 are labeled for 
ribose (blue and red sticks). The residues of BT1754peri around fructose presents in blue lines, while the residues of 
RBP are in red lines. Dashes present the hydrogen bonds between ligand and amino acids (green for BT1754peri, and 
blue for RBP). 
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3.3 Discussion 
3.3.1 BT1754peri binds specifically to fructose 
The specific binding ability of BT1754peri was revealed through this study. e fructose was found 
to be the only candidate could bind BT1754peri. The binding af ty is r ively h  (Ka 2.3 x 
105 (M  i metal independent. Even the refolded ill has the identical 
binding strength (Figure 3. 23). While other ligands, no matter how similar they ar ructose, 
could not bind. The 18 hydrogen bonds ma e by 9 
streng of bind g ability able 3. 3). Other sugars could not dock in the pocket of the two sub 
domains to form fective hydrogen onds as uctose because of the pocket shape an gar shape. 
Of fructose epimers (psicose, tagatose, and sorbose), only sorbose presented a faint binding capacity. 
ost of the residues around fructose are pivotal in ligand binding as evidenced by the ITC data and 
D spectra. Looking into the structure of BT1754peri, there are two tryptophans very close to 
be of pivotal importance in binding. This 
face-to-face stacking of aromatic residues with the sugar rings is a common feature of 
3. 18) (Boraston et al., 2004; Cuneo, 2008).  
ginning of helix α6, which is 
the outside of the structure. So the main function of this residue is presumed to form hydrophobic 
part of binding site like a shell, not so important for binding itself, even though it is close to the 
fructose O6 (3.57 Å).  
 
Specificity is important to a sensor protein as it prevents activation of the system in the presence of 
related sugars that cannot be utilised by the genes under its control. Fructose is a good molecule to 
choose to bind to because naturally fructose only occurs in inulin, levan, sucrose, and some plant 
derived oligosaccharides such as raffinose (all β-linked fructose). By sensing fructose, B. 
thetaiotaomicron knows the saccharides in gut to be one of these glycans. B. thetaiotaomicron can 
use all naturally occurring fructose containing sugars (D. Bolam, unpublished data), and therefore 
 Th
fini elat igh
-1)) and s  insoluble BT1754peri st
e to f
d residues around fructose could explain the 
th in  (T
 ef  b fr d su
The O6 of sorbose is different on location (Figure 3. 9), which hints the contracts between the 
amino acids and this hydrogen group are faint.  
 
M
C
fructose that sandwich the sugar and are shown here to 
carbohydrate-protein recognition (Figure 
 
The ITC data show that P168A and S41A retain some binding ability to fructose (Figure 3. 22). S41 
forms one hydrogen bond with fructose O1 (Table 3. 3) and S41 is the first residue of core fragment 
to hold fructose according to protease digestion analysis (section 3.2.1.3.3), so maybe that is why 
this residue is not so important for binding. P168 is at the site of the be
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the inulin-regulated PUL system should be able to degrade them. These data suggest that the same 
PUL should be activated in the presence of all f ntaining oligo- and polysaccharides, as 
well as monomeric fructose and recent qPCR data from our collaborators (J. Sonnenburg, personal 
communication) confirms this to be the case. The activation of the whole locus in the presence of 
fructose and sucrose would seem to be inefficient to B. thetaiotaomicron as the sus system and four 
different GH32s would not be required to utilise these small molecules. However it is likely that B. 
thetaiotaomicron has no chance to encounter these simple sugars in its niche of the large intestine as 
most will be removed by the host further up the digestive tract. Indeed a recent research has shown 
that B. thetaiotaomicron in mice fed a simple sugar diet upregulates genes involved in degradation 
of host glycans, strongly suggesting that no simple sugars reach the large intestine (Sonnenburg et 
al., 2005).  
oss of BT1754 resulted in a mutant 
train that could no longer utilise inulin or levan, but whose growth was unaffected on other 
tarch (J. Sonnenburg, personal communication). 
 
ains linked with a hinge area, where the ligand embeds. PBP proteins are known to 
bind a series of small molecule and response to the changing of environment, such as arabinose-
binding BP), histid
binding BP), and formation when binding to a 
suitable arvin and He ys the role nge which is 
closed i al open sta arvin and ga, 2001). In 
BT1754 70 l  i hat Ile-270 
may be or B
ructose co
 
The binding of BT1754peri to fructose and its location next to the locus upregulated in the presence 
of inulin indicates that this HTCS is the regulatory gene that controls fructan degradation in B. 
thetaiotaomicron. Recent gene knockout studies showed the l
s
unrelated polysaccharides such as s
3.3.2 Signal transduction in BT1754 
BT1754peri is a member of periplasmic binding protein (PBP) superfamily (section 1.2.3.2.1). 
Though the sequences variation in this family is high, the general structure fold is quite conserved:
two sub dom
 protein (A ine-binding protein (HBP), maltose-binding protein (MBP), glucose-
 protein (G RBP. And PBP proteins change the con
 ligand (M llinga, 2001). In MBP, Ile-329 pla  as a hi
n the glob te and open in global closed state (M  Hellin
peri, Ile-2 ocated at the same position as Ile-329 of MBP, which ndicated t
the hinge f T1754peri (Figure 3. 31).  
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Figure 3. 31 Hinge prediction of BT1754peri according to MBP structure. 
A: Maltose binding protein shifts from open state (left) to a ligand-binding close state by bending the two sub domains 
ellow and cyan) around the hinge region (green) where contains Ile-329 (red stick). Cited from (Marvin and Hellinga, 
. BT1754peri belongs to the first class. When 
MBP, GBP, or RBP fused to a green fluorescent protein, the fusion protein can be used for in vivo 
monitoring of cellular metabolism by fluorescence microscopy (Fehr et al., 2002; Fehr et al., 2003). 
The utilisation of this system will be expanded if combine computational design (Fukami-
Kobayashi et al., 1999). This super family explored as engineer biosensors opens a door potential 
for the usage of this fructose binding protein (Dwyer and Hellinga, 2004). 
 
 
Based on its similarity to other PBPs it seems very likely that conformational change on ligand 
binding occurs in BT1754peri. Evidence for this is provided here as we show that the protein 
displays increased stability against both protease action and thermal denaturation in the presence of 
fructose. It is likely this stabilisation is caused by tightening of the structure driven by domain 
closure around the sugar. 
 
(y
2001). B: BT1754peri binds to fructose with Ile-270 (red stick) as the possible hinge switch locates between two 
subdomains (yellow and cyan). The last helix is colored in palegreen. This structure is rotated around compared to 
Figure 3.17. 
 
 
 
 
 
According to the number of β-sheets in each sub-domain, PBPs are classified into three groups: 
ABP represents the first class, which has 6 β-sheets, the second has 5 β-sheets in each sub domain, 
such as HBP, and the third has 5 β-sheets in N-terminal sub domain and 4 in C-termini, such as 
vitamin B12 binding protein (Karpowich et al., 2003)
BT1754peri is present as a monomer in solution in the presence and absence of fructose by gel 
filtration chromatography and crosslinking analysis. But th orms a dimer in crystal, with 
the dimerisation interface formed betw  s ach monomer. BT1754peri is 
predicted to be a dimer in the cell as well be m homodimers (Lee et 
al., 2008a). It is likely that the la ss on is due to the fact that the 
protein is not tethered to the memb  i d e   known that attachment to the 
membrane to hold the protein in two-dimensions can se in the association constant 
for the interaction by up to 106-fold (M
 
Modelling the structure of the dimer of BT1754peri with the known structure of the cytoplasmic 
domains of the TM0853  histidine kinase from Th
the C-terminal helices of BT1754 into the mem well onto the helices of the 
dimeric cytoplasmic phosphoaccep mbrane (Marina et al., 2005) 
(Figure 3. 32). 
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Figure 3. 32 Model for structure of BT1754 sensor HK. 
Putative assembly of whole BT1754 structure based on known structure of BT1754peri, the cytoplasmic region of 
TM0835 sensor HK from Thermotoga maritima (PDB ID 2C2A) (Marina et al., 2005), the entire RR protein (receiver 
domain and DNA binding domain) of the nitrate responsive NarL (PDB ID 1A04) (Baikalov et al., 1998), and a 
possible transmembrane domain. The ATPase domain of each HK is linked to a RR domain as BT1754 is a hybrid two 
component system. The periplasmic sensor domain is predicted to form into a dimer with C-terminal helices contacting 
each other. When sensor binds the fructose, the conformational change is transferred across the membrane via the C-
terminal helices, possible via a piston like movement, to the equivalent helices of the dimeric cytoplasmic 
phosphoaccaptor domain. The TM helices are predicted to be dimerized into a 4-helix bundle. The phosphoacceptor 
domain dimer forms a 2 helix bundle that maps well onto the 2 helix bundle of the sensor C-terminal. The position on 
the phosphoacceptor domain of the His that is phosphorylated on activation of the HK is shown circled in red. Black 
arrow indicates the direction the ATPase domains would have to twist in order to phophorylate the His of the opposite 
monomer as proposed by (Marina et al., 2005). Precisely how a piston like movement of the sensor domain could be 
transduced into a twisting action is not clear. The activated phosphoacceptor then transfers the phosphate to the 
conserved Asp of the RR (circled in red; red arrows indicate direction of phosphotransfer) to activate the associated 
DNA binding domain. 
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Thus it appears that signal will be transduced in BT1754 by a conformational change in the sensor 
domain on ligand binding that is transmitted via the C-terminal helices of the dimer through the 
membrane helices to the dimeric helices of the phosphoacceptor domain to activate the 
phosphorelay. Activation of the HK is thought to be by phosphorylation of the opposite monomer, 
but precisely how the catalytic domain of one monomer moves to phosphorylate the conserved His 
f the acceptor domain is currently unknown.  The movement of the helices relative to one another 
 also unclear but it seems likely, based on the structure of BT1754peri, that ligand binding induces 
a ‘piston’ type movement of the helices away from the membrane (Figure 3. 33). This piston like 
 
o
is
movement has been suggested before for citrate sensing PAS domain of the citA sensor HK 
(Sevvana et al., 2008). 
 
 
 
Figure 3. 33 Model of piston like motion of C-terminal helices in BT1754 on fructose binding.  
The sensor linked with transmembrane domains is shown as a dimer. On ligand binding, the TM2 moves vertically 
towards the periplasm in a piston type fashion, thus transducing the signal across the membrane. Cited from (Sevvana et 
al., 2008). 
   
 
 
Overall, BT1754peri specially binds fructose to initiate the signalling transduction into the 
cytoplasm. Its structure revealed the binding specificity and possible conformation change during 
the signalling process.   
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Chapter 4: Glycoside hydrolase family 32 
4.1 Introduction 
The GH32 family contains nature fructan-degrading enzymes. Fructans are β-2,1 or β-2,6 linked 
omopolymers of fructose found in many plants and bacteria where they play a role a storage 
olysaccharides, resistance to drought and in biofilm formation (section 1.2.5). According to the 
Cazy database of Jan 2009 (www.cazy.org/fam/gh32.html
h
p
) GH32 has 833 members from archea, 
bacteria, fungi and plants, but not animals. Sucrose, a disaccharide of glucose and fructose is 
broken down in animals by an α-glucosidase, rather than a β-fructosidase (section 1.1.2). Because 
of this inability of humans to use fructans and the fact that they are readily utilised by health 
promoting symbiotic gut bacteria, these polymers are often used as prebiotics or ‘functional foods’. 
Most GH32s have an exo-mode of action, releasing fructose from the ends of both β-2,1-linked 
inulins and β-2,6-linked levans. Catalysis proceeds via a retaining mechanism, with a catalytic 
nucleophile (Asp) and a catalytic proton donor (Glu). They share a common 3D structure: a 5-fold 
β-propeller similar to the β-propeller of GH43 and GH68, with a C-terminal β-sandwich module of 
unknown function and are members of clan GH-J. All GH32s whose structure has been solved to 
date are exo acting and release fructose from their β-configured substrates (Figure 4. 1). These 
structures are of a GH32 from the bacterium Thermotoga maritima that acts on sucrose, raffinose, 
and inulin (Alberto et al., 2004), an exo-inulinase from the fungus Aspergillus awamori that can 
cleave levan, inulin, and sucrose (Nagem et al., 2004), a cell-wall invertase from Arabidopsis 
thaliana that hydrolyses sucrose preferentially but can also act on inulins and levans, albeit at a 
al., 2006), and the fructan 1-exohydrolase IIa from Chicory 
) which can not digest sucrose or levan, but can break down inulin-type fructans 
t et al., 2005). The distance between the two catalytic residues in these structures varies 
to 6.9 Å, which is slightly further apart than the typical distance for retaining 
much reduced rate (Verhaest et 
(Cichorium intybus
(Verhaes
between 6.1 Å 
enzymes of ~5.5 Å. 
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Figure 4. 1 GH32 structures solved to date. 
See legend at the next page. 
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Legend for Figure 4.1: 
 
 
between two domain. In the Chicory GH32 (panel H) a sucrose molecule is located in the catalytic pocket. This plant 
enzyme is unable to utilise sucrose so the sugar is binding as a competitive inhibitor. 
 
Genechip data from B. thetaiotaomicron grown on inulin as the sole carbon source revealed a 
unique locus upregulated in the presence of the β-2,1-linked fructan (Figure 4. 2; E.C. Martens, 
unpublished data).  
 
The four representatives of GH32 whose structures have been solved to date shown as secondary structure cartoon and 
surface. A and B: Thermotoga maritima (PDB ID 1UYP) (Alberto et al., 2004; Alberto et al., 2006), C and D: 
Aspergillus awamori (PDB ID 1Y9G) (Nagem et al., 2004), E and F: Cell wall invertase from Arabidopsis thaliana 
(PDB ID 2AC1) (Verhaest et al., 2006), G and H: fructan β-(2,1)-fructosidase, from Chicorium intybus (PDB ID 
2ADD) (Verhaest et al., 2007b). Left: The cartoon representation shows the GH32s have a two domain structure: a 5-
fold β-propeller catalytic domain (pink, cyan, orange, palegreen, and gray), and a C-terminal β-sandwich domain 
(yellow). All α-helices are indicated in red, loops are in green, and binding substrates are sticks. The catalytic 
nucleophile residue Asp (red stick) located on the first β-blade, while the conserved acid base Glu (blue stick) located at 
the beginning of the fourth blade (palegreen). Right: Surface representation of GH32s shows the two catalytic residues 
located in a pocket (Asp is red, Glu is blue). In B, there is a glycerol molecule from cryo bound in the catalytic pocket. 
In D, there is a fructose molecule located in the catalytic pocket and a few covalently bound GlcNAc molecules around 
the surface as the enzyme is a glycoprotein. In F, there is a glycerol molecule located in the catalytic pocket, and a few
GlcNAc molecules binding around the surface. A covalently bound (GlcNAc)2MAN4 molecule is located in the cleft
 
Figure 4. 2 Gene map of the unique locus upregulated in response to growth of B. thetaiotaomicron on inulin.  
All genes are shown except BT1764 upregulated in response to inulin. BT1759, BT1760, BT1765, and BT3082 are 
genes encoding  predicted GH32 enzymes. BT1763 and BT1762 are the SusC and SusD homologue, respectively, 
BT1757 is a fructokinase and BT1758 is an inner membrane monosaccharide transporter. 
 
 
 
Within this locus were genes encoding three predicted GH32 enzymes: BT1759, BT1760, and 
BT1765. In addition a fourth orphan GH32 gene BT3082 was also upregulated. To further our 
understanding of fructan degradation by this important gut symbiont, biochemical and structural 
analysis of the products of these genes was carried out. 
4.2 Results 
There are four GH32 found in B. thetaiotaomicron: BT1759 and BT1760, which are in the inulin 
locus of BT1757 to BT1763, BT1765 next to this gene cluster and BT3082. Multiple sequence 
alignments of these four GH32 against the four GH32s whose structures have been solved revealed 
that BT1759, BT1765, and BT3082 have extra N-terminal sequence, suggesting the presence of an 
additional domain, which is so far unique amongst characterised GH32 enzymes (Figure 4. 3). All B. 
thetaiotaomicron enzymes also have the typical C-terminal β-sheet domain of unknown function 
found in all GH32s to date. The central catalytic domain contains regions of high sequence 
similarity including the catalytic nucleophile and acid/base which indicates the functional 
conservation. Also worth noting is the Arg-Glu-Pro (RDP) motif (Figure 4. 3), which is conserved 
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in all enzymes that act on fructosyl containing substrates, including levansucrases and sucrose-6-
phosphate hydrolases, and has been suggested to play a critical role in fructose specificity (Alberto 
et al., 2004; Nagem et al., 2004). 
 
 
Figure 4. 3 GH32 multiple sequence alignment. 
Multiple alignment of B. thetaiotaomicron GH32s against structure solved GH32 enzymes. A: Thermotoga maritima 
(PDB ID 1UYP), B: Arabidopsis thaliana (PDB ID 2AC1) (Verhaest et al., 2006), C: Aspergillus awamori (PDB ID 
1Y9G), D: Chicorium intybus (PDB ID 2ADD). All proteins have an N-terminal signal peptide. BT1759, BT1765, and 
BT3082 have an extra N-terminal domain (pink box) when compared to other enzymes. The catalytic nucleophile (Asp) 
and acid/.base (Glu) residue are boxed in red and cyan. Another motif RDP is in orange box. The C-terminal β-
sandwich domain present in all GH32s is boxed in green. The similarity in C-terminal is lower than the catalytic domain. 
All GH32s have a RDP motif (orange box) and an Asp-Cys-Pro (ECP) motif (cyan box). This alignment is made by 
Multalin. 
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Sequence alignment revealed that BT1760 has lower identity to all other Bacteroides enzymes (less 
than 14 % for all), while BT1759 and BT1765 have 51 % identity. BT3082 is most similar to 
BT1759 (34 %) (Table 4. 1). 
 
% BT1759 BT1760 BT1765 BT3082 A B C D 
BT1759  5 51 34 26 18 35 20 
BT1760   8 11 10 14 7 12 
BT1765    30 29 16 30 18 
BT3082     27 17 29 21 
A      22 24 24 
B       21 48 
C        20 
D         
Table 4. 1 GH32 identities. 
Based on sequence alignment, the identities are issued. A: Thermotoga maritima (PDB ID 1UYP) (Alberto et al., 2004; 
Alberto et al., 2006), B: Arabidopsis thaliana (PDB ID 2AC1) (Verhaest et al., 2006), C: Aspergillus awamori (PDB 
ID 1Y9G) (Nagem et al., 2004), D: Chicorium intybus (PDB ID 2ADD) (Verhaest et al., 2007b). BT1760 has low 
identities to all other sequences (less than 14 % for all), while BT1759 and BT1765 have 51 % identity. BT3082 is most 
similar to BT1759 (34 %). 
 
 
 
4.2.1 Cloning and expression of the GH32s 
cteroides GH32 proteins were predicted by SMART and SignalP to have signal peptides 
nd are therefore either secreted into the environment or found in the periplasm of the gut symbiont. 
4.2.1.1 Signal peptide prediction 
The four Ba
a
BT1760 is a predicted lipoprotein using LipoP and is therefore likely positioned outside the cell 
embedded in the outer membrane (Figure 4. 4). The SignalP prediction for a signal peptide in 
BT1765 is unconvincing, suggesting it may be a cytoplasmic enzyme. 
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Figure 4. 4 Signal peptide prediction of GH32 members of B. thetaiotaomicron. 
The red domain at the N-terminal of each protein represents a likely signal peptide. This was confirmed using SignalP 
with all but BT1765 which had a very poor prediction. The green box is the region of each protein which is conserved 
in all GH32 members and includes the central catalytic domain. The gray lines indicate parts of the sequence which do 
not contain domains recognised by SMART. The N-terminal of BT1759, BT1765, and BT3082 are longer than in 
BT1760, indicating the putative extra N-terminal domain of these proteins. 
 
 
4.2.1.2 Primers and vectors 
to pET22b (C-His-tag). BT1760 [22-523] was cloned into pET28b BT1759 [29-610] was cloned in
(C-His-tag) and pET32b (N-Trx-His-tag plus C-His-tag) individually. BT1765 [27-627] was cloned 
into pET28b (C-His-Tag). BT3082 [24-548] was expressed in minipRSETA (N-His-tag). All 
primers were designed in MWG, with appropriate restriction site flanked (Table 4. 2). 
 
Primer ID Sequence ( 5’---------------------------------------------------------->3’) Note 
BT1759-1 CTCCCATGGATGCGGATTCTCCTTTGC F Nco I  
BT1759-2 CCGCTCGAGTTTCTTCAGTTTGTAAACC R Xho I 
BT1760-1 CTCCCATGGATAGTGACGAGACTGAC F Nco I 
BT1760-2 CCGCTCGAGATAAGTGCTTACCTG R Xho I 
BT1765-1 CTCCCATGGATTATTGCCAGTCGACC F Nco I 
BT1765-2 CCGCTCGAGTAAACCTAATCTATACACAC R Xho I 
BT3082-1 CTCGGATCCGGAGAAGTATCTTTTAAAATAACCAAGC F BamH I 
BT3082-2 CTCGAATTCCTACCAAATGGATTCTACGGAAAAGAC R EcoR I 
Table 4. 2 Primers for GH32 wild types.  
The restriction sites are listed in the last column. F: Forward primers, R: Reverse primers. 
 
4.2.1.3 Proteins expression 
His-tagged GH32 enzymes were over expressed in E. coli BL21 cell strain and then purified in a 
eins could be produced in a soluble form and were single step by IMAC (Figure 4. 5). All prot
dialysed into 20mM Tris-HCl, pH 8.0 buffer for enzyme assays. 
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Figure 4. 5 IMAC purified GH32s from B. thetaiotaomicron used in this study 
ane 1: Marker, Lane 2: BT1759-pET22b (66.3 kD, pI 5.9), Lane 3: BT1760-pET28b (57.0 kD, pI 5.20), Lane 4: 
T1765-pET28b (68.7 kD, pI 5.2).  Lane 5: Marker, Lane 6: BT3082-minipRSETA (62.5 kD, pI 6.7).  
.2.2 Biochemical characterisation of the GH32s 
4.2.2.1 Enzyme activ inst f s and fructol accharides 
The activity of the enzymes against a range of β-fructan oligo and polysaccharides was assessed 
using the DNSA method (section 2.40). The substrates include the levan (from Serratia levanicum), 
inulin (from chicory), sucrose (K2), Kestose (K3), Kestotetraose (K4), and Kestopentaose (K5). K2, 
K3, K4, and K5 are oligosaccharides of inulin, which are unbranched β-2,1 linked fructose with a 
terminal glucose (Figure 1.4). Levan oligosaccharides consist of β-2,6 linked fructose with no 
terminal glucose and are herefore redu rs which could e used for DNSA.  
 
The kinetic parameters ic act ainst a range of substrates are listed as Table 4. 3. 
Because the polysaccharide concentrations are in mg/ml, the ts for inulin and levan are not 
directly comparable. The concentrations for oligosaccharides are in molar and thus the results for 
them are comparable. Th β-2,1 linked, and 
β-2,6 linked fructans, wh 760 could only digest levan. BT1759 and BT3082 are not sensitive 
to the β-2,1 chain length 5 prefe chain fructans, ially sucrose and has only very 
low activity on polysaccharides. Indeed the activity of BT1765 against inulin and levan was too low 
to accurately determine K enzym
L
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 BT1759 BT1760 BT1765 BT3082 
 Kcat 
(min-1) 
Kma Kcat/Km Kcat 
(min-1) 
Km Kcat/Km Kcat 
(min-1) 
Km Kcat/Km Kcat
(min-1)
m  
 
Km Kcat/K
Inulin 26.5 ± 5.3 0.07± 0.0 379 NAb   5.9 NDc  88.1 ± 5.3 0.1 ± 0.0 881 
Levan 7.7 ± 0.5 0.05 ± 0.0 154 331.5 ± 42.8 0.3 ± 0.0 1105 1.1 ND  31.7 ± 4.5 0.4 ± 0.1 79.3 
Sucrose 336.0 ± 2.0 0.9 ± 0.1 373 NA   1759.0 ± 531.1 0.2 ± 0.0 8795 121.8 ± 3.8 0.1 ± 0.0 1353 
K3 34.0 ± 11.2 0.1 ± 0.0 378 NA   155.0 ± 41.4 0.2 ± 0.0 775 149.5 ± 25.6 0.1 ± 0.0 1869 
K4 47.8 ± 19.6 0.1 ± 0.0 478  NA   115.9 ± 8.4 0.1 ± 0.0 1288 104.8 ± 12.8 0.1 ± 0.0 1497 
K5 ND   NA   99.1 ± 17.8 0.2 ± 0.0 496 147.6 ± 14.0 0.1 ± 0.0 164 
Table 4. 3 Kinetic parameters for B. thetaiotaomicron GH32 enzymic activities against oligo and polysaccharides determined by reducing suga
Assays were carried out at least in triplicate to calculate standard deviations for each. aKm for polysaccharides is in mg/ml, for oligosaccharid cNot 
determined. 
r assays.  
es it is mM. bNo activity. 
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igure 4. 6 HPLC data of Bacteroides GH32sF  against polymeric fructans. 
A: BT1759 against inulin, 50 % gradient. B: BT1759 against levan, 50 % gradient. C: BT1760 against levan, 25 % 
gradient. D: BT3082 against levan, 15 % gradient (default). E: BT3082 against inulin, 15 % gradient. G is glucose, F is 
fructose, and L2-L3 are levan oligos. Reaction time points are from 0-500 min. Note: Inulin has a much shorter average 
chain length than levan, resulting in a large number of peaks being visible in the inulin traces.  
 
 
Analysis of the product profile of the GH32s against oligosaccharides showed a similar pattern  
with BT1759, BT1765, and BT3082 releasing fructose from kesto- (β-2,1) and levan- (β-2,6) 
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Figure 4. 7 HPLC data show product profile of BT1759, BT1765, and BT3082 against kestopentaose. 
A: BT1759, B: BT1765, 15 % C: BT3082. G means glucose, F is fructose and K2-K5 are oligosaccharides of inulin. 
Reaction time points are present as 0 to 750 min. Only K5 with each enzyme is displayed here as an example. The peak 
bigger than K5 may be K6 because no K6 standard used in this study, while it is unclear what the two small peaks 
around K4 are. 
 
 
oligosaccharides (example data shown in Figure 4. 7). Some minor peaks appear in the digestions 
that are not the linear n+1 or n-1 oligosaccharides that are the major products, but that are substrates 
for the enzymes (See for example Figure 4. 7B around K4). It is not clear what these peaks are, but 
they may be branched oligosaccharides produced by transglycosylation during the process of 
enzymic action. 
 
 
BT1760 was able to digest all levan-oligosaccharides tested from L2-L5. Activity against 
levanbiose was very low as would be expected of an endo acting enzyme (Figure 4. 8A). Against 
L5, fructose, L2, and L3 were released from the beginning of the reaction (10 min), rather than just 
L4 and Frc, again supporting the mixture of endo and exo action for this enzyme (Figure 4. 8D).   
 
 
 
 
Figure 4. 8 BT1760 digest levan oligos. 
A: L2, B: L3, C: L4, D: L5. F means fructose. Reaction time points from 0-220 min are shown.  
 
 
4.2.2.3 TLC 
TLC was carried out as alternative method of assessing the product profile of BT1760 and BT3082 
against polymeric levan. From the TLC data, the difference in mode of action between BT1760 and 
BT3082 can be easily observed (Figure 4. 9). BT1760 could digest the levan int nt lengths 
from the beginning, with L3 and L2 as the major products with some L4 earlier an se later in 
the reaction, while BT3082 just released fructose. These data confirm BT1760  an endo-
levanase. BT3082 is an exo acting β-fructosidase. 
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Figure 4. 9 TLC shows the process of levan digestion against BT1760 and BT3082 separately.  
Lanes 1-11: BT1760 digestion at time points: 0m, 1m, 2m, 5m, 10m, 20m, 30m, 1h, 2h, 3h, overnight, Lanes 12 and 24: 
Levan oligosaccharides marker. Lane 13-23: BT3082 digestion at time points: 0m, 1m, 2m, 5m, 10m, 20m, 30m, 1h, 
3h, overnight. The levan concentration was 1 % for both digestions. BT1760 final concentration was 0.1 µM. BT30
2h, 
82 
final concentration was 1 µM.  
 
 
4.2.3 Structural analysis of B. thetaiotaomicron GH32s 
Structural studies were undertaken with all four GH32s from B. thetaiotaomicron to investigate the 
molecular details of substrate binding and catalysis. Although extensive crystallization screens were 
set up with BT1759 and BT1765, no shootable crystals were obtained. Structures were determined 
for BT1760 and BT3082 by Dr. Susan Firbank and they are detailed as below. 
4.2.3.1 BT3082 fructosidase 
4.2.3.1.1 Structure of BT3082 
The nucleophile mutant D131A was obtained by site-directed mutagenesis with primers BT3082-3 
(5’-GGCTGGATCAATGCCCCTAACGGATTAATC-3’), and BT3082-4 (5’-
GATTAATCCGTTAGGGGCATTGATCCAGCC -3’. This mutant lost all enzymic activity against 
fructans as assessed by DNSA analysis and could form shootable long-needle crystals in condition: 
as solved by molecular replacement against the invertase 
om Thermotoga maritima at a maximal resolution of 2.2 Å (Figure 4. 10). The four copy structure 
0.1 M MES pH 6.5, 12 % w/v PEG 20000. The structure of the D131A nucleophile mutant of 
T3082 in complex with kestose (K3) wB
fr
unit has cell parameters a = 94.4 Å, b = 113.4 Å, c =134.1 Å, and β = 98.87°, containing 19320 
atoms.  
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Figure 4. 10 Structure of BT3082 nucleophile mutant (D131A) with kestose bound 
Left: Cartoon representation shows the structure of BT3082 nucleophile mutant D131A with ligand K3 binding in the 
middle of 5-blade β-propeller (purple, cyan, orange, palegreen, and blue). α-helices are colored red and loops are 
colored green. The β-strands of the N-terminal domain are shown in wheat. A131 (ala mutant of nucleophile) is blue 
stick and E301 (acid/base) is red stick. Right: Surface representation shows the active site of the enzyme is a pocket 
with bound K3 in green (A131 in blue and E301 in red). 
 
According to the mutant structure, BT3082 wild type structure was solved at a maximal resolution 
of 2.5 Å (Figure 4. 11). The four copy structure unit has cell parameters a = 94.3 Å, b = 114.3 Å, c 
=135.1 Å, and β = 99.23°, containing 17012 atoms. A monomer BT3082 structure comprises three 
modules: an extra N-terminal module (residues 24-107), linked to a catalytic five bladed β-propeller 
(residues 128-408) by a 10-residue loop, and then linked to a C-terminal β-sandwich (residues 416-
548) by a 7-residue loop. The N-terminal domain is completely novel within the GH32 family. The 
closest distance of two oxygens on side-chains of these two residues Asp131 and Glu301 is 5.89 Å. 
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Figure 4. 11 Structure of BT3082 fructosidase 
Left: This structure has an extra N-terminal of two α-helices (red) and 7 β-sheets, linked a 5-fold β-propeller (purple, 
cyan, orange, palegreen, and blue), and a C-terminal β-sandwich (yellow). Loops are colored green. The first helice is 
between the last two β-sheets, and the second helice is very small between extra module and catalytic module. The third 
helice is between blade 2 and blade 3, while the fourth links the catalytic domain and β-sandwich. There is an extra 
helice in β-sandwich on the very outside. The two catalytic residues are presented as red (D131) and blue (E301) sticks 
and are located on the first blade (purple) and the loop between the third blade (orange) and fourth blade (palegreen). 
Right: Surface representation shows the surface of BT3082 as grey, while the D131 (red) is at the bottom of a pocket 
and E301 (blue) is on the sidewall of the same pocket. The closest distance of the two catalytic residues is 5.89 Å 
between two oxygens of side-chains of the catalytic Asp and Glu. 
 
 
 
This wild type structure is identical to the D131A mutant except the mutated residue (Figure 4. 12). 
 
 
 
Figure 4. 12 Overlay of BT3082 WT with D131A. 
Left: BT3082 WT was colored green, while D131A was colored blue. The ligand K3 in D131A was not shown. Right: 
Zoom in the red box of left panel to show the D131 (green stick) in WT was replaced by alanine (blue stick) in mutant, 
while E301 is same location in both. 
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A DALI protein structure database search with the N-terminal domain of BT3082 only indicated 
that the protein has little similarity to other known structures (Figure 4. 13). The most similar 
structures are sensory rhodopsin transducer proteins although the Z scores are low. 
 
 
    No:  Chain   Z    rmsd lali nres  %id  Description 
   1:  2iia-A  5.7  2.4   64    89    2   SENSORY RHODOPSIN TRSANSDUCER PROTEIN;                      
   2:  2ii9-C  5.6  2.4   64    93    2   SENSORY RHODOPSIN TRANSDUCER PROTEIN;                       
   3:  2ii9-B  5.6  2.4   64    92    2   SENSORY RHODOPSIN TRANSDUCER PROTEIN;                       
   4:  2ii9-A  5.6  2.4   64    92    2   SENSORY RHODOPSIN TRANSDUCER PROTEIN;                       
   5:  2ii8-E  5.5  2.4   64    92    2   ANABAENA SENSORY RHODOPSIN TRANSDUCER  
   6:  2ii8-C  5.5  2.4   64    92    2   ANABAENA SENSORY RHODOPSIN TRANSDUCER              
   7:  2ii7-G  5.5  2.4   64    91    2   ANABAENA SENSORY RHODOPSIN TRANSDUCER  
   8:  2ii7-F  5.5  2.4   64    91    2   ANABAENA SENSORY RHODOPSIN TRANSDUCER  
   9:  2ii9-D  5.4  2.4   64    94    2   SENSORY RHODOPSIN TRANSDUCER PROTEIN    
   10: 2ii8-H  5.4  2.5   64    92    2   ANABAENA SENSORY RHODOPSIN TRANSDUCER 
Figure 4. 13 DALI results for BT3082 N-terminal domain. 
Dali matches the top 10 structures sorted by Z-score. These 10 structures all are sensory. Chain: PDB entry code plus 
chain identifier. Z: normalized Z-score that depends on the size of the structures. The program optimises a weighted 
sum of similarities of intramolecular distances. rmsd: root-mean-square deviation of C-alpha atoms in the least-squares 
superimposition of the structurally equivalent C-alpha atoms. The program does not optimise rmsd, this is only reported 
for your information. lali: number of structurally equivalent residues. nres: number of amino acids in the protein. %id: 
percentage of identical amino acids over all structurally equivalent residues. Description: the COMPND record from the 
PDB entry. 
 
 
 
DALI results with the C-terminal domain of BT3082 only reveal that it is related to sugar binding 
lectins though the highest Z score is only 11.3 (Figure 4. 14).  
 
 
  No:  Chain   Z    rmsd lali nres  %id  Description 
 the structurally 
n. lali: number 
   1:  2yv8-A 11.3  2.8  117   151    8   GALECTIN-8 VARIANT;                                         
   2:  2yxs-A 11.2  2.8  116   150    8   GALECTIN-8 VARIANT;                                         
   3:  2d6k-A 11.2  2.6  114   147    7   LECTIN, GALACTOSE BINDING, SOLUBLE 9;                       
   4:  2d6p-A 11.1  2.6  114   144    7   LECTIN, GALACTOSE BINDING, SOLUBLE 9;                       
   5:  1y9m-A 11.1  3.0  121   517   15   EXO-INULINASE;                                              
   6:  2qqv-A 11.0  2.9  124   537   15   BETA-FRUCTOFURANOSIDASE;                                    
   7:  2d6p-B 11.0  2.6  113   147    7   LECTIN, GALACTOSE BINDING, SOLUBLE 9;                       
   8:  2d6o-X 11.0  2.7  114   151    8   LECTIN, GALACTOSE BINDING, SOLUBLE 9;                       
   9:  2d6n-B 11.0  2.7  115   153    7   LECTIN, GALACTOSE BINDING, SOLUBLE 9;                       
  10:  1y9g-A 11.0  3.0  121   517   17   EXO-INULINASE;                                           
Figure 4. 14 DALI results for BT3082 β-sandwich. 
Dali matches the top 10 structures sorted by Z-score. Chain: PDB entry code plus chain identifier. Z: normalized Z-
score that depends on the size of the structures. The program optimises a weighted sum of similarities of intramolecular 
distances. rmsd: root-mean-square deviation of C-alpha atoms in the least-squares superimposition of
ly reported for your informatioequivalent C-alpha atoms. The program does not optimise rmsd, this is on
of structurally equivalent residues. nres: number of amino acids in the protein. %id: percentage of identical amino acids 
over all structurally equivalent residues. Description: the COMPND record from the PDB entry. 
 
 
 125
DALI searches revealed that the central β-propeller catalytic domain of BT3082 has high similarity 
to other solved GH32 proteins with Z score up to 39.9 (Figure 4. 15).  
 
 
  No:  Chain   Z    rmsd lali nres  %id  Description 
  1:  1y9m-A 39.9  1.7  299   517   42   MOLECULE: EXO-INULINASE;                                          
  2:  1y9g-A 39.7  1.8  300   517   42   MOLECULE: EXO-INULINASE;                                          
  3:  1y4w-A 39.7  1.8  300   517   42   MOLECULE: EXO-INULINASE;                                          
  4:  2ac1-A 34.9  2.1  284   537   33   MOLECULE: INVERTASE;                                              
  5:  2qqu-A 34.5  2.2  284   535   33   MOLECULE: BETA-FRUCTOFURANOSIDASE;                                
UCTAN 1-EXOHYDROLASE IIA;                             
 of BT3082 D131A with kestose allowed us to identify residues that contact 
the substrate in the active site and may therefore be important in binding and catalysis (Figure 4. 16 
and Table 4. 4). There are 11 hydrogen bonds formed between ligand K3 and BT3082 D131A. Ten 
of the 11 are formed with the fructose bound at the -1 position: O1 forms one with N130, O3 forms 
three hydrogen bonds with R256, D257, and E301 individually, O4 forms two hydrogen bonds with 
S188 and D257 separately, and O6 forms two hydrogen bonds with N130, one with Q147 and one 
with W155, with an extra bond formed by the O3 on the +1 fructose ring with catalytic residue 
E301 (Figure 4. 16E). There are four more aromatic residues (W120, F187, Y353, and W373) 
around kestose which do not form hydrogen bond with substrate, but form the hydrophobic surface 
of the binding pocket (Figure 4. 16D). Five other residues (A131, M158, D254, C302, and A354) 
around -1 fructose of kestose are around the bottom of the pocket (Figure 4. 16B). A131 is mutated 
from D131 which should have hydrogen bond with kestose if in wild type. So totally, there are 13 
residues involved in the formation of catalytic pocket. 
 
 
 
 
 
 
   6:  1st8-A 34.3  2.0  283   537   31   MOLECULE: FR
   7:  2aez-A 34.2  2.1  283   536   31   MOLECULE: FRUCTAN 1-EXOHYDROLASE IIA;                             
   8:  2ade-A 34.2  2.1  284   537   31   MOLECULE: FRUCTAN 1-EXOHYDROLASE IIA;                             
   9:  2add-A 34.1  2.1  284   537   31   MOLECULE: FRUCTAN 1-EXOHYDROLASE IIA;                             
  10:  1uyp-B 34.1  1.7  266   432   38   MOLECULE: BETA-FRUCTOSIDASE;                               
Figure 4. 15 DALI results for BT3082 catalytic domain. 
Dali matches the top 10 structures sorted by Z-score. These 10 structures all are from GH32 members. Chain: PDB 
entry code plus chain identifier. Z: normalized Z-score that depends on the size of the structures. The program 
optimises a weighted sum of similarities of intramolecular distances. rmsd: root-mean-square deviation of C-alpha 
atoms in the least-squares superimposition of the structurally equivalent C-alpha atoms. The program does not optimise 
rmsd, this is only reported for your information. lali: number of structurally equivalent residues. nres: number of amino 
acids in the protein. %id: percentage of identical amino acids over all structurally equivalent residues. Description: the 
COMPND record from the PDB entry. 
 
 
 
4.2.3.1.2 BT3082 active site 
Analysis of the complex
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Figure 4. 16 BT3082 D131A binding site to kestose. 
There are 16 residues are found around the ligand K3. Residues forming hydrogen bonds with kestose are drawn as 
pink sticks (panels A-E). Amino acid side chains making hydrophobic contacts with kestose are shown as yellow sticks 
(panels A-D) while other residues forming the active site pocket are shown in cyan (panels A-C). A: Surface 
representation from the side angle shows the binding pocket. C: surface representation from the top of the binding 
pocket. It is easy to see the pink residues are on two sides of the pocket, while aromatic residues are between the pink 
residues to form a whole pocket with a few cyan residues to form the pocket bottom. Panels B, D and E are different 
views of the active site to illustrate the interactions made by 3082 with kestose. 
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Kestose atom BT3082 D131A residue Distance (Å) 
Frc1 O1 N130-O 3.19 
R256-N 3.07 
D257-O 2.62 
E301-O 3.56 
C302-C 3.90 
W373-C 3.66 
Frc1 O3 
 
Y353-C 3.85 
S188-N 2.92 Frc1 O4 
 D257-O 2.51 
Frc1 O5 A131-N 5.05 
N130-O 3.09 
N130-N 3.45 
Q147-N 2.76 
Frc1 O6 
W155-N 2.90 
Frc1 C6 F187-C 3.98 
Frc2 O3 E301-O 3.06 
D254-O 4.45 Frc2 O4 
Frc2 O4 Q221-N 5.29 
Glc O5 W128-C 3.88 
Table 4. 4 Hydrogen bonding and close contacts between BT3082 active site residues and K3. 
Hydrogen bonds are bolded. Frc1 is the -1 site at the bottom of the pocket, while the Frc2 is the +1 site and Glc has no 
hydrogen bond formed. 
 
 
 
 
According to this analysis above, a group of 16 amino acids of BT3082 was chosen and mutated to 
alanine or phenylalanine (F) respectively to assess their importance in enzyme activity (Table 4. 5). 
All mutants could be expressed in soluble form. Activity was assessed by reducing sugar assay with 
a single high concentration of each substrate. The initial rates were calculated for each and then the 
molar amount of each enzyme was normalized to wild type to get a ratio of activity against each 
substrate compared to wild type, which was set at 100 %. 
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 Primer ID Sequence ( 5’---------------------------------------------------------->3’) Note 
Table 4. 5 Primers of 16 more single mutations of BT3082. 
 F: Forward primers, R: Reverse primers. 
 
The group of 17 BT3082 mutants including the nucleophile mutant D131A was tested by DNSA 
method against three ligands: inulin, levan, and sucrose. Generally, the enzymic activity shifts 
between different mutants and different substrates (Figure 4. 17). When the two catalytic residues 
Asp131 and Glu301 were mutated to alanine individually, the enzyme was abolished activity 
completely, which happened to D257A as well. Asp257 is buried at the bottom of the pocket and 
forms bidentate hydrogen bonds with O3 and O4 of the fructose at the -1 site. This residue is also 
BT3082-5 GTTACAGGCTTTTGGGCATGTCCCGAATTG E301A F 
BT3082-6 CAATTCGGGACATGCCCAAAAGCCTGTAAC E301A R 
BT3082-9 GAGAGGCTGGATCGCTGACCCTAACGGATTAATC N130A F 
BT3082-10 GATTAATCCGTTAGGGTCAGCGATCCAGCCTCTC N130A R 
BT3082-11 CACCTGTTCTACGCGCACAATCCTTTC Q147A F 
BT3082-12 GAAAGGATTGTGCGCGTAGAACAGGTG Q147A R 
BT3082-13 CTTTCGAAAGAGACGCGGAGAATATGCAC W155A F 
BT3082-14 GTGCATATTCTCCGCGTCTCTTTCGAAAG W155A R 
BT3082-15 CCTTTCGAAAGAGACTTTGAGAATATGCACTGGG W155F F 
BT3082-16 CCCAGTGCATATTCTCAAAGTCTCTTTCGAAAGG W155F R 
BT3082-17 CATTTAGGAACGATGGCCTCCGGTTCGGCAG F187A F 
BT3082-18 CTGCCGAACCGGAGGCCATCGTTCCTAAATG F187A R 
BT3082-19 CAGCAGTGACAGAGCAGTGCAGGGGATAG Q221A F 
BT3082-20 CTATCCCCTGCACTGCTCTGTCACTGCTG Q221A R 
BT3082-23 CAGGACACACGCGCCCCGAAAGTGTTC D257A F 
BT3082-24 GAACACTTTCGGGGCGCGTGTGTCCTG D257A R 
BT3082-25 GTATCCAGATAGGCGCGGGAAGAATCTCC W373A F 
BT3082-26 GGAGATTCTTCCCGCGCCTATCTGGATAC W373A R 
BT3082-27 CTACCCGGAGAGGCGCGATCAATGACCCTAAC W128A F 
BT3082-28 GTTAGGGTCATTGATCGCGCCTCTCCGGGTAG W128A R 
BT3082-29 CTGGATCAATGACGCAAACGGATTAATC P132A F 
BT3082-30 GATTAATCCGTTTGCGTCATTGATCCAG P132A R 
BT3082-31 GGCTTTTGGGAAGCTCCCGAATTGTTTG C302A F 
BT3082-32 CAAACAATTCGGGAGCTTCCCAAAAGCC C302A R 
BT3082-33 CTTTTGGGAATGTGCGGAATTGTTTGAAC P303A F 
BT3082-34 GTTCAAACAATTCCGCACATTCCCAAAAG P303A R 
BT3082-35 GTTACAGGCTTTGCGGAATGTCCCGAATTG W300A F 
BT3082-36 CAATTCGGGACATTCCGCAAAGCCTGTAAC W300A R 
BT3082-37 GTAAAGGTCTGGGTGCAGCGATACTTCCGGTG Y353A F 
BT3082-38 CACCGGAAGTATCGCTGCACCCAGACCTTTAC Y353A R 
BT3082-39 GTAAAGGTCTGGGTGCAAAGATACTTCCGGTG Y353F F 
BT3082-40 CACCGGAAGTATCTTTGCACCCAGACCTTTAC Y353F R 
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highly conserved in other GH32 members and forms part of the RDP motif that is conserved in all 
een 
t part of the active site and 
ay play a role in holding Arg256 and Asp257 in the correct position. N130A keeps about 10 % 
activity against all three substrates. Asn130 makes one hydrogen bond with O1 and two other ones 
with O6 of Frc1. W155F kept half enzymic activity while W155A just has 17 % ability against 
sucrose, 4 % to inulin, and 9 % to levan. Q221 is quite far from the active site (5.29 Å), but Q221A 
lost 91 % activity against sucrose, 42 % against inulin, and 67 % against levan, which indicated that 
this residue is involved in catalysis. Gln147 is at the bottom of the pocket, and its mutant Q147A 
almost lost ability against all substrates, Trp128 and Trp373 are at the same side wall of the pocket, 
ucleophile and 
cid base residues, respectively (Figure 4. 3). P132A and P303A mutations abolished 60 % to 80 % 
ilar to the location of Pro of the RDP motif discussed above. Trp300 is on the other 
enzymes that act on fructose containing substrates (Figure 4. 3). The Arg of this motif has not b
tested here as there was a problem with the mutagenesis reaction. The residue is positioned such 
that it makes up a significant part if the side wall of the active site and therefore likely plays a 
significant role in catalysis, although it appears to make only a single hydrogen bond with O3 of the 
Frc at -1. The Pro of the RDP is motif was not mutated here, as it is no
m
their mutant W128A kept around half ability against all substrates, while W373 almost lost ability 
against all substrates. Pro132 and Pro303 are both in conserved regions close to the n
a
activity compared to wild type against all three substrates indicating that while they likely play a 
role in holding the catalysis. Cys302 is closer to catalytic acid/base Glu301 than Pro303, while its 
mutant C302A lost more activity than P303A. Cys302 and Pro303 are part of the ECP motif that 
contains the catalytic acid base and is conserved in other GH32 members (Figure 4. 3). Pro303 is 
not part of the active site per se but likely holds the acid base and Cys302 in the close position for 
catalysis sim
side of Glu301, while its mutant W300A lost activity against sucrose completely. Against levan and 
inulin, W300A and C302A both are at same low level (about 4 % and 10 % respectively). Tyr353 is 
completely conserved in GH32 proteins and is close to O3 of Frc1. Its alanine mutant Y353A is 
totally dead against sucrose, and has the same low activity level against levan and inulin as W300A 
and C302A. These data suggest the residue plays an important role in stabilizing the position of the 
sugar, especially glucose, in the +1 site. It is interesting to note that Y353F has 140 % activity 
against sucrose and keeps more than half activity against inulin and levan. The hydroxyl of the 
tyrosine makes no contacts with kestose, but does form a hydrogen bond with the acid base residue. 
The data from the F187A mutation is also very interesting as it has a slightly higher activity than 
wild type against inulin, while against sucrose and levan, the activities are 4 % and 18 % of wild 
type, respectively. It is not clear why this may be the case as the residue forms an integral part of 
the active site, making contacts with the C4, C5, and C6 of the Frc at -1 and so its loss would be 
expected to reduce activity on all substrates. 
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The CD analysis revealed that the overall structures of all the mutants are very similar to wild type 
suggesting that any loss of activity seen were not due to major changes in conformation (Figure 4. 
18). 
 
 
 
 
Figure 4. 18 CD spectroscopy data showing the BT3082 WT and 17 mutants. 
CD data indicated that BT3082 WT and 17 mutants have secondary structure.  
 
 
 
4.2.3.1.3 Deletion analysis of BT3082 
T3082 comprises three distinct domains: the central catalytic domain and distinct β-sheet N- and 
C-terminal domains. A BLAST search indicated t inal domain appears so far 
gure 4. 19). The C-terminal domain is common to all 
ly conserved in the family (Figure 4. 19). 
B
hat the smaller N-term
to be unique to Bacteroides enzymes (Fi
structurally characterised GH32s, but it is not complete
 132
 
Figure 4. 19 BLAST result for BT3082. 
The data revealed the most similar sequences (red lines) to BT3082. The blue box presents some of them have N-extra 
domain as well which are all from Bacteroides. 
 
 
 
Based on the structure deletion analysis was carried out to assess the importance of the N and C-
terminal domains in enzyme activity. Two primers were designed as BT3082-7: 5’-
CTCGGATCCCTGTATAAGGAAAAGAACCG-3’ (from 111th aa, fused to BamH I site), and 
BT3082-8: 5’-CTCGAATTCAAGAGGCTTACACAAGGATTCG-3’ (to 419th aa, fused to EcoR I 
site). The ∆N BT3082 (residues 111-548) is over expressed as a soluble protein (Figure 4. 20), 
while ∆C BT3082 (residues 24-419) has no expression (data not shown). 
 
Figure 4. 20 Expression of ∆N BT3082. 
Lane 1: M
The molecu
arker, Lane 2: ∆N BT3082. This ∆N BT3082 ([111-548]) was cloned by primers BT3082-2 and BT3082-7. 
lar weigh is 50.5 kD, and the pI is 6.33. 
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The ∆N BT3082 (residues 111-548) deletion abolished activity against inulin, levan or sucrose. This 
, the enzyme is either unable to fold or fold aberrantly and gets degraded in the 
ell. 
ue linker. BT1760 has no distinct N-terminal β-
andwich domain as found in BT3082. The dimer represents a symmetry bringing the β-sandwich 
domain of monomer A in contact with the β-propeller of monomer B and vice versa. This kind of 
dimerized conformation was seen in other members of GH32 (Alberto et al., 2004). The 
nucleophile mutant D62A was crystallized in the presence of levan oligosaccharides to try and 
obtain a substrate complex, but was not successful (data not shown). 
 
 
result indicated that the N-extra is necessary for the enzymic activity, although the function is 
unknown so far and the C-terminal β-sandwich is also important for the conformational stability as 
ithout this domainw
c
4.2.3.2 Structure of BT1760 levanase 
BT1760 wild type could form shootable long-needle crystals in condition: 0.2 M K/Na tartrate, 0.1 
M tri-Sodium citrate, pH 5.6, 1.4 M Ammonium sulfate in the presence of 0.5 M fructose. BT1760 
structure was solved as a dimer by SeMet-substituted protein at a maximal resolution of 2.6 Å 
(Figure 4. 21). The dimer structure unit has cell parameters a = 176.3 Å, b = 176.3 Å, c =215.8 Å, 
and β = 90°, containing 8915 atoms. One molecule of BT1760 has two individual domains: the N-
terminal five-bladed β-propeller catalytic domain (residues 34-358) linked to a C-terminal β-
sandwich domain (residues 368-523) by a 10-resid
s
 
Figure 4. 21 Structure of BT1760 endo levanase. 
The resolution for BT1760 is 2.6 Å. Left: This structure has an N-terminal 5-fold β-propeller catalytic domain (purple, 
cyan, orange, palegreen, and blue), and a C-terminal β-sandwich domain (yellow). Loops are colored green, while 4 α-
helices are colored in red. The first helice is between blades 2 and 3, while the second is between blades 4 and 5. There 
is another helice between catalytic domain and β-sandwich. There is a small helice in the β-sandwich between two β-
sheets. The two catalytic residues are presented as red (Asp-62) and blue (Glu-242) sticks which located on the first 
blade (purple) and the loop between third (orange) and fourth (palegreen) blades respectively. Right: Surf
e bottom of a pocket and E242 (blue) is 
ace 
representation shows the surface of BT1760 as grey, while the D62 (red) is at th
on the sidewall of the same pocket. This catalytic pocket is larger and more open than the BT3082 pocket. 
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The DALI search for BT1760 presented a group of most similar structures, in which the top 25 are 
from the four solved GH32 proteins (Z scores from 33.6 to 29.5) while a few from GH43 family 
hich includes β-xylosidases (PDB ID: 3CPN and 1YI7, Z score 24.3 and 23.6 respectively) from 
Clostridium Acetobutylicum (Figure 4. 22) (Osipiuk, 2008; Teplyakov, 2005) and several from 
 23.9) (Meng and Futterer, 2003).  
    No:  Chain   Z    rmsd lali nres  %id  Description 
        
        
        
          
          
          
        
        
ASE;                                      
 10:  1w2t-A 33.2  2.8  399   432   16   MOLECULE: BETA FRUCTOSIDASE;                                      
 11:  1uyp-E 33.2  2.8  399   432   16   MOLECULE: BETA-FRUCTOSIDASE;                                      
  12:  1uyp-A 33.2  2.8  399   432   16   MOLECULE: BETA-FRUCTOSIDASE;                                     
  13:  1y9g-A 30.6  2.8  425   517   15   MOLECULE: EXO-INULINASE;                                          
  14:  1y4w-A 30.6  2.9  424   517   16   MOLECULE: EXO-INULINASE;                                          
  15:  2qqw-A 30.5  2.8  427   534   17   MOLECULE: BETA-FRUCTOFURANOSIDASE;                                
  16:  2qqu-A 30.5  2.8  424   535   17   MOLECULE: BETA-FRUCTOFURANOSIDASE;                                
  17:  2ac1-A 30.5  2.8  427   537   17   MOLECULE: INVERTASE;                                              
  18:  1y9m-A 30.5  2.9  424   517   15   MOLECULE: EXO-INULINASE;                                          
  19:  2aez-A 30.1  2.8  422   536   17   MOLECULE: FRUCTAN 1-EXOHYDROLASE IIA;                            
  20:  2qqv-A 30.0  2.8  426   537   17   MOLECULE: BETA-FRUCTOFURANOSIDASE;                                
  21:  2ade-A 30.0  2.8  421   537   17   MOLECULE: FRUCTAN 1-EXOHYDROLASE IIA;                             
  22:  2add-A 30.0  2.8  421   537   17   MOLECULE: FRUCTAN 1-EXOHYDROLASE IIA;                             
  23:  1st8-A 30.0  2.8  421   537   17   MOLECULE: FRUCTAN 1-EXOHYDROLASE IIA;                             
  24:  2aey-A 29.7  2.8  422   537   17   MOLECULE: FRUCTAN 1-EXOHYDROLASE IIA;                             
  25:  2oxb-A 29.5  2.8  425   537   18   MOLECULE: BETA-FRUCTOFURANOSIDASE;                                
  26:  3cpn-A 24.3  2.9  262   319   13   MOLECULE: BETA-XYLOSIDASE, FAMILY 43 GLYCOSYL 
HYDROLASE;              
  27:  1pt2-A 23.9  3.1  275   440   15   MOLECULE: LEVANSUCRASE;                                           
  28:  3byn-A 23.8  3.1  271   440   15   MOLECULE: LEVANSUCRASE;                                          
  29:  3byl-A 23.8  3.1  275   440   15   MOLECULE: LEVANSUCRASE;                                           
  30:  3byj-A 23.8  3.1  274   440   15   MOLECULE: LEVANSUCRASE;                                           
  31:  1yrz-A 23.8  3.7  270   522   15   MOLECULE: XYLAN BETA-1,4-XYLOSIDASE;                              
  32:  1oyg-A 23.8  2.9  272   440   15   MOLECULE: LEVANSUCRASE;                                           
  33:  1yrz-B 23.7  3.7  267   522   14   MOLECULE: XYLAN BETA-1,4-XYLOSIDASE;                              
  34:  1yif-A 23.7  3.2  259   532   12   MOLECULE: BETA-1,4-XYLOSIDASE;                                    
  35:  3byk-A 23.6  3.0  273   440   15   MOLECULE: LEVANSUCRASE;                                          
  36:  2exj-B 23.6  3.9  273   533   13   MOLECULE: BETA-D-XYLOSIDASE;                                      
  37:  2exh-A 23.6  3.3  260   533   14   MOLECULE: BETA-D-XYLOSIDASE;                                      
  38:  1yif-D 23.6  3.8  273   532   11   MOLECULE: BETA-1,4-XYLOSIDASE;                                    
  39:  1yif-C 23.6  3.8  273   532   11   MOLECULE: BETA-1,4-XYLOSIDASE;                                    
  40:  1yi7-A 23.6  3.1  258   534   14   MOLECULE: BETA-XYLOSIDASE, GH FAMILY 43  
Figure 4. 22 DALI result of the top 40 structures similar to BT1760. 
Dali matches the first 40 structures sorted by Z-score. Chain: PDB entry code plus chain identifier. Z: normalized Z-
score that depends on the size of the structures. The program optimises a weighted sum of similarities of intramolecular 
distances. rmsd: root-mean-square deviation of C-alpha atoms in the least-squares superimposition of the structurally 
equivalent C-alpha atoms. The program does not optimise rmsd, this is only reported for your information. lali: number 
of structurally equivalent residues. nres: number of amino acids in the protein. %id: percentage of identical amino acids 
over all structurally equivalent residues. Description: the COMPND record from the PDB entry. 
w
GH68 family (PDB ID: 1PT2, Z score
   1:  1uyp-B 33.6  2.7  400   432   16   MOLECULE: BETA-FRUCTOSIDASE;                              
   2:  1w2t-E 33.5  2.7  394   432   16   MOLECULE: BETA FRUCTOSIDASE;                              
   3:  1uyp-C 33.5  2.8  398   432   17   MOLECULE: BETA-FRUCTOSIDASE;                             
   4:  1w2t-F 33.4  2.8  402   432   15   MOLECULE: BETA FRUCTOSIDASE;                            
   5:  1w2t-C 33.4  2.8  399   432   17   MOLECULE: BETA FRUCTOSIDASE;                            
   6:  1uyp-F 33.4  2.8  399   432   16   MOLECULE: BETA-FRUCTOSIDASE;                            
   7:  1w2t-D 33.3  2.8  399   432   16   MOLECULE: BETA FRUCTOSIDASE;                              
   8:  1w2t-B 33.3  2.7  399   432   16  MOLECULE: BETA FRUCTOSIDASE;                              
   9:  1uyp-D 33.3  2.8  399   432   16   MOLECULE: BETA-FRUCTOSID
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DALI results of structures in PDB bank presented that the most similar structure to the N-terminal 
β-propeller catalytic 2 from Arabidopsis 
thaliana with the Z score 29.6 % (Figure 4. 23), while the most similar one to the C-terminal β-
e molecule B of PDB 1DHK from a mammalian alpha-amylase with the Z 
           
          
          
          
          
         
         
          
        
        
domain of BT1760 is the molecule A of PDB 2AC1, a GH3
sandwich of BT1760 is th
score of 15.4 % (data not shown). 
 
 
 
  No:  Chain   Z    rmsd lali nres  %id  Description 
   1:  2ac1-A 29.6  2.7  280   537   20   MOLECULE: INVERTASE;                                   
   2:  2qqu-A 29.4  2.8  280   535   20   MOLECULE: BETA-FRUCTOFURANOSIDASE;                      
   3:  2qqv-A 29.0  2.8  280   537   20   MOLECULE: BETA-FRUCTOFURANOSIDASE;                      
   4:  1y4w-A 29.0  2.7  281   517   18   MOLECULE: EXO-INULINASE;                                
   5:  2qqw-A 28.5  2.8  280   534   20   MOLECULE: BETA-FRUCTOFURANOSIDASE;                      
   6:  2aez-A 28.1  2.8  280   536   19   MOLECULE: FRUCTAN 1-EXOHYDROLASE IIA;                    
   7:  2aey-A 28.1  2.8  280   537   19   MOLECULE: FRUCTAN 1-EXOHYDROLASE IIA;                    
   8:  2ade-A 28.1  2.8  280   537   19   MOLECULE: FRUCTAN 1-EXOHYDROLASE IIA;                   
   9:  2add-A 28.1  2.8  281   537   19   MOLECULE: FRUCTAN 1-EXOHYDROLASE IIA;                     
  10:  1st8-A 28.0  2.8  280   537   19   MOLECULE: FRUCTAN 1-EXOHYDROLASE IIA;                
Figure 4. 23 DALI result of β-propeller catalytic module of BT1760. 
Dali matches the top 10 structures sorted by Z-score. These 10 structures all are from GH32 members. Chain: PDB 
entry code plus chain identifier. Z: normalized Z-score that depends on the size of the structures. The program optimises 
a weighted sum of similarities of intramolecular distances. rmsd: root-mean-square deviation of C-alpha atoms in the 
least-squares superimposition of the structurally equivalent C-alpha atoms. The program does not optimise rmsd, this is 
only reported for your information. lali: number of structurally equivalent residues. nres: number of amino acids in the 
protein. %id: percentage of identical amino acids over all structurally equivalent residues. Description: the COMPND 
record from the PDB entry. 
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4.3 Discussion 
4.3.1 GH32 enzyme activity 
The DNSA assay (Table 4. 3) revealed that together the four GH32 from B. thetaiotaomicron could 
digest all fractions of inulin and levan and even the fructose containing plant oligosaccharide 
raffinose (data not shown). BT1760 is only active against levan and levan oligos. BT1759 acts on 
all oligosaccharides and polymeric substrates, but prefers sucrose. BT1765 prefers short substrates, 
especially sucrose, with very low activity on inulin and levan. BT3082 appears not be so sensitive 
to the chain length of fructans, but has a strong preference for β-2,1 over β-2,6 fructans. The 
different substrate preferences of the Bacteroides GH32s and their predicted cellular location enable 
us to suggest a role for each of these enzymes in fructan utilisation in this dominant gut bacterium. 
BT1760 may be located on the outer membrane, which is supported by the LipoP prediction that 
BT1760 is lipoprotein. BT1760 could cleave long-chain levan initially; then shortened levan 
oligosaccharides could be transferred into periplasmic domain through the β-barrel of SusC 
transducer BT1763 for further digestion. BT1759 and BT3082 are most likely located in periplasm 
to digest levan and inulin oligosaccharides coming through the SusC porin. The rationale for two 
fructosidases with similar specificity is not clear, but may be due to a certain level of redundancy in 
the system. The location of BT3082 outside the locus supports this view as it suggests the three 
enzymes in the locus are themselves sufficient to digest fructans and that BT3082 was acquired 
later by a gene duplication or horizontal gene transfer event. BT1765 is possibly located in 
cytoplasm because the value of signal peptide prediction was low, where it could digest smaller 
oligosaccharides taken up by the inner membrane transporter, BT1758 (Figure 4. 24). This kind of 
complementary character could exist in other GH and PL groups against different polysaccharides 
in B. thetaiotaomicron and other symbiotic gut bacteria. 
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Figure 4. 24 Model for location and role of GH32s in B. thetaiotaomicron. 
The possible location of BT1760 is on the outer membrane (OM), which digest coming levan. Fructan oligosaccharides 
get into periplasm through the β-barrel of SusC (red arrows), and then digested by BT1759 and BT3082. The smaller 
sugars get into the cytoplasm via the inner membrane transporter BT1758 (green box) and are digested into 
monosaccharides by BT1765. 
 
 
 
BT1760 demonstrates the endo-activity while other three are exo-acting from the HPLC data 
(Figure 4. 8) and the TLC analysis (Figure 4. 9). And there is no minimum length of oligo-levan 
required for BT1760; it could cut even the shortest levanbiose. By this means, BT1760 is mixed 
endo and exo acting, which is different with the typical endo-acting GH proteins (Pell et al., 2004). 
And BT1760 is different from other two reported endo-levanase, β-2,6-fructan fructanohydrolase 
from Bacillus sp. (strain L7) which needs at least 3 fructose units and β-2,6-fructan 
levan chain 
e to the 
utritional status, which is different to its function in bacteria (Sturm and Tang, 1999). Many plant 
GH32s cannot cleave sucrose, probably because this molecule plays an important role in signalling 
erhaest et al., 2007a). This class of enzymes is known as fructan 
levanbiohydrolase from Bacillus subtilis which remove levanbiose from the end of the 
(Daguer et al., 2004; Miasnikov, 1997). The enzyme to digest sucrose is called invertase (β-D-
ructofuranosidase), a key enzyme to control the sucrose concentration in plants in responsf
n
in plants (Alberto et al., 2004; V
exohydrolases (FEH). FEHs are either specific for inulin type fructans (1-FEH) or levan type 
fructans (6-FEH). The structural basis for this specificity is currently unknown as to date there are 
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no structures of 6-FEH, however an overlay of BT3082 (which cleaves levan, but ~10-fold less well 
than inulin) and 1-FEH from Chicory, both with kestose bound, suggests the structural differences 
that drive this specificity must be very subtle as the active sites of BT3082 and 1-FEH are very 
similar. The only obvious difference is the position of the +1 Frc and Glc of the kestose which adopt 
significantly different positions in the active site of BT3082 compared to 1-FEH (Figure 4. 25). 
Whether this is relevant to the specificity difference seen between these two enzymes is not clear 
and it would require a complex with a β-2,6 linked oligosaccharide to understand the molecular 
etails of this specificity.  
 
ccurs because in the 1-FEH-sucrose complex a hydrogen bond is formed between the O2 of the 
ction obviously does not occur in BT3082 or other 
e no invertase-sucrose complexes available to study it is not 
d
Sucrose is a substrate of invertases such as BT1759, BT1765, and BT3082, but an inhibitor of FEH, 
uch as 1-FEH (PDB ID 2ADD) from Chicorium intybus (Verhaest et al., 2007a). This inhibition s
o
glucose and the acid base catalyst. This intera
invertase type enzymes, but as there ar
possible to see the alternative ‘non-inhibiting’ interaction between the sugar and the enzyme. 
 
Figure 4. 25 Overlay shows kestose difference of BT3082 and 1-FEH from Chicorium intybus. 
A: Overlay of BT3082 D131A (green) with 1-FEH (red, PDB ID 2AEZ) shows the kestose locations are very similar. B: 
The zoom in of the blue box of panel A reveals the positions of the Frc at +1 and the Glc of kestose are in different 
positions in the two enzymes. The hydrogen bonds (red dash lines) formed by the +1 fructose (red stick) with enzyme 1-
FEH and solution, while the +1 fructose in kestose just formed one hydrogen bond. C: The 90° rotation of panel B. 
From panel C, the kestose in 1-FEH rotated about 20° around the -1 fructose of kestose in BT3082 D131A. 
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4.3.2 Role of the N- and C-terminal domains in enzyme activity 
BT3082 has three domains. The catalytic domain is flanked with two smaller, mainly β-sheet 
domains (Figure 4. 26). The number of β-sheets in the N-terminal domain is less than in the C-
terminal, which forms a β-sandwich and is highly conserved in GH32 members, while the N-
terminal is unique, at least amongst structurally characterised members 
 
 
Figure 4. 26 Three domains of BT3082. 
The N-terminal domain (green) has two sets of β-sheets and one α-helix. The middle domain (orange) is the catalytic β–
ropeller domain. The C-terminal β-sandwich (cyan) has two sets of β-sheets and one α-helix as well. 
The most sim uctures in T psin transducer proteins, 
which hints that BT3082 N-extra may be a degraded sensor (Figure 4. 13). Deletion analysis 
talytic function of BT3082 (section 
.2.3.3.3). The BLAST analysis of BT3082 revealed that the N-terminal domains are only 
conserved in other Bacteroides species and so could be an adaptation to the gut environment. 
 
The DALI analysis of C-terminal of BT3082 (Figure 4. 14) and the alignment of these 4 GH32 
proteins against structure solved GH32 members (Figure 4. 3) indicated that the C-terminal 
similarity is very low except two residues Asp-498 and Phe-505 of BT3082 are highly conserved. 
All these results suggested that though the C-terminals of GH32s vary highly in sequence identity 
they have significant structural similarity. The role of these domains in enzyme function is unclear. 
Previous studies with Chicory 1-FEH have suggested the domain plays a role in inulin binding, as 
introduction of an N-glycosylation site in the cleft formed between the catalytic domain and the C-
terminal domain reduced the activity of the mutant enzyme against high DP inulins. However, 
although this may be the role in 1-FEH, the presence of the C-terminal domains in BT1760 and 
BT1765, which has no, or very low activity against inulins, respectively, indicates it is not the 
function of the C-terminal domain in all GH32s. Deletion from BT3082 results in a loss of 
expression in the heterologous host. This may be due to an inability to fold correctly without the C-
terminal domain or that the truncated enzyme is unstable and is degraded by proteases. These data 
p
 
 
 
ilar str to the N-term al domain of B 3082 are rhodo
indicated that this N-terminal domain is necessary for ca
4
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suggest the domain plays a key role in enzyme stability, as suggested previously (Alberto et al 
ce in all known GH32s would support a general stabilisation 
ytic pocket (Figure 
. 16C). W128, Y353, and W373 are aromatic residues on the other side of the pocket with which 
have no hydrogen bond with kestose as well, but their mutants W128A, Y353A, and W373A have 
oval of the hydroxyl of Y353 could make the product move out of 
ore effectively while the hydrophobic surface keeps identical. W155 is the 
atic residue forming hydrogen bond with kestose. W155F was abolished half enzymic 
ability against all three substrates, which is predicted still close enough to form one hydrogen bond 
with kestose, while W155A is too far to do so, which is supported by the low enzymic activity 
(Figure 4. 17).  
 
When the residues which form hydrogen bonds with kestose (N130, Q147, D257, and E301) were 
mutated to alanine individually, the enzymic activity was abolished to less than 10 % or completely 
lost. E301 is the catalytic acid residue of BT3082. Other two such residues (R256 and S188) were 
not mutated as alanine in this study for time limitation, but mutants of both residues would be 
igure 4. 17), which is predicted to be caused by subtle changes to the shape of the binding pocket. 
se to two catalytic residues and completely conserved in GH32 
2004). Indeed their ubiquitous presen
role for this domain as opposed to a substrate specific function. 
4.3.3 Active site of BT3082 
BT3082 prefers inulin-type fructans, while it can digest levan at a low activity (Table 4. 3). BT3082 
F187A digests inulin more effectively than wild type. F187 does not form hydrogen bonds with 
kestose module (Table 4. 4). But this aromatic residue forms one side of the catal
4
different enzymic activity against inulin, especially W373A which loses activity against all 
substrates and Y353A which loses activity against sucrose.  
 
The mutagenesis results also indicated the docking of inulin has special orientation which is 
predicted to be from the angle of F187. So the location of F187A makes the catalytic site wider and 
gives more flexibility to the access of inulin. It is interesting to find the higher activity of Y353F 
against sucrose than wild type, which indicated the hydroxyl from Y353 could restrict the enzymic 
activity in some level. It is possible that the released fructose from sucrose slips away from the 
orientation of Y353, so the rem
the catalytic pocket m
only arom
predicted to lose activity as well. The closest distance to kestose to Q221 is 5.29 Å which is quite 
far from catalytic pocket (Table 4. 4). The Q221A mutant has more than half activity against inulin 
(F
P132, C302, and P303 are clo
proteins, so it is not surprising to see their alanine mutants are abolished some activity against all 
three substrates. It is surprising to find W300A totally lost activity against sucrose because the 
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closest distance of W300 to kestose is 5.01 Å and it is on the outside of the pocket edge. But this 
residue is highly conserved in GH32 proteins, suggesting it is important in other GH32 members as 
well. 
 
R256 and D257 both are in the RDP motif, which are highly conserved in GH68 family (retaining 
mechanism, levansucase) as well (Meng and Futterer, 2003). GH68 members possess same activity 
and same substrate (sucrose), which have 5-blade β-propeller as catalytic module as well. This kind 
f similarity reveals the structural relationship. 
 it is similar to GH43 and GH68 enzymes. Though there is structural similarity, GH43 are 
lved, so the accurate binding conformation of 
talytic pocket is still unknown.  
o
4.3.4 BT1760  
BT1760 is predicted to be the first endo-acting levanase with solved structure. The DALI analysis 
evealedr
inverting mechanism, which is opposite to GH32 and GH68 (retaining mechanism). And GH43 uses 
different substrate, while GH32 and GH68 use same substrate (sucrose) and both have the RDP 
motif (Alberto et al., 2004). 
 
Even BT1760 and BT3082 which have different activity and low amino acid similarity, have 
structural similarity, though BT3082 has an N-terminal function-unknown essential domain (Figure 
, the BT1760 D62A was not so4. 27). Unfortunately
levan oligosaccharides in the ca
 
 
 
Figure 4. 27 BT1760 WT overlays BT3082 WT. 
lue: BT3082, Green: BT1760. Compared with BT1760, BT3082 has an extra N-terminal domain, which mainly is β-
ropellers. And at the C-terminal, BT3082 has one more α-helix. 
B
p
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But overlay the catalytic domain of BT1760 with other three GH32s presents the active site 
fference (Figure 4. 28). The catalytic pocket in BT1760 is larger and more open than exo-acting 
T1760 is flatter than others (Figure 4. 28, circled in 
di
enzymes, and the space above the pocket of B
red), which may provide binding sites for the levan chain to allow endo-activity. 
 
 
Figure 4. 28 Surface representation shows the overlay GH32s β-propeller catalytic domains with kestose in the 
active site. 
A: BT1760, B: BT3082 wild type, C: invertase of Aspergillus awamori (PDB ID 1Y9G), and D: invertase from 
Thermotoga maritima (PDB ID 1UYP). The catalytic residues Asp (red) and Glu (blue) is highlighted to show the 
active pocket. Note: The kestose in the enzymes shown in panels A and C is not bound, but is positioned from an 
overlay with BT3082. 
 
Comparing the modeled structures of levan-hexaose and inulin-hexaose reveals that the β 2,1-linked 
inulin-hexaose has a tighter twist than the β 2,6-linked levan-hexaose (Figure 4. 29). BT1760 may 
cut the fructose labeled in the red circle of Figure 4. 29, while other joined fructose units bind the 
flatter surface around the catalytic pocket. An inulin molecule may not get to the bottom of the 
catalytic pocket based on the possible location of kestose from the BT3082 structure (Figure 4. 
30A). 
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Figure 4. 29 Modeled structures of fructooligosaccharides 
The two structures of levan-hexaose and inulin-hexaose were generated using the program SWEET. Both are present 
from two views with 90° rotation and colored from blue to red. Inulin is much tighter twist than levan. The middle panel 
(boxed) presents the overlay of levan (red) and inulin (green) to show the different twist of the chains with the first 
fructose units overlaid. 
 
 
When looking into the residues around the BT1760 catalytic pocket, it is interesting to find that all 
aromatic residues (Y90, W338, W300, and Y303) and a histidine H91 gather on one side, while 
other residues (A122, I123, G124, T125, N144, Q155, R189, D190, C243, S258, D260, R265, A304, 
and E335) are on the other side (Figure 4. 30A). This kind of residue arrangement makes the pocket 
more spacious for BT1760 to dock levan oligosaccharides from endo while for smaller pocket of 
BT3082 substrates can only drop in by terminal fructose. 8 residues (T142, Q155, R189, D190, 
C243, Y303, A304 and W319) of BT1760 are completely conserved in other GH32s (Figure 4. 3), 
which suggests the mechanism of GH32 is conserved between endo-acting enzymes such as 
BT1760 and exo-acting enzymes such as BT3082. 
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Figure 4. 30 BT1760 catalytic pocket with kestose positioned from BT3082. 
A: Surface representation shows the catalytic pocket of BT1760 with kestose (green stick) from BT3082 D131A via 
overlay method of PyMol. The pink surface indicates the aromatic residues (see labels in panel B), other residues except 
base D62 (red) and donor E242 (blue) are presented in yellow (see labels in panel C). B: The aromatic residues Y90, 
W338, W300, Y303 and H91 are presented in pink, while D62 in red stick, and E242 in blue. C: Residues A122, I123, 
G124, T125, N144, Q155, R189, D190, C243, S258, D260, R265, A304, and E335 are presented in orange sticks, while 
E242 in blue and D62 in red. Totally, there are 22 residues involved in the formation of catalytic pocket.  
 
4.3.5 Applications of GH32s 
GH32 enzymes are used widely in the food industry to make fructose and glucose from sucrose as 
the monosaccharides are sweeter and don’t crystallize as easily as the disaccharide (VanDamme and 
D.G.Derycke, 1983). It is also possible to use these enzymes to digest levan and inulin to make 
ethanol, the biofuel (Fortman et al., 2008; Groom et al., 2008). Fructose is a good source of 
dimethylfuran because of the furan ring, which could be a potential liquid fuel with 2.5 fold higher 
energy per unit weight than ethanol (Roman-Leshkov et al., 2007). 
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Chapter 5 SusD homologue BT1762 
5.1 Introduction  
There are 101 SusC/D paralog pairs in B. thetaiotaomicron genome which are ubiquitous 
omponents of PULs; indeed the presence of a susC/D gene pair is one of the defining features of a 
UL (Bjursell et al., 2006). Previous studies have revealed that SusD associates with the β-barrel 
porin SusC to bind starch and transport the polysaccharide into the periplasmic space (Shipman et 
al., 2000). The structure of SusD has recently been solved and reveals it has a novel fold of 22 α-
helices and 3 sets of two-antiparallel β sheets, of which 8 helices formed four tetratricopeptide 
repeat (TPR) units that are thought to be the interaction surface for the complex with SusC 
(Koropatkin et al., 2008) (Figure 5. 1). SusD has been shown to be essential for growth on 
maltooligosaccharides larger than maltopentaose, a feature mirrored in its ligand specificity 
(Koropatkin et al., 2008). The preference for maltooligosaccharides larger than ~5 sugar units is 
likely due to its curved binding site that complements the natural helical structure of starch. Only 
sugars larger than maltopentaose adopt this helical structure as a stable form and therefore smaller 
sugars bind with much reduced affinity (Koropatkin et al., 2008). Recently the structure of another 
SusD homologue, BT1043, was solved in complex with the disaccharide N-acetyllactosamine 
(Koropatkin et al., 2009). BT1043 is involved in mucin utilisation, but the interaction with the 
mucins component (N-acetyllactosamine) is very weak (Kd ~12 mM) indicating this is not the true 
ligand or is only a small fragment of it. So far, however, the functions of other SusD homologues 
are not well understood at the molecular level. Indeed it is not clear why B. thetaiotaomicron 
contains so many homologues of this gene. One possibility is that each SusD variant has a distinct 
o degrade. To further our 
ucture of the SusD homologue BT1762 from the fructan activated PUL 
panning genes BT1757-BT1765 (see Figure 3.2). 
 
c
P
specificity related to the carbohydrate the PUL has evolved t
understanding of the role of these proteins, experiments were carried out to characterize the ligand 
pecificity and the strs
s
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F
A
igure 5. 1 SusD location and structure. 
: SusD locates on the outer membrane and associates with SusC to bind and import polysaccharide. This kind of 
complex is energy dependent and relies on the TonB complex which locates on the inner membrane. 
B: The structure of SusD with maltoheptaose bound (blue ring). PDB ID is 3CK9 (Koropatkin et al., 2008). 
 
 
5.2 Results 
5.2.1 Sequence analysis 
 
Several SusD homologues (BT2625, BT3789, BT3855) were randomly chosen to align with 
BT1762, SusD (BT3701), and one recently-solved SusD homologue BT1043 involved in mucin 
degradation (Koropatkin et al., 2009). SusD is predicted to be an outer membrane lipoprotein with a 
conserved cysteine at the N-terminal end of the Type II signal peptide that is covalently attached to 
a lipid tail embedded in the membrane. The alignment reveals that all the SusD homologues chosen, 
including BT1762, have a cysteine at the same position near the N-terminus, indicating they are all 
outer membrane lipoproteins (Figure 5. 2). Although all the sequences have a conserved region near 
the N-terminus which is a TPR helix domain of SusD and BT1043 (boxed in Figure 5. 2), the 
sequence identity on the whole is low (only ~7 % between BT1762 and SusD), especially BT1043 
is the least similar of all aligned sequences.  
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Figure 5. 2 Alignment of SusD, BT1762, and four other SusD homologues from B. thetaiotaomicron. 
All proteins are from B. thetaiotaomicron. BT3701 is SusD. The conserved cysteine at the end of the signal peptide that 
is lipidated and attached to the outer membrane is indicated by an arrow. The boxed region is highly conserved in SusD 
homologues, which is a TPR helix domain of SusD and BT1043. The alignment was produced using Tcoffee. 
 
 
 
5.2.2 Protein expression 
Native BT1762 is a predicted outer membrane lipoprotein (LipoP server) with the cleaved type II 
signal peptide spanning residues 1-19 (Figure 5. 2), so, only residues 19-570 of BT1762 were 
expressed in E. coli. The gene of BT1762 was cloned into minipRSETA between BamH I and EcoR 
I. The forward and reverse primers used are BT1762-F: 5’-
CTCGGATCCTGTGACGATTTTTTGGAC-3’, and BT1762-R: 5’-
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CTCGAATTCTTACCAACCGAAATTCTGTG-3’, respectively. This generated a recombinant 
cell strain. 
This was then purified in a soluble form from the CFE by IMAC (Figure 5. 3). The calculated MW 
 
protein with a His tag fused to its N-terminus when expressed in BL21 (DE3) E. coli 
of recombinant BT1762 is 65.1 kD. 
 
Figure 5. 3 N-terminal His ta
Lane 1: M ig n  4: material eluted 
form IMA ith 100 D. 
 
 
 
5.2.3 Ligand binding studies 
Conside igand specif 3) and the enzymic activity of 
GH32 p hapter 4), ding ab T1762. ITC 
data revealed that BT1762 could not bind inul ould not recognize the β-
2,1 link tans. So i e, were sed further. 
BT1762  levan wit d Table 5. 1), and this binding 
is metal nt (data no rable cha thalpy, with 
an unfavorable entropic comp tein-carbohydrate interactions. 
Levanoligosaccharides smalle  binding 62 (data not 
shown). ty of BT17 TC. How inding was 
too weak to be accurately fitte
  
gged BT1762 purification.   
ht marker, Lane 2: CFE, Lane 3: flow through from IMAC columolecular we , Lane
C column w mM imidazole. The molecular weight of BT1762 is 65.1 k
ring the l icity of BT1754 recognition (chapter 
roteins (c only fructans were used to analyse the bin ility of B
in, which means BT1762 c
age of fruc nulin oligos, such as sucrose and kestos not analy
 could bind h a Ka of ~1.1 x 104 M-1 (Figure 5. 4 an
 independe t shown). Binding was driven by a favo nge in en
onent; a feature common to many pro
r than levanheptaose (L7) displayed no to BT17
 The affini 62 for L7 was low but detectable by I ever the b
d to a single site model (Figure 5. 4). 
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Figure 5. 4 ITC data show the binding ability of BT1762 to different fructans. 
A: Inulin, B: L7, C: Levan. The top part of each figure shows the raw binding heats and the bottom the integrated heat 
ata. In panel C the integrated data is fitted to a single site binding model to generate values for n, Ka, ∆H, and T∆S. 
evan was at 10 mg/ml and proteins were used at 100 µM. To obtain the molar concentration of levan the WT was fit 
such that n=1 (number of binding sites on the protein). This assumption is deemed valid due to the structural and 
mutagenesis data that indicates only a single binding site on the protein (see later). 
d
L
 
 
 
 
Ligand Ka × 103 (M-1) ∆H (kcal mol-1) T∆S (kcal mol-1) n*
Levan 9.1 ± 0.8 -7.7 ± 1.5 -2.8 ± 0.3 1.0 ± 0.1 
Table 5. 1 ITC data show the binding ability of BT1762 to levan. 
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5.2.4 BT1762 crystallization 
In order to crystallize BT1762, it was over expressed in BL21 (DE3) E. coli and purified by IMAC 
primarily (Figure 5. 3), followed by ion exchange purification (Figure 5. 5A). The purified protein 
was dialyzed against 10 mM Tris pH 8.0 buffer, and then concentrated down and buffer exchanged 
into water. After extensive screening, rod-like crystals formed in three conditions: 2.0 M 
Ammonium sulphate; 0.1 M Sodium acetate, pH 4.6, 8 % (w/v) PEG 4000; and  0.2 M Ammonium 
acetate, 0.1 M tri-Sodium citrate, pH 5.6, 30 % (w/v) PEG 4000 (Figure 5. 5B).  
 
 
Figure 5. 5 Native BT1762 for crystallization. 
A: Lane 1: Maker, Lane 2: BT1762 after IMAC purification, Lanes 3-5: Collected fractions of BT1762 from ion 
exchange Q12 column. B: The condition for this drop is 2.0 M Ammonium sulfate, from robot tray. This rod-like crystal 
gave a good diffraction, which is enough to solve the structure. 
 
 
 
The Se-Met method was employed to solve the structure of BT1762 as the sequence similarity to 
SusD was too low to use molecular replacement. Se-Met BT1762 was purified by IMAC and ion 
exchange methods and then crystallized in the same conditions as native protein crystals (Figure 5. 
6). When crystals grew up, the drop was soaked with ligand L7 to a final about 10 mM 
ployed with 5 mM L7 concentration in order to find the binding sites. Co-crystallization was also em
final in the protein solution. 
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Figure 5. 6 Se-Met BT176 for tion. 
A: Lane 1: Marker, e-  pu AC puri on, Lanes 3-13  fractions of Se-Met 
0.2 M Ammonium acetate, 0.1 M tri-
is 
onomer-like structure unit has cell parameters a = 107.77 Å, b = 129.64 Å, c =86.73 Å, and β = 
0°, containing 4958 atoms. Residues 32-294 and 300-570 were defined in the native protein. 
ause they likely form a flexible 
xtension from the lipid anchor. One BT1762 molecule has 22 α helices, 2 pairs of antiparallel β 
heets, and two glycerol molecules (Figure 5. 7). Inside of the 22 helices, 8 helices: α1 (40-56), α4 
(103-128), α5 (137-159), α6 (185-204), α7 (215-230), α8 (245-255), α14 (424-439), and α15 (447-
2  crystalliza
 Lane 2: S Met BT1762 rified by IM ficati : Collected
BT1762 from Q12 column. B: BT1762 formed rod-like crystals in condition: 
Sodium citrate, pH 5.6, 30 % (w/v) PEG 4000. 
 
5.2.5 BT1762 structure 
BT1762 native structure was determined to a resolution of 1.9 Å by Dr. Susan Firbank. Th
m
9
Residues 295-299 are DGTYN were not visible in electron density map. There is no density for the 
first 13 residues of the structure, which is not surprising bec
e
s
455) formed into four TPR units. 
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Figure 5. 7 Structure of BT1762. 
Cartoon representation shows the structure of BT1762 of residues 32-570, which has 22 α helices, 2 pairs of antiparallel 
β sheets, and two glycerol molecules bound from the cryo (blue sticks) There is a unstructured gap which has no 
electron density, suggesting the region is highly flexible in the unliganded structure (residues 295-299: DGTYN - see 
arrow).  
 
 
A highly unusual disulphide ring is formed by two adjacent cysteine residues C316 and C317 in 
BT1762 (Figure 5. 8). This ring is not present in the SusD or BT1043 structures. The presence of 
reducing agent TCEP (Tris (2-carboxyethyl) phosphine hydrochloride) in the ITC buffer abolished 
the ability of BT1762 to bind levan (data not shown), suggesting that this disulphide ring is 
functionally important. There are another two cysteine residues C405 and C407 in BT1762 but they 
 
 
do not form a disulphide in the native structure. 
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Figure 5. 8 BT1762 disulphide ring. 
Stick representation shows the disulphide ring formed by C316 and C317 which is between L314, G315, D318, and 
F319. 
 
 
 
DALI analysis of the 3D structure of BT1762 indicates that the most similar structure is SusD 
(Figure 5. 9). Unfortunately, the complex structure of BT1762 with L7 was not solved as only very 
small crystals could be produced, so the binding site is not confirmed.  
 
    
                             
 6:  3ckc-B 30.1  2.7  424   500   20 PDB  MOLECULE: SUSD;                                                       
 7:  3ck7-B 30.1  2.7  426   497   21 PDB  MOLECULE: SUSD;                                                       
 8:  3ckc-A 30.0  2.7  425   501   20 PDB  MOLECULE: SUSD;                                                       
 9:  3ckb-B 30.0  2.7  425   501   20 PDB  MOLECULE: SUSD;                                                       
        
 PEPTIDYLPROLYL ISOMERASE, PUTATIVE;                  
ROTEIN;                                               
20:  2hr2-E  8.7  3.4  149   157    8 PDB  MOLECULE: HY OTHETICAL PROTEIN;                      
Figure 5. 9 DALI analysis for BT1762 structure. 
 of SusD, with the Z scores around 30 %.  Other structure is less 
  No:  Chain   Z    rmsd lali nres  %id PDB  Description 
   1:  3ck7-A 30.3  2.7  426   496   21 PDB  MOLECULE: SUSD;                          
   2:  3ck8-B 30.2  2.8  429   501   21 PDB  MOLECULE: SUSD;                                                       
   3:  3ck8-A 30.2  2.8  429   501   21 PDB  MOLECULE: SUSD;                                                       
   4:  3ck7-C 30.2  2.7  426   497   21 PDB  MOLECULE: SUSD;                                                       
   5:  3ck7-D 30.2  2.7  426   498   21 PDB  MOLECULE: SUSD;                                                       
  
  
  
  
  10:  3ck9-A 29.8  2.7  428   508   20 PDB  MOLECULE: SUSD;                                                       
  11:  3ckb-A 29.8  2.7  425   504   20 PDB  MOLECULE: SUSD;                                                       
  12:  3ck9-B 29.5  2.7  428   515   20 PDB  MOLECULE: SUSD;                                                       
  13:  3fdh-A 20.1  3.3  355   472   14 PDB  MOLECULE: SUSD HOMOLOG;                                               
  14:  3cgh-A 19.7  3.3  381   507   11 PDB  MOLECULE: SUSD HOMOLOG;                                               
  15:  3ejn-A 18.5  3.6  358   450   10 PDB  MOLECULE: SUSD HOMOLOG;                                               
  16:  2pl2-B  9.0  3.9  150   194    9 PDB  MOLECULE: HYPOTHETICAL CONSERVED PROTEIN TTC0263;             
  17:  2qfc-B  8.9  5.2  165   284    9 PDB  MOLECULE: PLCR PROTEIN;                                               
  18:  2fbn-B  8.9  3.1  140   151   11 PDB  MOLECULE: 70 KDA
  19:  2qfc-A  8.8  5.2  165   284    9 PDB  MOLECULE: PLCR P
P
The most similar structures so far are different versions
similar with Z score around 20 % (PDB ID 3fdh), which is a SusD homolog from B. thetaiotaomicron solved by a 
structural genomics consortium. 
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Overlays of BT1762 with SusD and BT1043 reveal that BT1762 matches all TPR units of SusD and 
BT1043 individually (Figure 5. 10). These high similar TPR units of SusD homologues are on one 
has one pair of anti-parallel β-sheets matching one of SusD. 
 
 
side spanning helices while another side of SusD and BT1043 are the ligand binding sites. BT1762 
 
Figure 5. 10 Cartoon representations show the overlay of BT1762, BT1043, and SusD. 
: BT1762 (blue) presents conserved structure when comparing with SusD (green) (PDB ID 3CK9). BT1762 has one 
pair of anti-parallel β-sheets matching one of SusD. SusD has 8 α-helices (purple) formed into four tetratricopeptide 
peat (TPR) units on one side of the structure. BT1762 has 8 α-helices to match all TPR units of SusD: α1 (40-56), α4 
ID 3EHN) shows the conserved 8 α-helices (pink) TPR units. A molecule of N-acetyllactosamine is bound to BT1043 
A
re
(103-128), α5 (137-159), α6 (185-204), α7 (215-230), α8 (245-255), α14 (424-439), and α15 (447-455). Maltoheptaose 
(red stick) binds to SusD on the other side of these TPR repeats. B: BT1762 (blue) overlay with BT1043 (khaki) (PDB 
and is shown in green sticks. 
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The alignment of BT1762 against SusD also revealed that the TPR locations are parallel to each 
other (Figure 5. 11). 
 
 
 
 
Figure 5. 11 Alignment of BT1762 and SusD. 
Tcoffee alignment of BT1762 and SusD. Waves indicate α-helices, black lines indicate loops, and arrows indicate β-
strands. 
 
 157
Overlays of BT1762 with SusD and BT1043 also reveal that the location of the ligand binding sites 
i
levan binding site of BT1762 m he red circle of Figure 5. 12). 
However, the ligand binding si not visible in the structure of 
ted that the binding residues are different (Figure 5. 12). 
n SusD and BT1043 is conserved and on the opposite side of the protein to the TPR domains. The 
ay be around this site as well (see t
tes of SusD and BT1043 are both 
BT1762 when overlaid, which indica
 
 
 
Figure 5. 12 Surface representation shows the possible binding site of BT1762. 
BT1762 is shown in all three pan
overlaid. Panel C shows BT1762
els with maltoheptaose from SusD (panel A) and LacNac from BT1043 (panel B) 
 alone with the location of the putative binding site based on the other SusD structures 
ighlighted by a red circle 
 
 
h
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Looking at the binding sites of BT1043 and SusD, there are a several aromatic residues around 
ligand. In SusD four aromatic residues form an arch that mirrors the helix of starch (Figure 5. 13). 
According to this analysis, the aromatic residues around the predicted ligand binding site of 
BT1762 are potential key residues. 
 
 
 
 
Figure 5. 13 Key residues around ligands of SusD and BT1043. 
A: Key residues of SusD around maltoheptaose (cyan stick), in which four aromatic residues W96, W98, Y296, and 
W320 (red sticks) formed one arch around half ring of maltoheptaose, while other four residues formed hydrogen bonds 
with ligand. B: Key residues (
aromatic residues W87 and Y
red sticks) of BT1043 around N-acetyllactosamine (cyan sticks), in which have two 
281 (red sticks), and two charged residues. 
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Using PyMol, the aromatic residues around the otential binding site are pointed out as W103, 
lphide ring formed by C316 and C317 is also in this area, and 
p
W304, Y413, and W414. And the disu
it could be looked as an aromatic residue as well (Figure 5. 14). 
 
 
 
 
 
 
 
Figure 5. 14 Surface and ribbon representation show the aromatic residues of potential binding area. 
A: Surface representation of BT1762 with maltoheptaose (cyan sticks) positioned from the SusD structure to indicate 
the possible position of the levan binding site in BT1762. The disulphide ring of C316 and 317 (red), W304 (pink), 
ear maltoheptaose, which is half-buried inside of the surface of BT1762. W103 
anel B. 
C
Y413 (blue), and W414 (yellow) are n
(green) is quite far from the maltoheptaose, but may be still important for ligand recognition in BT1762 as levan forms 
a more extended structure to starch (Figure 5. 19) and so may bind across more of the protein surface. B: Same residues 
of BT1762 as panel A around N-acetyllactosamine of BT1043. C: Ribbon representation of panel A. D: Ribbon 
representation of p
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The disulphide ring (C316 and C317) and aromatic residues W103, W304, Y413, W414 form a 
yo, suggesting a possible involvement in 
arbohydrate binding. 
potential ligand binding site of BT1762 (Figure 5. 15). C405, C407 and the gap (residues 295-299: 
DGTYN) are close to this area as well. In addition a semi-exposed Trp-497 on the other side of the 
protein has a glycerol molecule bound from the cr
c
 
 
 
Figure 5. 15 Putative ligand binding site of BT1762. 
Several residues are highlighted in red sticks: W103, W304, C316, C317, C405, C407, Y413, and W414. These residues 
may be involved in ligand binding as they are solvent exposed and in the same region as the binding sites of SusD and 
BT1043. C405 and C407 are in a loop near W304, Y413 and W414. Y298 in the unstructured loop may also be 
involved in levan recognition as it is near the same region.  W497 is on the opposite side of the protein, but has glycerol 
molecule bound in the crystal structure. Glycerol can sometimes mimic a carbohydrate due to its hydroxyls and may 
indicate that W497 is involved in levan binding despite its location. 
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5.2.6 Mutational analysis of predicted binding site of BT1762 
binding. Solvent exposed aromatic residues were 
chosen as they are a common feature of carbohydrate binding sites where they stack against the 
sugar rings. In addition, one cysteine residue, C316, from the disulphide ring was mutated to 
alanine and serine separately to analysis the function of the disulphide bond. C405 in the other pair 
of cysteine residues was mutated to alanine and serine separately as well. Site directed mutagenesis 
was carried out using primers in Table 5. 2 and BT1762-minipRSETA as template. All mutants 
could be produced in the cytoplasm of E. coli in a soluble form (Figure 5. 16). 
 
 
Primer ID Sequence ( 5’---------------------------------------------------------->3’) Note 
5.2.6.1 BT1762 mutant protein production 
Alanine mutants of W103, Y298, W304, Y413, W414, and W497 from BT1762 were produced to 
assess the importance of these residues in levan 
BT1762-3 CAATACCACCGACGCGAATATCAATGATATATG W103A F 
BT1762-4 CATATATCATTGATATTCGCGTCGGTGGTATTG W103A R 
Bt1762-5 GAAAATGCTGAAAGCGGAACGCCGCGTAG W497A F 
BT1762-6 CTACGCGGCGTTCCGCTTTCAGCATTTTC W497A R 
BT1762-7 GGTAACCTGAATGCGGGAATGGGACTG W304A F 
BT1762-8 CAGTCCCATTCCCGCATTCAGGTTACC W304A R 
BT1762-9 GAAGAAAGGTTCTGCTTGGGCCAGTTCTC Y413A F 
BT1762-10 GAGAACTGGCCCAAGCAGAACCTTTCTTC Y413A R 
BT1762-11 GAAAGGTTCTTATGCGGCCAGTTCTCTG W414A F 
BT1762-12 CAGAGAACTGGCCGCATAAGAACCTTTC W414A R 
BT1762-13 CAGATACTGGGCGCCTGCGACTTCCAC C316A F 
BT1762-14 GTGGAAGTCGCAGGCGCCCAGTATCTG C316A R 
BT1762-15 CAGATACTGGGCACCTGCGACTTCCAC C316S F 
BT1762-16 GTGGAAGTCGCAGGTGCCCAGTATCTG C316S R 
BT1762-17 GTAGATCCCGATGCTGACTGTCTGAAG C405A F 
BT1762-18 CTTCAGACAGTCAGCATCGGGATCTAC C405A R 
BT1762-19 GTAGATCCCGATAGTGACTGTCTGAAG C405S F 
BT1762-20 CTTCAGACAGTCACTATCGGGATCTAC C405S R 
BT1762-21 CAACGACGGTACTGCCAACGGTAACCTG Y298A F 
BT1762-22 CAGGTTACCGTTGGCAGTACCGTCGTTG Y298A R 
Table 5. 2 Primers for BT1762 mutations. 
F: Forward primers, R: Reverse primers. 
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Figure 5. 16 SDS-PAGE showing purified BT1762 mutants. 
Lane 1: Marker, Lane 2: BT1762 WT, Lane 3: W103A, Lane 4: W497A, Lane 5: W304A, Lane 6: Y413A, Lane 7: 
W414A, Lane 8: Y298A, Lane 9: C316A, Lane 10: C316S, Lane 11: C405A, and Lane 12: C405S, All mutants were 
purified by IMAC in a single step from the CFE of the BL21 expression strain. 
 
 
5.2.6.2 Ligand binding analysis of BT1762 mutants. 
All the 10 mutants of BT1762 were analysed for ligand binding ability against the levan using WT 
as control. (Figure 5. 17 and Table 5. 3).  ITC revealed that C316A and C316S abolished binding 
affinity, indicating that the disulphide ring is essential for the ligand recognition. W103A shows no 
binding to levan, whereas Y413A displayed only very weak binding, which suggest W103 and 
Y413 also play key roles in levan recognition. W304A and W414A showed some reduced but still 
significant affinity, whereas the Y298A mutant has the same affinity as wild-type indicating that this 
residue is not involved in ligand binding. The ITC data also revealed that W497 and C405 are not 
involved in levan recognition in BT1762. Parameters for mutants are from single titrations only. 
Although the affinities determined for each of the levan binding mutants is similar to wild-type, 
there are significant differences in thermodynamics and stoichiometries (Table 5. 3). These may be 
actual differences driven by the mutation, but are more likely to be errors of the fit caused by using 
the estimated molar value of levan calculated from the wild-type titrations for all mutants. 
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 inding ability against levan. 
The upper part of each panel shows the raw heats, the lower part is the integrated data. This is fit to a single site model 
to derive Ka, ∆H, and stoichiometry. Levan was at 10-20 mg/ml and proteins were used at 100-200 µM. To obtain the 
molar concentration of levan, the WT was fit such that n=1 (number of binding sites on the protein). This assumption is 
deemed valid due to the structural and mutagenesis data that indicates only a single binding site on the protein. All 
mutants were then fit to this same molar concentration (10 mg/ml = 3 mM). 
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WT W103A Y298A W304A 
C316A C316S C405A C405S 
W414A Y413A W497A 
Figure 5. 17 ITC data show the BT1762 mutants b
 Mutant Ka × 103 (M-1) ∆H (kcal mol-1) T∆S (kcal mol-1) n*
WTa 9.1 ± 0.8 -7.7 ± 1.5 -2.8 ± 0.3 1.0 ± 0.1 
Y298A 13.3 ± 1.7 -5.5 ± 1.0 0.2 1.0 ± 0.2 
W304A 12.1 ± 1.0 -4.5 ± 0.6 1.1 1.0 ± 0.3 
C405A 14.5 ± 0.2 -4.5 ± 0.5 1.2 1.9 ± 0.0 
C405S 32.3 ± 2.4 -3.6 ± 0.9 2.4 2.4 ± 0.0 
W414A 24.3 ± 5.1 -2.7 ± 0.5 3.2 1.2 ± 0.3 
W497A 15.4 ± 1.1 -4.3 ± 0.2 1.3 2.0 ± 0.1 
Table 5. 3 ITC parameter of the BT1762 mutants binding to Levan  
*: The ITC data were fitted to a single site binding model for all titrations. The n-value was iteratively fitted to as close 
as possible to one, by adjusting the molar concentration of levan from 10 mg/ml to 3 mM. a: The parameters for WT are 
average values from three repeats. Parameters for mutants are from single titrations individually. The Ka values are 
quite similar except for C405S and W414A, which may be caused by the limitation of prediction of software Origin. 
  
 
 
Circular dichroism spectroscopy revealed that none of the mutations had caused significant changes 
in the secondary structure compared to wild-type (Figure 5. 18). 
 
 
 
Figure 5. 18 CD spectroscopy BT1762 wild type and mutants. 
ealed these proteins All mutants and WT were checked at 10 µM concentrations in 10 mM Tris pH 8.0 buffer. Data rev
keep the secondary structure as wild type. 
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5.3 Discussion 
The sequence similarity of SusD homologues is low (only ~7% between SusD and BT1762), but the 
structural comparison here reveals that the general fold, TPR repeats and general location of the 
binding sites are highly conserved. TPRs are mainly involved in protein-protein interactions and it 
has been suggested that the TPR domains are involved in the formation of a complex with the SusC 
porin and possibly SusE, F and G (Koropatkin et al., 2008). It seems likely that the TPR units of 
 same scaffold role and bind the SusC homologue BT1763. It is also possible that 
bility of normally membrane 
ssociated proteins to interact (Moore et al., 2008).  
SusD could bind a range of malto-oligosaccharid s, cyclodextrins and starch, while BT1762 can 
uctan, showing no affinity for β-2,1 linked inulin. Levan is predicted to have a secondary structure 
hich comprises 5 fructose rings in one left-hand twist of the helix with the distance of 12.74 Å 
between sugars (F ). uch al structure, thus 
explaining the lack of interaction with BT1762 (Figure 5. 19B). as a helical secondary 
structure with the helix repeated every 7-glucose rings with an average diameter of 10.51 Å (Figure 
tarch and levan explains the difference in the residues 
BT1762 play the
the TPRs in BT1762 bind the predicted outer membrane GH32 enzyme BT1760 to form a 
multiprotein complex, although no interaction between these two proteins was detected on a native 
gel (data not shown). However, the proteins were expressed in a soluble form rather than tethered to 
the membrane and this is known to have a significant affect on the a
a
 
e
just bind polymeric levan but not to levan-oligosaccharides smaller than seven sugars, suggesting 
the protein has a larger binding site than SusD. In addition BT1762 is specific for β-2,6 linked 
fr
w
 n and n+4 igure 5. 19A  Inulin has a m  tighter helic
Starch h
5. 19C). The structural difference between s
involved in the binding sites (Figure 5. 15).  
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Figure 5. 19 Structures of levan hexaose, inulin hexaose, and maltoheptaose. 
A: Levan hexaose modelled using SWEET2 forms a left-hand helix with the repeat unit of 5 fructose rings. The distance 
of C2 of frc1 (blue) to C2 of frc5 (orange) is 12.74 Å, which equals the C2 of frc2 (cyan) to frc6 (red). B: Inulin 
hexaose modelled using SWEET2. C: Maltoheptaose from the SusD complex forms a much tighter twist. 
 
 
ing site composed of W96, W98, Y296, and W320, that docks SusD has a crescent shaped bind
exactly with the tight helical twist of polymeric starch (Figure 5. 20A). In contrast, BT1762 has 
much more extended binding site, composed of a unique functional disulphide ring (C316 and 
C317), a tyrosine (Y413), and a tryptophan (W103) which fits the more extended model of a levan 
chain in two possible orientations (Figure 5. 20B/C).  
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Figure 5. 20 SusD and BT1762 ligand binding sites. 
A: Ribbon representation shows SusD complex with maltoheptaose (cyan sticks) in the arch formed by four aromatic 
sidues (red sticks). B and C: Ribbon representation shows BT1762 with aromatic residues W103, Y413, and 
 
The disulphide ring in BT1762 formed between adjacent cysteines (C316/317) is a very unusual 
feature of any protein and has only been seen before in the active site of a quinohemoprotein 
alcohol dehydrogenase (Figure 5. 21) (Oubrie et al., 2002). However, the disulphide ring in this 
enzyme was shown to be functionally nonessential, unlike in BT1762 where it seems to be essential 
for levan binding (Kay et al., 2004). It is possible the disulphide ring has a structural, rather than a 
carbohydrate-binding role, but as CD spectra recorded for the C316A and C316S mutants are 
indistinguishable from the wild-type protein spectra indicates that this is not the case (Figure 5. 18). 
Precisely how this disulphide ring could interact with levan is currently unclear, however it may 
stack against the fructose rings in the same way as an aromatic residue. 
 
re
disulphide ring (C316 and C317) highlighted as red sticks. Levan hexaose (cyan sticks) is put among these residues to 
mimic the possible binding orientations (see arrows). 
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 Figure 5. 21 Overlay the disulphide rings from BT1762 and quinohemoprotein alcohol dehydrogenase. 
The green ring is from BT1762, while the cyan ring is from the alcohol dehydrogenases of Comamonas testosterone 
(PDB 1KB0). The disulphide bonds are present in yellow while oxygen is red, and nitrogen is blue. 
 
 
BT1762 may be essential for the utilisation of levan long chains, as SusD is essential for use of 
oligosaccharides bigger than 5 glucose units. The decreased binding affinity to L7 also suggests 
BT1762 mainly binds long chains, which is also partly due to that fact that L7 has only one possible 
helical unit and it is not a standard shape of levan because no other helices before and after it to 
form internal hydrogen bonds to sustain the secondary structure. Combined with the enzyme 
BT1760 on the outer membrane which can cleave long levan chains, BT1762 can transfer digested 
levan oligosaccharides though SusC homologue BT1763 to the periplasm. BT3082 and BT1759 can 
degrade levan oligosaccharides efficiently in the periplasm. A model for the role of BT1762 in levan 
degradation system of B. thetaiotaomicron is shown in Figure 5. 22. 
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Figure 5. 22 Model for the function of BT1762.  
BT1762 (green) binds levan (red rings) in a binding site (blue sticks), which anchors levan in close proximity to the 
GH32 levanase BT1760 (purple) and enable the enzyme to hydrolyze the levan. The cleaved levanoligosaccharides 
bound SusD are then presented to the entrance of SusC homologue BT1763 porin channel (yellow; structure shown is a 
β-barrel porin from Salmonella typhimurium, (PDB ID 1A0T) (Forst et al., 1998), as the structure of BT1763 has not 
been solved yet). In this way, BT1762 binds levan tightly to enable enzymic hydrolysis, while levanoligosaccharides 
interact weakly with BT1762 enabling its efficient transfer to transporter BT1763. Levanoligosaccharides in periplasm 
are digested by BT3082 (blue). 
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Chapter 6 Analysis of the trans-envelope signalling apparatus 
of B. thetaiotaomicron  
6.1 Introduction 
Many ECF sigma factors are known to signal via trans-envelope signaling. The best studied similar 
signaling system is the Fec system of E. coli. E. coli employs the Fec system to transport ferric 
citrate into the bacterium, which has seven genes: fecIR, fecABCDE (Figure 6. 1). First, cells 
respond to iron deficiency by synthesizing the regulatory proteins FecI and FecR. But the low iron 
concentration is not enough to induce transcription. The presence of ferric citrate is also needed for 
this transcription (Braun et al., 2003b). The system is activated by ferric citrate in the form of 
dinuclear ferric citrate (Fe3+ citrate)2 binding to the OMP FecA which has a β-barrel domain, a plug 
domain and an N-terminal periplasmic extension. The signal from FecA is transmitted to the C-
terminal periplasmic domain of the transmembrane protein FecR through its N-terminal extension. 
The activated N-terminal cytoplasmic domain of FecR then stimulates the ECF sigma factor, FecI, 
to bind the RNAP to transcribe the fecABCDE operon which directs the synthesis of proteins that 
mediate ferric ion transport (Angerer et al., 1995; Enz et al., 2003; Kim et al., 1997; Ochs et al., 
1995). An energy-transducing system is associated with the process of iron up-taking which 
contains TonB, ExbB, and ExbD. The C-terminal region of TonB interacts with a specific region of 
the N-terminal extension (TonB-Box) of FecA (Braun and Mahren, 2005; Koebnik, 2005). It is 
believed that the binding with TonB changes the structure of FecA which results in the dissociation 
of ferric citrate from FecA. 
 
 171
 
Figure 6. 1 Schematic of the FecAIR transmembrane signaling apparatus from E. coli.  
In FecA, part of the barrel is not drawn to show the plug domain (yellow). The model depicts the movement of loops L7 
and L8 upon binding of dinuclear ferric citrate. FecA signals its occupation by ferric citrate into the periplasm, where it 
interacts with FecR, which transmits the information across the cytoplasmic membrane and activates the FecI sigma 
factor. The TonB–ExbB–ExbD complex is involved in transport and signaling across the outer membrane. Cited from 
(Braun and Mahren, 2005). 
 
 
 
The interacting site of the FecR with FecA is located between residues 237-317 of FecR within 
which region has a leucine heptad motif that is conserved in other predicted FecR like proteins. 
Mutations around this region reduce most of the FecR induction activity and its ability to bind in 
vitro to the N-terminal periplasmic extension of OMP FecA (Figure 6. 2) (Braun et al., 2003b). That 
FecI does not induce the transcription of fec genes without FecR would suggest the FecR is not or 
not only an anti-sigma factor, but is in fact an activator of FecI.  
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 Figure 6. 2 Domain structures of FecAIR.  
The bottom panel shows the sigma factor FecI. Domains 1 to 4 are shown as is the binding site for the cytoplasmic 
domain of FecR. The middle panel shows anti–sigma FecR which has a single cytoplasmic membrane spanning domain 
(TM). The N-terminal is the cytoplasmic domain which interacts with the sigma factor; the C-terminal periplasmic 
domain interacts with the N-terminal extension found on FecA (The top panel). Cited from (Braun et al., 2003b; Garcia-
Herrero and Vogel, 2005). 
 
TonB is a cytoplasmic membrane protein which utilises the proton motive force to provide energy 
for active transport of large molecules across the outer membrane by the TonB dependent OMP. The 
mechanism for this is via a contact in the periplasm between the TonB and the OM receptor (Figure 
6. 3).  
 
 
Figure 6. 3 TonB-dependent sy
OM means the out membrane. C
Plug domain, while the N-termi
(Koebnik, 2005). 
 N term 
stem. 
M means the cytoplasmic membrane. TonB/EXbB/ExbD complex binds SusC homolog 
nal tail of SusC homolog (blue) interacts with anti-sigma factor in periplasm. Cited from 
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TonB normally forms into a complex with cytoplasmic membrane proteins ExbB and ExbD. TonB-
dependent signaling mechanism appears to be common. TonB-dependent proteins are found to have 
four different types depend on the structure analysis with presence or absence of signal transduction 
(Figure 6. 4). Without the function of signal transduction, TonB-dependent proteins are named 
receptors (Koebnik, 2005). 
 
 
 
 
Figure 6. 4 Diversity of TonB-dependent proteins.  
All TonB-dependent proteins have a C-terminal β-barrel (orange) and a plug domain (green), TonB-dependent 
transducers have an extra N-terminal periplasmic extension (blue) of about 70 amino acids. Oar-subclass proteins often 
have another additional domain in the N-terminal region (pink) which include Myxococcus, xanthus, Bacteroides, 
Xanthomonasm and Xylella species. Cited from (Koebnik, 2005). 
 
 
B. thetaiotaomicron contains at least 12 ECF σ/anti- σ polysaccharide utilization loci (PUL), which 
have all essential components for trans-envelope signaling. The anti-sigma factors have homology 
to FecR, the sigma factors have homology with FecI, and the SusC homologues are likely TonB 
dependent transducers as they have the N-terminal extension (Koebnik, 2005). The sequence 
alignments of PUL elements to Fec proteins reveal more details about the conservation. ECF sigma 
factors of B. thetaiotaomicron are aligned to FecI of E. coli (Figure 6. 5) while anti-sigma factors 
are aligned to FecR (Figure 6. 6 and Figure 6. 7) and the SusC transducers are aligned to FecA 
(Figure 6. 8). The ECF sigma factors’ alignment indicates the N-terminal is variable; the middle is 
conserved and then followed a flexible C-terminal domain. Anti-sigma factors cytoplasmic domains 
(N-terminal) (Figure 6. 6) have low similarity, while the periplasmic domains (C-terminal) 
including FecR are highly conserved. The barrel domain of SusC transducers are conserved, whilst 
the N-terminal extensions are diverse. Furthermore, the alignment of SusC transducers also 
indicates that non-ECF sigma PULs have no N-extension tail (Figure 6. 8). In addition, B. 
thetaiotaomicron possesses 8 TonB genes and the SusC transducers contain TonB boxes, which also 
suggests the similar energy-dependent process exists in this organism involved in the transport of 
polysaccharides (Xu et al., 2003).  
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Figure 6. 5 Alignment of ECF sigma factors to FecI. 
d, the conservation score goes up. Residues in white lettering on 
ins are quite conserved with variation at some region as well. The C-terminal 10-15 residues are 
iverse.  
Tcoffee presents the score of alignment. From blue to re
red boxes are completely conserved. Color codes for other alignments are identical. The diversity of the N-terminal is 
high. The middle doma
d
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Figure 6. 6 The alignment of the cytoplasmic domain (N-terminal) of anti-sigma factors to FecR. 
Totally, the cytoplasmic domain of all anti-sigma factors including FecR are high diverse. Not all ECF sigma factors are 
presented here, but the rule is general. 
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 Figure 6. 7 The alignment of the periplasmic domain (C-terminal) of anti-sigma factors to FecR.  
Generally, the C-terminal of anti-sigma factors are much conserved, especially in the middle area, while some of them 
(BT3518 and BT4635) have longer N-terminal tails. 
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Figure 6. 8 The alignment of the SusC transducers of B. thetaiotaomicron with FecA of E. coli. 
In this alignment, all SusC transducers are from PULs. Only the N-terminal fractions of SusC transducers presented 
here, because generally SusC-homologs are between 600 to 800 residues. The top 4 are from loci including ECF 
sigma/anti-sigma factors, while the next 3 are from Non-ECF PULs, including SusC (BT3702). ECF-PULs group has 
N-terminal 70-80 residues after signal peptide, but Non-ECF PULs do not, including SusC. FecA has this N-extension 
tail, and the similarity to SusC transducers of B. thetaiotaomicron is low. 
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These data suggest that the ECF-sigma PULs in B. thetaiotaomicron signal in the same way as the 
Fec system, but E. coli has one system whereas B. thetaiotaomicron has at least 12. A lot of sensory 
systems of B. thetaiotaomicron present high sequence similarity (for example, TCS HK and RR 
receive domain, and anti-sigma factor periplasmic domains), which increase the chance of 
unexpected cross-talk. Some research has detected the cross-talk of TCS in E. coli (Siryaporn and 
Goulian, 2008). My objectives are to investigate the pathway of signaling of ECF-PULs in B. 
thetaiotaomicron and possibility of specificity in the ECF-sigma linked PULs.  
6.2 Results 
Four ECF-sigma linked gene clusters (or PULs) which have an ECF-sigma factor, an anti-sigma 
factor, SusC transducer homolog, SusD homolog, and at least one glycoside hydrolase were chosen 
for analysis (Figure 6. 9 and Table 6. 1). All of these systems have been shown to be involved in 
either dietary or host polysaccharide utilisation (Bjursell et al., 2006). 
 
 
 
Figure 6. 9 ECF-PUL gene clusters for this study. 
There are four gene clusters (A, B, C, D) studied in this chapter. Green box shows the ECF-σ factor, red presents the 
anti-σ factor with transmembrane (TM), pink means SusC-like OMP, and orange means SusD-like OMP. Light green in 
A represents the sulfatase. Blue boxes means GHs and grey boxes represents a protein of unknown function.  
 
 
 
Gene Cluster Sigma factor Anti-sigma factor SusC homolog 
A BT0752 BT0753  BT0754 
B BT1877 BT1876  BT1875 
C BT3517 BT3518  BT3519 
D BT4705 BT4706  BT4707 
Table 6. 1 Gene clusters expressed in this chapter. 
Gene clusters, A, C, and D are transcribed from the sense strand. Gene cluster B is transcribed from the anti-sense. 
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Based on the E. coli Fec system model it was hypothesized that the ECF-sigma, anti-sigma and 
SusC transducer from each cluster were able to interact to form a trans-envelope signalling system 
whereby binding and transport of a specific complex glycan to the SusC transducer would initiate 
the signalling cascade that ultimately led to the upregulation of the genes required for its 
degradation by the cognate ECF sigma factor (Figure 6. 10). 
 
 
Figure 6. 10 Model of the predicted transenvelope signalling system in B. thetaiotaomicron based on the E. coli 
Fec system.  
Polysaccharide binding to the SusC homologue (blue) in the outer membrane induces conformational change that 
allows the N-terminal periplasmic extension to contact the periplasmic domain of the cognate anti-sigma factor (red). 
This signal is then transduced across the membrane to the cytoplasmic ECF sigma factor (green) which is activated and 
inititiates expression of the genes under its control. The inner membrane TonB apparatus which provides the energy 
required for active uptake of the polysaccharide is also shown. 
 
6.2.1 Protein Expression 
In total, four proteins were expressed in a recombinant form from each ECF-PUL. They are the 
sigma factor, anti-sigma cytoplasmic domain, anti-sigma periplasmic domain, and N-terminal 
periplasmic extension of SusC transducers after the signal peptide (Figure 6. 11 and Table 6. 1). 
Signal peptides were predicted using SignalP (Figure 6. 13) and the transmembrane domains were 
predicted using TMHMM (Figure 6. 15). 
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Figure 6. 11 Domains expressed in this study. 
The 16 genes are listed from N-terminal to C-terminal. The second gene cluster is conversed because the gene cluster 
order is different to other three. The anti-σ cyto in the first red box means the cytoplasmic domain of anti-σ factors. The 
N-tail in the purple box means the N-terminal extension of ~80 residues after the signal peptide of the SusC transducer. 
The numbers between each gene ID present the protein start and end residue numbers.  
 
 
The proteins used in this chapter are listed in Table 6. 2. 
 
Protein ID Note 
BT0752 ECF sigma factor of PUL A 
BT1877 ECF sigma factor of PUL B 
BT3517 ECF sigma factor of PUL C 
BT4705 ECF sigma factor of PUL D 
BT0753N Anti-sigma factor cytoplasmic domain of PUL A 
BT1876N Anti-sigma factor cytoplasmic domain of PUL B 
BT3518N Anti-sigma factor cytoplasmic domain of PUL C 
BT4706N Anti-sigma factor cytoplasmic domain of PUL D 
BT0753C Anti-sigma factor periplasmic domain of PUL A 
BT1876C Anti-sigma factor periplasmic domain of PUL B 
BT3518C Anti-sigma factor periplasmic domain of PUL C 
BT4706C Anti-sigma factor periplasmic domain of PUL D 
BT0753C∆ Anti-sigma factor C-terminal of periplasmic domain of PUL A 
BT1876C∆ Anti-sigma factor C-terminal of periplasmic domain of PUL B 
BT3518C∆ Anti-sigma factor C-terminal of periplasmic domain of PUL C 
BT4706C∆ Anti-sigma factor C-terminal of periplasmic domain of PUL D 
BT0754N N-extension of SusC homolog of PUL A 
BT1875N N-extension of SusC homolog of PUL B 
BT3519N N-extension of SusC homolog of PUL C 
BT4707N N-extension of SusC homolog of PUL D 
Table 6. 2 Proteins used in this chapter. 
There are 20 proteins used in this study. The anti-sigma facto C-terminal of periplasmic domain is about the half length 
of periplasmic domain after a cleavage site (see Figure 6.20). More details about this will be described later in this 
chapter. 
 
Target genes were amplified by PCR using the genome of the B. thetaiotaomicron as template 
(Figure 6. 12).  
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Figure 6. 12 Amplification of BT4705 sigma factor from B. thetaiotaomicron genomic DNA.  
Lane 1: marker, lane 2: BT4705 PCR product. 
 
6.2.1.1 Expression of the N-terminal periplasmic domain of the SusC 
transducers 
According to the research on the function and structure of OMP FecA, the periplasmic N-terminal 
81 residues of FecA after the signal peptide form a distinct domain that plays an important role in 
information transmission (Figure 6. 3 and Figure 6. 8). The N-terminal 80 residues after the signal 
peptide of the B. thetaiotaomicron SusC transducers used in this study were cloned. The position of 
the signal peptide cleavage site was determined by SignalP (Figure 6. 13).  
 
 
Figure 6. 13 A map shows the predicted signal peptide cleavage site of BT0754 SusC transducer. 
The red line indicates the cleavage site of BT0754 which is between residues 28 and 29 (LSA-QEQ). 
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The primers for SusC transducers used in this study are shown in Table 6. 3.  
 
Primer ID Sequence ( 5’---------------------------------------------------------->3’) Note 
BT0754-1 CGCGCTAGCCAGGAACAAAACAAG F Nhe I 
BT0754-2 CCGCTCGAGGGCATGGAATATGACC R Xho I 
BT0754-3 CATGCGGCCGCATGCAGGAACAAAAC F Not I 
BT1875-1 CGCGCTAGCGTTTCATTGAAAATGG F Nhe I 
BT1875-2 CCGCTCGAGCTTTGAAGTATTCTGCC R Xho I 
BT3519-1 CGCGCTAGCAATAACAATAATTATTC F Nhe I 
BT3519-2 CCGCTCGAGAAAAACTTGTCTGTC R Xho I 
BT3519-3 CGCGCTAGCCAGCTCAAAACTCTCTCGG F Nhe I 
BT3519-4 CCGCTCGAGAGCTGACTTTCCTGAG R Xho I 
BT4707-1 CGCGCTAGCCAACGGACGCATGTTG F Nhe I 
BT4707-2 CCGCTCGAGCATTTTATTAGTCGATAAAATAATC R Xho I 
Table 6. 3 Primers for the N-terminal extension of SusC transducers studied. 
F: Forward primer, R: Reverse primer. 
 
The N-terminal 80 residues of the SusC transducers were cloned into pET21a which has a C-
terminal His tag, expressed in E. coli C41 cell strain. The IMAC purified proteins were all produced 
in a soluble form (Figure 6. 14).  
 
Figure 6. 14 SDS-PAGE of purified BT4707N SusC transducer. 
BT4707N was expressed as a C-terminal His tag construct and purified by IMAC in a single step form the cell free 
extract of lysed E. coli C41cells. Lane 1 is eluted pure BT4707N, lane 2 are molecular weight markers. 
6.2.1.2 Expression of the periplasmic domain of the anti-sigma factors 
The periplasmic domain, cytoplasmic domain and transmembrane domain of anti-sigma factors 
were determined using the software Prediction of transmembrane helices in proteins (TMHMM). 
All anti-sigma factors’ N-terminals are in cytoplasm, while C-termini are in the periplasm. Figure 6. 
15 shows an example of a TMHMM transmembrane location prediction.  
 184
 Figure 6. 15 Transmembrane prediction for BT0753 anti-sigma factor.  
Residues 1-85 (purple) are cytoplasmic domain, residues 86-108 (red) are transmembrane domain and 109-341 residues 
(blue) are periplasmic domain.  
 
 
The transmembrane regions and orientation of each anti-sigma factor predicted by TMHMM are 
listed in Table 6. 4. 
 
Gene 
Cluster 
cytoplasmic domain 
(N-terminal) 
Transmembrane periplasmic domain 
(C-terminal) 
BT0753 [1-85] [86-108] [109-341] 
BT1876 [1-91] [92-114] [115-337] 
BT3518 [1-97] [98-120] [121-400] 
BT4706 [1-53] [54-76] [77-307] 
Table 6. 4 The transmembrane regions and orientation of anti-sigma factors used in this study. 
All the prediction for transmembrane regions and locations of anti-sigma factors are made by TMHMM. Generally, the 
N-terminal domains are in cytoplasm, which are less than 100 residues. The transmembrane domains are 22 residues in 
each anti-sigma factor, while the lengths of C-terminal periplasmic domain shift from 222 (BT1876) to 279 amino acids 
(BT3518). 
 
 
The primers originally designed for full length of periplasmic domain of anti sigma factors are 
listed as Table 6. 5. 
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Primer ID Sequence ( 5’---------------------------------------------------------->3’) Note 
BT0753-1 CGCGGATCCACGTATACGGAAAATCTGACG F BamH I 
BT0753-2 CCGGAATTCTTATCTTACCCCCTTTCTTTTATCG R EcoR I S 
BT0753-3  CCGCTCGAGTCTTACCCCCTTTCTTTTATCG R XhoI 
BT0753-4 CTAGCTAGCACGTATACGGAAAATCTGACGG F Nhe I 
BT0753-5 CGCGGATCCTTATCTTACCCCC R BamH I 
BT0753-12 CTAGCTAGCACGTATACGGAAAATCTGACGG F Nhe I 
BT0753-13 CGCGGATCCTTATCTTACCCCCTTTC R BamH I 
BT1876-1 CGCGGATCCGAGGTGAATGTGAAAG F BamH I 
BT1876-2 CCGGAATTCATAGATAGTTATATTAC R EcoR I S 
BT3518-1 CTCCCATGGCGAATTATCAGGCGGTTTTGGC F Nco I 
BT3518-2 CTCCTCGAGTTTTTTCACGACCCGATAAG R Xho I 
BT3518-3  CCGCTCGAGCTATTTTTTCACGACCCG R Xho I S 
BT3518-7 CCGGAATTCCTATTTTTTCACGACCCG R EcoR I 
Table 6. 5 Primers for the full length of periplasmic domain of anti-sigma factors. 
F: Forward primer, R: Reverse primer, S: with Stop code on. The primers for full length of BT4706 were not designed. 
 
The periplasmic domains of anti-sigma factors (BT1876C, BT3518C) in pET32b (see Appendix C; 
recombinant protein expressed as a fusion with thioredoxin, Trx) were over expressed in E. coli C41 
cell strain. All IMAC purified proteins were produced in a soluble form in the E. coli cytoplasm. 
The Trx-BT1876C fusion should be 47 kD, and the purified two bands are 16 kD and 31 kD, which 
indicated that BT1876C fusion was cut at one point by unknown protease (Figure 6. 16). The 
digestion could not be inhibited by protease inhibitors or 8 M urea added to the cell suspension 
prior to sonication indicating it was taking place in the cells during expression. 
 
 
 
Figure 6. 16 SDS PAGE of purified BT1876C fused to thioredoxin.  
BT1876C expressed in pET32 as two separated bands. One is predicted to be about 16 kD including a His tag, while 
another is about 31 kD. BT1876C is 25.5 kD itself, while the N-terminal tags are 21.5 kD. So the total length of 
BT1876C fusion is 47 kD and equals the length sum of the two bands, which indicated this fusion is cleaved at some 
point. The small band was predicted to be the second fragment (C-terminal), while the big band was the N-terminal. 
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The Trx-BT3518C is about 50 kD. After IMAC purification, there were two fragments shown on 
the SDS-PAGE gel (Figure 6. 17). The length sum of these two bands is about 50 kD, which 
indicated that BT3518C fusion was cleaved at one point by unknown protease, which could not be 
inhibited by protease inhibitor either. 
 
Figure 6. 17 BT3518C express two bands in pET32b. 
Lane 1: BT3082C. Lane 2: Marker. The small band is about 15 kD, while the big band is about 35 kD. The length sum 
of these two bands equals 50 kD, which is the full length of BT3518C fusion. This result indicated that BT3518C fusion 
was cleaved at one point. And the small band is predicted to be the second fragment (C-terminal), while the big one is 
the first fragment. 
 
BT0753C was cloned into minipRSETA (N-terminal His-tag, 1.7 kD), minipRSET-Trx (N-terminal 
His tag, plus thioredoxin tag, about 14 kD), and pGEX-6P-1(N-terminal GST tag, about 25 kD) 
respectively (Appendix C). BT0753 fusions were expressed in a range of E. coli strains and purified 
by IMAC method. In all cases two bands were produced (Figure 6. 18) and all have one fraction at 
the same size. That would suggest a specific protease cut at a special site of this protein, so the sizes 
of the C-terminal (second fragments) would not be influenced. 
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His-tagged GST-tagged Trx-tagged 
Figure 6. 18 BT0753C expressed as two bands when fused to three tags.  
The BT0753C is 26.4 kD, which expressed two bands in three different vectors: minipRSETA, minipRSET-Trx, and 
pGEX-6p-1 which have tags at N-terminal respectively. There is always one band kept at the same size position (about 
16 kD), which was predicted to be the second band (C-terminal) because the N-terminal is shifting the length with the 
length of tags in different vectors. 
 
 
In order to check out the cleavage site, the small band of BT0753C in minipRSETA-Trx was blotted 
to PVDF membrane for N-terminal 6 amino acid sequencing, and cut from SDS gel for molecular 
mass analysis by MALDI-TOF mass spectrum (Figure 6. 19). The data from MALDI-TOF and N-
terminal sequencing show that BT0753C had been cleaved by an unknown protease between Gly-
197 and Thr-198 in the full length protein specifically (Figure 6. 20). So the small fragment of 
BT0753C started from residues: TVFNNR and had the molecular weight at 16.5 kD. 
 
 
 
Figure 6. 19 MADL-TOF map shows the C-terminal fraction of BT0753 peri. 
BT0753C was fused to minipRSETA-Trx, over expressed in E. coli and purified by IMAC and the molecular weight of 
the smaller band determined by MALDI-TOF. The molecular weight is 16515.17 Dalton. 
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This cleavage event occurred in the cell as evidenced by the presence of two bands even when the 
cells were resuspended in 8 M urea before lysis (data not shown). A similar phenomenon was 
observed with FecR in E. coli (Wriedt et al., 1995). According the alignment of FecR and 19 anti-
sigma factors, we found that both G and T sites are conserved in anti-sigma factors (Figure 6. 20). 
 
 
Figure 6. 20 Alignment of partial periplasmic domains of anti-sigma factors from B. thetaiotaomicron and E. coli 
FecR showing position of conserved cleavage site.  
A presents the location of conserved Gly-197 and Thr-198 (red box) in BT0753. B shows conserved site in all anti-
sigma factors as well as FecR. All anti-sigma factors in gene cluster which has an ECF type sigma factor adjacent to 
homologues of susC, susD, and glycoside hydrolases. Star symbol indicates the residues are completely conserved. 
 
In the following experiments, only the portions after this conserved residue glycine were cloned. 
They are BT0753C∆ [198-341]), BT1876C∆ ([198-337]), BT3518C∆ ([263-401]), and BT4706C∆ 
([198-307]). Primers for C-terminal of periplasmic domain of anti-sigma factors were designed as 
Table 6. 6. Subsequently, only one band was seen on SDS-PAGE gel (Figure 6. 21). 
 
Primer ID Sequence ( 5’---------------------------------------------------------->3’) Note 
BT0753-6 CGCGGATCCACGGTATTCAATGTCCG F BamH I 
BT1876-3 CGCGGATCCACAAAATTCAATTTCCG F BamH I 
BT1876-4 CCGGAATTCTTAATAGATAGTTATATTACG R EcoR I 
BT3518-4 CGCGGATCCACTAAATTCAATGTGAC F BamH I 
BT3518-7 CCGGAATTCCTATTTTTTCACGACCCG R EcoR I S 
BT4706-3 CGCGGATCCACCAAATTTAATGTG F BamH I 
BT4706-4 CCGGAATTCCTAATATAAATCTACTATTATC R EcoR I S 
Table 6. 6 Primers for the second part of periplasmic domain of anti-sigma factors. 
F: Forward primer, R: Reverse primer, S: with Stop code on. 
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Figure 6. 21 SDS-PAGE shows purified BT0753C∆. 
This protein fusion (lane 1) (30.5 kD) has an N-terminal His tag and a Trx tag (14 kD) and the C-terminal BT0753C∆ 
(16.5 kD, [198-341]). 
 
6.2.1.3 Expression of the cytoplasmic domain of the anti-sigma factors 
The cytoplasmic domains of anti-sigma factors were determined as described before. Their genes 
were cloned into pET21a by PCR with primers from MWG (Table 6. 7), expressed in E. coli C41 
cell strain. The IMAC purified BT0753N, BT1876N, and BT3518N are all expressed in a soluble 
form in the cytoplasm of E. coli. BT4706N has no expression in pET21a, but it expressed as soluble 
protein in pGEX-6p-1 which has an N-terminal GST tag. Figure 6. 22 shows BT0753N as an 
example of cytoplasmic domain of the anti-sigma factors. 
 
Primer ID Sequence ( 5’---------------------------------------------------------->3’) Note 
BT0753-10 CGCGCTAGCATAGAATATTACGATAAAG F Nhe I 
BT0753-7 CGCGGATCCATAGAATATTACGATAAAGAAGAACTGG F BamH I 
BT0753-11 CCGCTCGAGTTTCCGGACAGGC R Xho I 
BT1876-5 CGCGCTAGCGAAGAAGAAAATAAAC F Nhe I 
BT1876-6 CCGCTCGAGTGACAGGCTAAAAC R Xho I 
BT3518-5 CGCGCTAGCATTAATTCAGAACTG F Nhe I 
BT3518-6 CCGCTCGAGTTTATGTTTAATCTTATC R Xho I 
BT4706-1 CGCGCTAGCATGGAAAATATGAATCCGG F Nhe I 
BT4706-2 CCGCTCGAGACGCATCAACTGATTATAC R Xho I 
BT4706-8 CGCGGATCCATGGAAAATATGAATCCGG F BamH I 
BT4706-9 CCGGAATTCACGCATCAACTGATTATAC R EcoR I 
Table 6. 7 The primers for cytoplasmic domain of anti-sigma factors. 
F: Forward primer, R: Reverse primer. 
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Figure 6. 22 SDS-PAGE of purified N-terminal cytoplasmic domain of BT0753 anti sigma factor (BT0753N).  
BT0753N (lane 2) is 9.6 kD and was purified in a single step by IMAC. 
 
 
6.2.1.4 Expression of sigma factors 
There are four sigma factors BT0752 ([1-195]), BT1877 ([1-196]), BT3517 ([1-190]), and BT4705 
([1-189]) cloned by PCR using primers from Table 6. 8 and the B. thetaiotaomicron genomic as 
template, ligated into minipRSETA which has a thrombin cleavage site immediately after the N-
terminal His tag. The fusions of sigma factors were over expressed in E. coli C41 cell strain. Sigma 
factors BT0752, BT3517, and BT4705 are IMAC purified from CFE and soluble in Tris pH 8.0 
buffer while BT1877 has no expression in a range of E. coli cell strains, such as BL21, JM83, and 
Tuner and so could not be studied. Figure 6. 23 shows purified BT0752 as an example. 
 
Primer ID Sequence ( 5’---------------------------------------------------------->3’) Note 
BT0752-1 CGCGGATCCAATTTACCAGAAGTC F BamH I 
BT0752-2 CCGGAATTCTTAAAGAAACATCAAAATAGC R EcoR I S 
BT0752-3 CGCGCTAGCAATTTACCAGAAGTC F Nhe I 
BT1877-1 CGCGGATCCGAGAATACTGAAAC F BamH I 
BT1877-2 CCGGAATTCTTACCTGAAAAAAAATAGTAATAG R EcoR I S 
BT3517-1 CGCGGATCCGCCTCAGATATAC F BamH I 
BT3517-2 CCGGAATTCCTATTCTCGCTTG R EcoR I S 
BT4705-1 CGCGGATCCAAAATATCTTTTTCCAGAC F BamH I 
BT4705-2 CCGGAATTCTTACAGTTGCTCGGGAG R EcoR I S 
Table 6. 8 Primers for sigma factors. 
F: Forward primer, R: Reverse primer, S: with Stop code on. 
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Figure 6. 23 SDS-PAGE of purified N-terminal cytoplasmic domain of BT0752 sigma factor.  
Sigma factor BT0752 is 22.5 kD and was purified in a single step by IMAC. 
6.2.2 Protein Interaction Studies 
6.2.2.1 The N-terminal periplasmic extension of SusC transducers binds 
specifically to the periplasmic domain of their cognate anti-sigma factor 
AGE was used to evaluate the binding of N-extension of OMP SusC transducers and the C-terminal 
of anti-sigma periplasmic domain initially. The native gels reveal the specific binding of anti-sigma 
peri to N-terminal of SusC transducers from the same gene cluster with the presence of a third band 
when mixed (Figure 6. 24). No cross binding was seen between anti-sigma peri and SusC 
transducer N-[1-80] derived from different gene clusters (data not shown).  
 
 
Figure 6. 24 Native gel of SusC transducer N-extension and periplasmic domain of anti-sigma factor interaction 
from same PUL.  
Lane 1: BSA, lane 2: BT0754N, lane 3: BT0753C∆, lanes 4-8 are the mixture of BT0753C∆ and BT0754N at ratio 4:1, 
4:2, 4:4, 2:4, and 1:4. The arrow shows the new band resulting from the complex formed between BT0753C∆ and 
BT0754N. 
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ITC was then used to quantify the binding of the C-terminal of anti-sigma factor periplasmic 
domain to N-extension of SusC transducer. The data show the interaction has a Ka of between 1.7 
and 14.5 x 106 M-1 for the gene pairs analysed. Interestingly, the thermodynamics of the interaction 
vary significantly between cognate gene pairs. In all cases binding involves a favourable change in 
enthalpy (-∆H), but the entropic contribution varies from being strongly favourable for BT1875C∆ 
/BT1876N (T∆S +6.1 kcal mol-1) to slightly unfavourable for BT0753C∆ /BT0754N (T∆S -1.1 kcal 
mol-1) (Figure 6. 25 and Table 6. 9). 
 
Figure 6. 25 ITC shows the binding of SusC N-extension and periplasmic domain of anti-sigma factors from 
same PUL. 
A: BT0753C∆ vs BT0754N, B: BT1876C∆ vs BT1875N, C: BT3518C∆ vs BT3519N, D: BT4706C∆ vs BT4707N. 
 
 
The ITC data supports the results from native gels: binding just occurs between proteins from same 
gene cluster and does not happen between proteins of different gene clusters (Figure 6. 26).  
 
 
Figure 6. 26 ITC shows no cross binding of SusC N-extension and periplasmic domain of anti-sigma factors from 
different gene clusters. 
A: No cross-binding of BT1875N to BT0753C∆. B: No cross-binding of BT3519N to BT0753C∆. 
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No change in binding affinity was observed in the presence of 5 mM EDTA, indicating that the 
interaction of anti-sigma peri with the SusC N-extension is metal independent (data not shown). 
 
ITC pair Ka × 106
(M-1) 
∆H 
(kcal mol-1) 
T∆S 
(kcal mol-1) 
n* 
BT0753C∆ vs 
BT0754N 
1.7 ± 0.2 -9.6 ± 0.1 -1.1 1.1 ± 0.0 
BT1876C∆ vs 
BT1875N 
3.4 ± 0.9 -2.8 ± 0.5 6.1 0.9 ± 0.0 
BT4706C∆ vs 
BT4707N 
14.5 ± 3.0 -6.3 ± 0.5 3.4 0.9 ± 0.0 
Table 6. 9 ITC data of SusC N-extension and periplasmic domain of anti-sigma factors. 
*: The ITC data were fitted to a single site binding model for all titrations. ITC was carried out in 10 mM Tris/HCl pH 
8.0. Protein concentrations are from 50 to 500 µM. The titration of BT3518C∆ vs BT3519N could not calculated 
correctly using Origin software. This set of binding looks like enthalpy decrease, while entropy varies in each. The free 
energy change in each case is around -9 kcal mol-1. 
6.2.2.2 The cytoplasmic domains of anti-sigma factors bind specifically to their 
cognate ECF-sigma factors 
To evaluate the binding ability of sigma factor and cytoplasmic domain of anti-sigma factor native 
gel electrophoresis was used initially. The data revealed that the sigma factors bind the cytoplasmic 
domain of anti-sigma factors of a same PUL (Figure 6. 27), but do not associate with other anti-
sigma cytoplasmic domains from different gene clusters (data not shown).  
 
 
Figure 6. 27 Native gel shows binding of sigma to cytoplasmic domain of anti-sigma factor from the same PUL.  
The ratio of BT0753N/BT0752 in lanes 1-11: 0:4, 4:0, 4:1, 4:2, 4:3, 4:4, 4:6, 4:8, 4:10, 4:12, and 0:8, Lane 12: BSA. 
The binding arrow points to the new band produced by the complex of BT0753N and BT0752. 
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ITC was then used to quantify the affinity of sigma factor to anti-sigma cytoplasmic domain. 
BT1876N was not tested against BT1877 because of no expression of the latter. The results show 
that the association constant varies from 9.5 to 34.4 x 106 M-1 (Figure 6. 28 and Table 6. 10). In 
addition, the thermodynamics of the interactions vary significantly; both are dominated by a 
favourable enthalpy, but whilst BT0752/BT0753N has a favorable entropic component, 
BT3517/BT3518N has significantly unfavorable entropy. Addition of 5 mM EDTA had no effect on 
the magnitude of the interaction indicating that the binding is metal independent (data not shown).  
 
 
Figure 6. 28 ITC of sigma factors and anti-sigma factor cytoplasmic domains from the same PUL. 
A: BT0752 vs BT0753N. B: BT3517 vs BT3518N. C: BT4705 vs BT4706N. 
 
As expected, no cross binding was seen between the BT0752 sigma factor and BT3518N anti-sigma 
cytoplasmic domain (Figure 6. 29). 
 
 
Figure 6. 29 ITC shows no binding of BT0752 to BT3518N.  
No cross-binding of sigma factor BT0752 to anti-sigma BT3518-cyto which belong to different clusters. 
 195
 ITC pair Ka × 106
(M-1) 
∆H 
(kcal mol-1) 
T∆S 
(kcal mol-1) 
n* 
BT0752 vs BT0753N 9.5 ± 0.2 -7.6 ± 0.9 2.0 1 ± 0.0 
BT3517 vs BT3518N 34.4 ± 4.6 -28.2 ± 0.1 -17.9 1.1 ± 0.0 
Table 6. 10 ITC data of the interaction between cognate sigma and anti-sigma factors. 
*: The ITC data were fitted to a single site binding model for all titrations. ITC was carried out in 10 mM Tris/HCl pH 
8.0. Protein concentrations are from 50 to 500 µM. Titration of BT4705 vs T4706N could not be fitted correctly by the 
Origin software.  
 
 
6.2.3 Protein Crystallization 
The specific binding of sigma/anti-sigma factors and the anti-sigma factors with the N-extension of 
SusC transducers led us to further research the interaction using protein crystallography to 
understand the specificity at a molecular level. We used different ways to approach producing 
complexes of BT0752/BT0753N and BT0753C∆ /BT0754N. 
 
First we used digestion by thrombin to remove the Trx tag from BT0753C∆ fusion, but this cleaved 
protein could bind IMAC nonspecifically, which would suggest this digested protein could not be 
used to co-purify with BT0754N. Then we modified pET21a to enable co-expression of BT0753C∆ 
and BT0754N (Figure 6. 30 and Figure 6. 31).  
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Figure 6. 30 Sequence of both the BT0753C∆ and BT0754N genes in pET21a for co-expression. 
DNA map was made by NTI vector to show the structure of BT0753C∆ (green) and BT0754N (Red) in mutated 
pET21a. This mutated pET21a has a second ribosome binding site (AAGGAG, blue box) before Not I site and after 
BamH I site, while other restriction sites after BamH I and before Not I were removed by site directed mutagenesis. 
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Figure 6. 31 Agarose gel shows co-expression structure of BT0753C∆ and BT0754N in modified pET21a.  
Using different pairs of primers and a same plasmid as template to run PCR, different products demonstrate different 
parts of insert. Using primers T7 and T7-term, a 1156 bp band is produced which is between T7.tag and T7 terminator 
including BT0753C∆ and BT0754N. Using primer BT0753-12 and primer BT0753-13, a 720 bp band is produced 
which is BT0753C∆. Using primer BT0754-3 and primer BT0754-2, a 263 bp band is produced which is BT0754N. 
Using primer BT0753-12 and BT0754-2, a 983 bp DNA band is produced which are BT0753C∆ and BT0754N. Lanes 2, 
3, and 4 are size markers. 
 
 
The co-expressed complex BT0753C∆ and BT0754N was purified by the IMAC method, but is not 
pure enough for crystallization (Figure 6. 32). Even with gradient elution increasing the imidazole 
from 10 mM, 30 mM, 50 mM, 75 mM, up to 100 mM, the impurity remained (Figure 6. 33). 
 
 
 
Figure 6. 32 SDS-PAGE shows the co-expression of BT0753C∆ with BT0754N.  
This complex is not pure enough for crystallization. BT0753C∆ is the periplasmic domain of anti-sigma factor BT0753, 
while BT0754N is the N-terminal tail of SusC transducer BT0754. 
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 Figure 6. 33 SDS-PAGE shows the co-expression of BT0753C∆ and BT0754N.  
Following the IMAC purification for the co-expression of BT0753C∆ and BT0754N, a contamination could not be 
removed by gradient elution, which influenced the purity of the co-expressed protein and crystallization afterwards.  
 
Finally, a fishing approach was used to achieve the complex. BT0754N was bound to IMAC 
column before loading the CFE of untagged BT0753C∆. The latter binds BT0754N to form a 
complex because of the high affinity, while other proteins in CFE flow away. Then, the complex 
was eluted from the column, which was not pure enough for crystallization because of extra bands 
(Figure 6. 34 Lane 1). Then gel filtration was used to further purify the two-component complex of 
BT0753C∆ and BT0754N. Unfortunately, this complex was dissociated through the process of 
purification (Figure 6. 34). 
 
 
Figure 6. 34 Gel filtration for the complex of BT0753C∆ and BT0754N.  
Lane 1: the complex of untagged BT0753C∆ and BT0754N after IMAC purification. Lanes 2-21 are the fractions 
collected from gel filtration column. In lanes 2-11, most BT0753C∆ has been eluted while BT0754N still binds to the 
column. In lanes 12-21, the remained BT0754N was eluted.  
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A fishing approach was used to achieve the complex of BT0752 and BT0753N as well, by using the 
binding ability of BT0753N against BT0752 to fish out untagged BT0752 from CFE solution when 
BT0753N was bound on IMAC column (Figure 6. 35). 
 
 
 
Figure 6. 35 SDS-PAGE shows untagged BT0752 was fished by tagged BT0753N.  
The purified BT0753N (lane 2) fishes out untagged BT0752 from CFE (lane 3), the flow though has less BT0752 
protein left (lane 4). After a series of elution with imidazole concentration from 10 mM, 30 mM, 50 mM, 75 mM, to 100 
mM (lanes 5-9), in the final 100 mM elution, the proteins are pure enough for crystallization (lane 9).  
 
The pure complex (BT0752/BT0753N) was set up for sitting-drop crystallization trials on four 
screens (JCSG, PACT, Classics, and Newcastle, see Appendix B). Unfortunately, no crystals were 
obtained in any of the conditions tested.  
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6.3 Discussion 
B. thetaiotaomicron possesses 88 PULs to sense the environment variation (Bjursell et al., 2006). In 
which, ECF-PULs are similar to Fec system of E. coli. They employ ECF sigma/anti-sigma factors 
as sensors, and SusC transducers as polysaccharide transducers to accomplish the sensing and 
transport process. Compared to the SusC transducers in Non-ECF PULs, ECF-PULs ones have N-
extensions, which is about 80 residues after a signal peptide. This extra domain plays the signalling 
function. Binding of polysaccharide to the SusC transducer causes the N-extension to bind the 
periplasmic domain of the anti-sigma factor. This signal is passed to the cytoplasmic domain of the 
anti-sigma through the membrane. The change of cytoplasmic domain will stimulate the sigma 
factor to join the core RNA polymerase to form a complete RNAP, which will start to transcript the 
catabolic enzymes required to degrade the initially bound polysaccharide. This pathway enables B. 
thetaiotaomicron to sense the variation of niches in human gut accurately and efficiently, which 
enhances the competition ability of the bacterium which lives in a very densely populated 
environment. This kind of ECF sigma factor sensing pathway is common in many organisms that 
are able to respond to a large number of environmental variations, such as Bacillus subtilis, 
Mycobacterium tuberculosis, Caulobacter crescentus, Pseudomonas aeruginosa, and Streptomyces 
coelicolor. In many cases ECF sigmas outnumber all other types of sigma factors (Table 1.1) 
(Helmann, 2002). 
 
However, B. thetaiotaomicron genome contains more two component systems (79 classic plus 32 
hybrided) than ECF sigma/anti-sigma pairs (25 in number) (Xu et al., 2003). The coexistence of 
TCS and ECF sigma factors signalling mechanisms reflects the high stress level from human gut 
and multiple response policy of B. thetaiotaomicron. TCS may respond to the signalling in human 
gut at regular level, while ECF mechanisms are only activated when signalling level is lower, i.e., 
stressful. The high number of TCS and high level of sequence similarity may be sufficient to allow 
some level of cross-talk, which has been detected in other organism, such as E. coli (Siryaporn and 
Goulian, 2008). This kind of cross-talking capacity may be an economy way for B. 
thetaiotaomicron, as in some cases, a set of signallings from human gut may come together 
regularly, such as plant cellulose always come with hemicellulose, the signalling from cellulose 
could initiate hemicellulose hydrolases to transcript. Further research is needed to support this 
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hypothesis. Data presented here shows that ECF-PULs in B. thetaiotaomicron have no cross-talk 
recognition of anti-sigma factors to sigma factors, or sigma factors to SusC transducers. The 
recognition only happens between proteins in the same gene cluster. This could explain the 
sequence similarity variations of sigma/anti-sigma factors, and SusC transducers. The low sequence 
similarity of both N- and C-terminal of sigma factors, but high similarity in the middle region is 
because the N-terminal recognize special promoter of RNA polymerase, while the C-terminal 
recognize matched N-terminal of anti-sigma factor only. But the main function of ECF sigma factor 
is conserved, so the middle region is highly similar. Meanwhile, the lack of binding of sigma/anti-
sigma factors also explained the low similarity of N-terminal of anti-sigma factor (cytoplasmic 
domain). The lack of binding of anti-sigma C-terminal to N-terminal of SusC explains the low 
similarity of C-terminal 15 residues of anti-sigma factor and N-terminal 80 residues of SusC 
transducers. And the high similarity of other fraction of C-terminal of anti-sigma factors addressed 
the functional conservation, while the high similarity of barrel of SusC transducers indicates the 
functional conservation as well. 
 
The binding of sigma/anti-sigma factors, anti-sigma factor/SusC N-extension has a stoichiometry of 
1:1 and the interaction is an exothermic reaction though the entropy changes and association 
constants vary considerably (Table 6. 9 and Table 6. 10). It is currently not clear why there is such 
difference in the affinity and thermodynamic signature of the different protein pairs. It is possible  
the actual residues involved in the interactions have diverged significantly between proteins in 
different PULs. However it is also possible the differences seen are due to errors in the fit of the 
data. 
 
The unknown E. coli cytoplasmic protease that cleaves the periplasmic domain of anti-sigma factors 
can not be inhibited by commercial protease inhibitor, or urea and the Trx tag and GST tag could 
not stop the fused protein being cleaved either. It is possible that this event is biologically relevant, 
but it is hard to envisage how cleaving half of the periplasmic domain of the anti-sigma in the 
inactive (unbound) form would have any useful role in the system. It seems more likely that this is 
simply an artifact of the expression system as the protein is present in the cytoplasm of E. coli, but 
is not a periplasmic protein in B. thetaiotaomicron. However, the highly conserved sequence of the 
cleavage site and that fact that the same proteolytic even occurs with FecR, suggests that this region 
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is important for function, even if it is not normally cleaved. Interestingly, expression of only the C-
terminal portion of the periplasmic domain of the anti-sigma after the cleavage site produces a 
protein that is able to bind the cognate SusC transducers’ N-extension indicating a distinct two-
domain structure of the periplasmic region of the anti-sigma. One domain (the C-terminal) binds the 
transducers N-extension, while the other (the N-terminal extending from the inner membrane) may 
be involved in signal transduction across the membrane.  
 
Comparing the Ka of BT0753C∆/BT0754N to BT4706C∆/BT4707N, a possible reason to explain 
the dissociation of BT0753C∆/BT0754N complex from gel filtration (Table 6. 9) is that the affinity 
is not high enough. If we employ the complex of BT4706C∆/BT4707N for crystallization, a higher 
purity of complex may be achieved. A possible explanation for the crystallization failure of 
BT0752/BT0753N is the His6 tag takes a large ratio of BT0753N when compared to the size of this 
protein. This kind of tag could be very flexible and prevent the complex to form into proper crystal 
lattice. If the His tag was removed, the chance to crystallize may be higher. NMR could be another 
potential method to solve the structures of the complexes. 
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Chapter 7 Final Discussion 
Combining all result chapters, a final discussion was drawn to further understand the overall 
mechanism of carbohydrate sensing and utilisation system of B. thetaiotaomicron. 
 
B. thetaiotaomicron is prominent in the normal human gut microflora as a symbiont (Xu et al., 
2003). Its genome revealed a large group of proteins involved in the sensing, acquisition and 
degradation of carbohydrates (Xu et al., 2003). These proteins include 209 SusC/D homologues, 
241 carbohydrate-active enzymes, 76 ECF-σ/anti-σ factors, 111 TCS (included HTCS), and 41 
related transporters (Magnus et al., 2006; Shipman et al., 2000; Xu et al., 2003).  
 
Glycoside hydrolase and polysaccharide lyase genes are frequently adjacent to SusC and SusD 
homologues and sensors, such as pairs of ECF-sigma/anti-sigma factors and hybrid two-component 
system. These linked genes combine into polysaccharide utilisation loci (PULs) (18 ECF-PULs and 
70 non-ECF-PULs) to sense, bind, and degrade specific polysaccharides (Bjursell et al., 2006). The 
PULs expand the carbohydrate utilisation ability from human and establish the dominate status of B. 
thetaiotaomicron in gut. So far, the carbohydrate sensing and utilisation mechanism is not fully 
understood at molecular level.  
 
An ECF-PUL gene cluster comprises SusC transducer, ECF-σ/anti-σ factors, and at least one 
glycoside hydrolase or one polysaccharide lyase, in which SusC transducer has an N-terminal tail as 
a signal peptide (chapter 6). The tail binds to the anti-sigma factor in periplasm which passes the 
signal to the cytoplasmic domain through the transmembrane domain. Finally, the associated sigma 
factor is released by anti-sigma factor to form a RNAP to transcribe the polysaccharide enzymes. 
Compared to non-ECF PULs, the N-tail of SusC transducer is unique, which indicates that in non-
ECF PULs, the mechanisms are different. ECF-PULs have no cross recognition of anti-sigma 
factors to sigma factors, or sigma factors to SusC transducers in the systems tested. If we want to 
fully understand level of cross-talk, we need to analyse all the ECF-sigma and anti-sigma factors, 
possibly using a yeast 2-hybrid system. ECF-PULs transfer signals from C-terminal of SusC 
transducer to N-terminal tail, then to C-terminal of anti-sigma factor (periplasmic domain), 
followed by the N-terminal of anti-sigma factor interacts with C-terminal domain of ECF sigma 
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factor (Figure 6. 1) (Braun and Mahren, 2005). All system components signal from C- to N-
terminus.  
 
In comparison, the sensory component of hybrid two component systems of non-ECF PULs has 
lower binding affinity (chapter 3: BT1754peri against fructose, the Ka is only 2.3 x 105 M-1). 
Classical two component systems are predicted to have cross-talk opportunity according to other 
two component system studies where the response regulator is free in the cytoplasm (Siryaporn and 
Goulian, 2008). Hybrid two component system is different to two component system as the fusion 
of the response regulator to the histidine kinase means it is unlikely to have any cross talk in these 
systems or signal amplification. Two component systems (including HTCS) are N- to C-terminal 
signalling (Figure 1. 13). The sensor histidine kinase is predicted to be a homodimer according to 
the crystal structure (Lee et al., 2008), even though BT1754peri presents as a monomer in solution 
(section 3.2.1.3.1). According to the comparison of ECF-PULs and non-ECF-PULs, the sensing 
mechanism difference is obvious.  
 
In the operon controlled by HTCS BT1754, there are four GHs which belong to GH32 family, only 
one of which is an endo-acting enzyme, BT1760 (chapter 4). BT1760 functions a mixture of endo-
acting and exo-acting. The low rate of endo-acting in a group of same activity enzymes could be an 
effective arrangement for carbohydrate digestion. BT1760 is located on the outer membrane and 
cuts levan into small oligosaccharides which are transfered into the B. thetaiotaomicron periplasm. 
BT1760 could not digest inulin, which may not be a problem in vivo because native inulin are <~20 
DP which may translocate though the barrel of SusC transducer straight away, while levans are 
generally much longer chains (Figure 4. 6E). BT1759 and BT3082 appear to have similar 
specificity and both are periplasmic. There is no clue as why the two enzymes play one role, 
although there may be redundancy. Knockout of one of the two chondroitin sulfate lyases in B. 
thetaiotaomicron does not affect its growth on chondroitin, so redundancy may be a common theme 
in B. thetaiotaomicron (Shaya et al., 2008). BT1765 prefers short oligosaccharides and likely 
accomplishes the final digestion step of fructans in cytoplasm. Totally this group of GH32s could 
digest all kinds of fructans including oligosaccharides and sucrose. Their substrate preferences 
complement each other to increase fructan digestion from long chains to monosaccharides. 
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The outer membrane SusD homologue BT1762 could bind levan, but not inulin, while BT1760 
GH32, which is located on the outer membrane as well, could digest levan, but not inulin. The 
identical ligand-specificity revealed that these two proteins are cooperative. BT1762 binds 
polymeric levan tightly, but oligosaccharides only weakly.  When BT1760 cleaves the levan chain 
while the polysaccharide is bound to BT1762, the binding will become much weaker and this may 
facilitate transport through the SusC homologue BT1763. BT1762 presents identical TPR motif to 
SusD though, which indicated BT1762 may play a scaffold role to link SusC transducer BT1763, 
levanase BT1760, and other related proteins on the outer membrane. Although we could see no 
interaction between BT1762 and BT1760 by native gels, if we could mimic the lipid-layer 
environment of outer membrane and also express full lengths of both proteins, it may be possible to 
detect an interaction between them. Levan-binding of BT1762 is probably based on the endo-
recognition of the secondary structure rather than the exo-action against terminal fructose units, as 
SusD could form hydrogen bonds with G4, G5, and G6 of helical maltoheptaose, which is a cycle 
unit of starch and levan is predicted to have such a helical secondary structure as well, but more 
extended than starch (Koropatkin et al., 2008). This kind of endo-binding of BT1762 could help the 
endo-acting of levanase BT1760. 
 
Generally, all the components of B. thetaiotaomicron sensing and utilisation of carbohydrates are 
organized as a team to accomplish the whole process from sensing carbohydrate in the gut 
environment and stimulating related enzymes to transcript to digesting carbohydrate for the 
consumption of B. thetaiotaomicron and host (Figure 7. 1). SusC/D homologues locate on the outer 
membrane associated with GH enzyme to mediate polysaccharides to get into periplasm. In ECF-
PULs, the N-terminal tail of SusC transducer could interact with C-terminal of anti-σ periplasmic 
domain to change the N-terminal structure of anti-σ and release the C-terminal associated σ factor 
which then binds RNAP to initiate the transcription of ECF-PULs. In non-ECF-PULs the activating 
signal is sensed by the periplasmic domain of dimerized sensor HKs of HTCS to phosphorelay to 
cognate RR which then binds DNA directly to activate transcription of the catabolic genes. 
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Figure 7. 1 Overall process of B. thetaiotaomicron sensing and utilisation of polysaccharides. 
Blue dash arrow means the movement of polysaccharides and proteins. SusD homologues (light blue circle) located on 
the outer membrane (OM: upper green line), associated with SusC homologues (purple barrel) and GH enzyme (grass 
green) to mediate polysaccharides to get into periplasm. The N-terminal tail of SusC transducer could interact with C-
terminal of anti-σ periplasmic domain to change the N-terminal structure of anti-σ and release the C-terminal associated 
σ factor (σ4) which then binds RNAP (grey cycle) to initiate the transcription of ECF-PULs. In non-ECF-PULs the 
activating signal is recognised directly by the periplasmic domain of dimerized sensor HKs of HTCS (orange) to initiate 
the phosphorelay that results in activated cognate response regulator (RR). The phosphorylated RR output domain then 
binds DNA directly to activate transcription of the catabolic genes under its control. Whether this occurs by proteolytic 
release of the RR or the DNA is brought to the membrane and the RR remains attached to the HK domain is currently 
unknown. 
 
 
 
Compared to polysaccharide utilisation mechanisms in other bacteria, which mainly use CBMs to 
bind plant cell wall polysaccharides and secreted enzymes to degrade the polysaccharides, B. 
thetaiotaomicron catabolic enzymes are different. Instead B. thetaiotaomicron uses the Sus complex 
and more specifically SusD homologues, to bind polysaccharides and pull them into the periplasm 
for degradation. This adaptation will provide B. thetaiotaomicron with a competitive advantage in 
the very densely populated niche of the human gut as none of its products of degradation will be 
available for use by its competitors. 
 207
Future work 
Some plans for future studies in the area of polysaccharide utilisation by Bacteroides 
thetaiotaomicron are as follows: 
 
1) What is the mechanism of signal transduction in BT1754? Is it the same in other HTCS?  
 
2) How does the RR domain of the HTCS bind the genomic DNA to activate transcription? Is it 
proteolytically cleaved or does the DNA come to the membrane? Research on ToxR suggested that 
DNA may come to the membrane to bind RR output domain (Crawford et al., 2003). 
 
3) How is the mechanism in other PULs that degrade more complex polysaccharides than fructan?  
 
4) What is the levan structure bound to levanase BT1760 and SusD homologue BT1762? Will this 
help explain the unique activity of BT1760 and understand the role of BT1762 better? 
 
5) What is the role of the N- and C-terminal domains in GH32s? Why does BT1760 have no N-
terminal domain? 
 
6) How many proteins involved in Sus complex and role and structure of each? 
 
B. thetaiotaomicron has a lot of interesting genes with potential function to sense and utilise 
carbohydrates which could be utilised in industrial applications, such as production of biofuel and 
biosensors. Further understanding of this organism will also enhance our knowledge of its role in 
nutrition of human gut.  
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Appendices 
Appendix A: Chemicals, Media, and Enzymes used in this study 
A1 Chemicals 
Acrose Organics  
      D-(+)-Turanose 
      D-(-)-Tagatose 
      L-(-)-Sorbose 
 
Amersham-Boehringer Mannheim 
      2’-Deoxyadenosine 5’-triphosphate (dATP) 
2’-Deoxycytidine 5’-triphosphate (dCTP) 
2’-Deoxyguanosine 5’-triphosphate (dGTP) 
2’-Deoxythymidine 5’-triphosphate (dTTP) 
 
Bio-Rad 
      Bradfords Reagent 
 
BioGene 
      Electrophoresis grade Agarose 
 
British Drug Houses (BDH) 
      Acetic acid (Glacial) 
      Acrylamide solution (40% (w/v); Electran) 
      Boric acid 
      Bromophenol Blue 
      Citric Acid 
      Calcium chloride 
      Chloroform 
      Dimethylformamide 
      Ethanol (industrial grade) 
      Hydrochloric acid 
      Isopropanol 
      Magnesium chloride 
      Magnesium sulphate 
      Mineral oil 
      Methanol 
      Polyethelen glycol MW 8000 (PEG-8000) 
      Polyethelen glycol MW 550 monomethyl ether (PEG550 mme) 
      Potassium dihydrogen orthophosphate 
      Sodium acetate 
      Sodium chloride 
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      Sodium dihydrogen orthophosphate 
      Sulphuric acid 
      Triton X-100 
      Xylene cyanol FF 
 
Calbiochem 
      Deoxymannojirimycin 
      Lactulose 
 
Fisons 
      46/48% (w/v) NaOH 
Sodium acetate trihydrate 
 
Hampton Research 
      Aqua Sil® 
 
James Burrough (F.A.D.) Ltd 
      Ethanol 
 
Megazyme 
1-Kestose 
1,1-Kestotetraose 
1,1,1-Kestopentaose 
 
Melford Laboratories 
      Isopropyl-β-D-thiogalactoside (IPTG) 
      Urea (ultrapure) 
      HEPES 
 
Pharmacia 
     Adenosine 5’-triphosphate (ATP) 
     Agarose (ultrapure) 
 
Roche 
     Complete Protease Inhibitor Cocktail Tablets 
     Complete Protease Inhibitor Cocktail Tablets, EDTA-free 
 
Sigma  
      Ammonium persulphate 
      Ampicillin 
      Bis tris propane 
      Bovine serum albumin, fraction V (BSA) 
      N-Butyl-deoxynojirimycin 
      Castanospermine 
      Chondroitin 4-sulfate sodium salt from bovine trachea 
      Chondroitin 6-sulfate sodium salt from shark cartilage 
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      Coomassie Brilliant Blue G 
      Copper sulphate 
      DEAE-Trisacryl 
      Deoxynojirimycin 
      Digalacturonic acid 
      Dimethylsulphoxide 
      2, 4-Dinitrophenol 
      3, 5-Dinitrosalasylic acid (DNSA) 
      Dithiothrietol (DTT) 
      Ethidium bromide 
      Ethelene diamine tetra-aceticacid, disodium salt (EDTA) 
      Ethylene glycol 
      D-(-) Fructose 
      Galacturonic acid 
      Guanosine 5’ diphosphoglucose 
      Gadolinium chloride 
      D-Glucose 
      Gluteraldehyde 
      Glyceraldehyde-3-phosphate 
Glycerol 
D-Glycerate 
Imidazole 
Inulin from chicory 
D-lactete 
Levan from Erwinia herbicola 
Levan from Zymomonas mobilis 
Lithium acetate 
Lithium chloride 
β-Mercaptoethanol 
2, 4-methane-pentanediol (MPD) 
Mineral oil (light) 
Nicotinamide adenine dinucleotide-reduced 
Polyethylene glycol MW 350 
Phenol 
Potassium acetate 
Potassium chloride 
Potassium thiocyanate 
D-(+)-Raffinose pentahydrate 
Sodium carbonate  
Sodium dodecyl sulphate (SDS) 
      Sucrose dihydrogen orthophosphate 
      Sodium fluoride 
      Sodium sulphate 
      di- Sodium hydrohen Phosphate 
      Sucrose (nuclease free) 
      N, N, N’, N’-Tetramethylethylenediamine (TEMED) 
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       Trichloroacetic acid (TCA) 
      Trigalacturonic acid 
      Trizma base (Tris) 
      D-Xylulose 
      Zinc sulphate 
A2 Media 
Difco 
      Bacto®tryptone 
      Bacto®yeast extract 
 
Oxoid 
      Bacteriological Agar No.1 
A3 Enzymes 
NBI Fermentase 
      DNA restriction endonucleases 
 
Gibco BRL 
      Bacteriophage T4 DNA ligase 
      DNA restriction endonucleases 
 
Novagen  
      KOD HotStart DNA polymerase 
 
Sigma 
      Lactate dehydrogenase (LDH) 
Pyruvate Kinase 
Protease K 
Trypsin 
α-Chymotrypsin 
 
Stratagene 
      Pfu Turbo DNA polymerase 
      DpnI restriction endonuclease 
A4 DNA 
BT genome 
      Prepared by labmates. Kept at 4 oC in EB buffer 
 
MWG Biotech 
      All primers 
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A5 Kits 
Invitrogen 
      Zero Blunt™ Cloning Kit 
 
Qiagen 
      Plasmid mini kit 
 
Eppendorf 
      Perfectprep® Gel cleanup kit 
 
Stratagene 
      QuikChange™ Site-Directed Mutagenesis kit 
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Appendix B Crystallization Screens 
B1 Newcastle Screen Composition Table 
Number Salt Buffer  Precipitant 
1 0.2M Lithium Sulphate 0.1M Sodium Acetate pH 5.1 50% PEG 400 
2  0.1M Sodium Citrate pH 5.5 20% PEG 3000 
3  
0.2M Diammonium Hydrogen Citrate pH 
5.0 20% PEG 3350 
4 0.08M Calcium Chloride 0.1M Sodium Acetate pH 4.6 30% MPD 
5  0.2M Magnesium Formate pH 5.9 20% PEG 3350 
6 
0.2M Lithium Sulphate 
0.25M Sodium Citrate  
0.25M Sodium Dihydrogen Phosphate  
pH 4.2 20% PEG 1000 
7  0.1M CHES pH 9.5 20% PEG 8000 
8  0.2M Ammonium Formate pH 6.6 20% PEG 3350 
9  0.2M Ammonium Chloride pH 6.3 20% PEG 3350 
10  0.2M Potassium Formate pH 7.3 20% PEG 3350 
11 
0.2M Ammonium 
Dihydrogen Phosphate 0.1M Tris pH 8.5 50% MPD 
12  0.2M Potassium Nitrate pH 6.9 20% PEG 3350 
13 0.8M Ammonium Sulphate 0.1M Citric Acid pH 4.0   
14  0.2M Sodium Thiocyanate pH 6.9 20% PEG 3350 
15  0.1M Bicine pH 9.0 20% PEG 6000 
16 8% Ethylene Glycol 0.1M HEPES pH 7.5 10% PEG 8000 
17  0.1M Sodium Cacodylate pH 7.0 
40% MPD 
5% PEG 8000 
18 0.25M Sodium Citrate 
0.25M Sodium Dihydrogen Phosphate pH 
5.2 
5% PEG 1000 
40% Ethanol 
19  0.1M Sodium Acetate pH 4.6 8% PEG 4000 
20 0.2M Magnesium Chloride 0.1M Tris pH 7.0 10% PEG 8000 
21  0.1M Citric Acid pH 5.0 20% PEG 6000 
22 0.2M Magnesium Chloride 0.1M Sodium Cacodylate pH 6.6 50% PEG 200 
23   1.6M Sodium Citrate pH 6.5   
24  0.2M Potassium Citrate pH 8.3 20% PEG 3350 
25 0.02M Calcium Chloride 0.1M Sodium Acetate pH 4.6 30% MPD 
26 
0.2M Sodium Chloride 
0.25M Sodium Citrate  
0.25M Sodium Dihydrogen Phosphate pH 
4.2 20% PEG 8000 
27 1.0M Lithium Chloride 0.1M Citric Acid pH 4.0 20% PEG 6000 
28  0.2M Ammonium Nitrate pH 6.3 20% PEG 3350 
29  0.1M HEPES pH 7.0 10% PEG 6000 
30 
0.8M Ammonium 
Dihydrogen Phosphate 
0.8M Potassium 
Dihydrogen Phosphate 0.1M HEPES pH 7.5   
31 0.25M Sodium Citrate 
0.25M Sodium Dihydrogen Phosphate pH 
5.2 40% PEG 300 
32 0.2M Zinc Acetate 0.1M Sodium Acetate pH 4.5 10% PEG 3000 
33  0.1M Tris pH 8.5 20% Ethanol 
34 25% 1-2-Propanediol 
0.1M Sodium Potassium Phosphate pH 
6.8 10% Glycerol 
35 2% Dioxane 0.1M Bicine pH 9.0 10% PEG 20000 
36 2.0M Ammonium Sulphate 0.1M Sodium Acetate pH 4.6   
37   
10% PEG 1000 
10% PEG 8000 
38 20% Glycerol  24% PEG 1000 
39 0.2M Magnesium Chloride 0.1M HEPES pH 7.5 30% PEG 400 
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40 0.2M Sodium Chloride 
0.1M Sodium Potassium Phosphate pH 
7.2 50% PEG 200 
41 0.2M Lithium Sulphate 0.1M Sodium Acetate pH 4.5 30% PEG 8000 
42 0.2M Magnesium Chloride 0.1M HEPES pH 7.5 70% MPD 
43  0.1M Tris pH 8.5 20% PEG 8000 
44 0.2M Lithium Sulphate 0.1M Tris pH 8.4 40% PEG 400 
45  0.1M Tris pH 8.0 40% MPD 
46 0.17M ammonium Sulphate  
25.5% PEG 4000 
15% Glycerol 
47 0.2M Calcium Acetate 0.1M Sodium Cacodylate pH 7.0 40% PEG 300 
48 0.14M Calcium Chloride 
0.07M Sodium Acetate pH 4.6 
 
14% Isopropanol 
30% Glycerol 
49 
0.04M Potassium 
Dihydrogen Phosphate  
16% PEG 8000 
20% Glycerol 
50 1.0M sodium Citrate 0.1M Sodium Cacodylate pH 6.5   
51 0.2M Sodium Chloride 0.1M Sodium Cacodylate pH 6.5 
2.0M Ammonium 
Sulphate 
52 0.2M Sodium Chloride 0.1M HEPES pH 7.5 10% Isopropanol 
53 
1.26M ammonium Sulphate 
0.2M Lithium Sulphate 0.1M Tris pH 8.5   
54  0.1M CAPS pH 10.1 40% MPD 
55 0.2M Zinc Acetate 0.1M Imidazol pH 8.0 20% PEG 3000 
56 0.2M Zinc Acetate 0.1M Sodium Cacodylate pH 6.5 10% Isopropanol 
57 
1.0M Diammonium 
Hydrogen Phosphate 0.1M Sodium Acetate pH 4.5   
58 1.6M Magnesium Sulphate 0.1M MES pH 6.5   
59 10% PEG 6000 0.1M Bicine pH 9.0   
60 0.16M Calcium Acetate 0.08M Sodium Cacodylate pH 6.5 
14.4% PEG 8000 
20% Glycerol 
61  0.1M Imidazol pH 8.0 10% PEG 8000 
62 0.05M Caesium Chloride 0.1M MES pH 6.5 30% Jeffamine 
63 3.2M Ammonium Sulphate 0.1M Citric Acid pH 5.0   
64  0.1M Tris pH 8.0 20% MPD 
65  0.1M HEPES pH 6.5 20% Jeffamine 
66 0.2M Magnesium Chloride 0.1M Tris pH 8.5 50% Ethylene Glycol 
67  0.1M Bicine pH 9.0 10% MPD 
68 0.2M Ammonium Sulphate 0.1M Sodium Acetate pH 4.6 30% PEG MME 2000 
69 0.2M Ammonium Sulphate 0.1M MES pH 6.5 30% PEG MME 5000 
70 0.01M Zinc Suplhate 0.1M MES pH 6.5 25% PEG MME 550 
71 0.01M Nickel Chloride 0.1M Tris pH 8.5 20% PEG MME 2000 
72 0.1M Sodium Chloride 0.1M Bicine pH 9.0 20% PEG MME 550 
73 
0.005M Magnesium 
Chloride 0.05M HEPES pH 7.0 25% PEG MME 550 
74 
0.1M Potassium Chloride 
0.015M Magnesium 
Chloride 0.05M Tris pH 7.5 10% PEG MME 550 
75 0.2M Lithium Sulphate 0.1M MES pH 6.0 20% 1-4-Butandiol 
76 0.2M Sodium Chloride 0.1M Imidazol pH 8.0 
1M Sodium 
Potassium Tartrate 
77  0.1M Sodium Acetate pH 4.5 20% 1-4-Butandiol 
78 0.2M Lithium Sulphate 0.1M CHES pH 9.5 
1M Sodium 
Potassium Tartrate 
79  0.1M Sodium Cacodylate pH 6.5 35% Ethoxyethanol 
80 35% Propanol 0.1M Tris pH 8.5   
81 3.5M Sodium Formate     
82   0.8M Succinuc Acid pH 7.0   
83  2.1M Mailc Acid pH 7.0   
84  2.4M Sodium Malonate pH 7.0   
85 0.2M Potassium Chloride 0.05M HEPES pH 7.5 35% Pentaerythritol 
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Propoxylate 
86 
0.005M Ammonium 
Sulphate 0.05M Tris pH 6.5 
30% Pentaerythritol 
Ethoxylate 
87 0.2M Potassium Bromide 0.1M HEPES pH 7.5 25% PEG MME 2000 
88 0.2M Potassium Bromide 0.1M Tris pH 8.5 
8% PEG 20000 
8% PEG MME 550 
89 
1.0M Potassium 
Dihydrgoen Phosphate 0.1M Sodium Citrate pH 4.6   
90 
0.5M Potassium 
Dihydrogen Phosphate 0.1M HEPES pH 7.0   
91 0.005M Cadmium Chloride 0.1M Tris pH 8.0 20% PEG 4000 
92 0.005M Nickel Chloride 0.1M MED pH 6.5 20% PEG 4000 
93 0.8M Sodium Formate 0.1M Imidazol pH 8.0 
10% PEG 8000 
10% PEG 1000 
94 0.005M Cadmium Sulphate 0.1M Sodium Cacodylate pH 6.5 15% PEG 4000 
95 0.005M Cobalt Chloride 0.1M HEPES pH 7.5 20% PEG 600 
96  0.1M Tris pH 8.0 
2M Ammonium 
Sulphate 
10% Jeffamine 
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B2 The Classics Suite™ (Qiagen) Composition Table 
Number Salt  Buffer  Precipitant  
1 0.01 M Cobalt chloride  0.1 M Sodium acetate pH 4.6 1.0 M 1,6-Hexanediol 
2  0.1 M tri-Sodium citrate pH 5.6 2.5 M 1,6-Hexanediol 
3 0.2 M Magnesium chloride  0.1 M TRIS pH 8.5 3.4 M 1,6-Hexanediol 
4   
5 %(v/v) Isopropanol, 2.0 
M Ammonium sulfate 
5  0.1 M HEPES sodium salt pH 7.5 
10 %(v/v) Isopropanol, 20 
%(w/v) PEG 4000 
6 0.2 M Calcium chloride  0.1 M Sodium acetate pH 4.6 20 %(v/v) Isopropanol 
7  0.1 M tri-Sodium citrate pH 5.6 
20 %(v/v) Isopropanol, 20 
%(w/v) PEG 4000 
8 0.2 M tri-Sodium citrate  0.1 M HEPES sodium salt pH 7.5 20 %(v/v) Isopropanol 
9 0.2 M tri-Sodium citrate  0.1 M Sodium cacodylate pH 6.5 30 %(v/v) Isopropanol 
10 0.2 M Magnesium chloride  0.1 M HEPES sodium salt pH 7.5 30 %(v/v) Isopropanol 
11 0.2 M Ammonium acetate  0.1 M TRIS.HCl pH 8.5 30 %(v/v) Isopropanol 
12   
10 %(v/v) Ethanol, 1.5 M 
Sodium chloride 
13  0.1 M TRIS pH 8.5 20 %(v/v) Ethanol 
14   25 %(v/v) Ethylene glycol 
15 0.02 M Calcium chloride  0.1 M Sodium acetate pH 4.6 30 %(v/v) MPD 
16 0.2 M Sodium chloride  0.1 M Sodium acetate pH 4.6 30 %(v/v) MPD 
17 0.2 M Ammonium acetate  0.1 M tri-Sodium citrate pH 5.6 30 %(v/v) MPD 
18 0.2 M Magnesium acetate  0.1 M Sodium cacodylate pH 6.5 30 %(v/v) MPD 
19 0.2 M tri-Sodium citrate  0.1 M HEPES sodium salt pH 7.5 30 %(v/v) MPD 
20 0.5 M Ammonium sulfate  0.1 M HEPES pH 7.5 30 %(v/v) MPD 
21 0.2 M Ammonium phosphate  0.1 M TRIS pH 8.5 50 %(v/v) MPD 
22  0.1 M HEPES pH 7.5 70 %(v/v) MPD 
23  0.1 M TRIS pH 8.5 25 %(v/v) tert-Butanol 
24  0.1 M tri-Sodium citrate pH 5.6 35 %(v/v) tert-Butanol 
25   
0.4 M Ammonium 
phosphate 
26  0.1 M tri-Sodium citrate pH 5.6 
1.0 M Ammonium 
phosphate 
27  0.1 M TRIS.HCl pH 8.5 
2.0 M Ammonium 
phosphate 
28  0.1 M HEPES pH 7.5 2.0 M Ammonium formate 
29  0.1 M Sodium acetate pH 4.6 2.0 M Ammonium sulfate 
30  0.1 M TRIS.HCl pH 8.5 2.0 M Ammonium sulfate 
31   2.0 M Ammonium sulfate 
32 0.1 M Sodium chloride  0.1 M HEPES pH 7.5 1.6 M Ammonium sulfate  
33 0.01 M Cobalt chloride  0.1 M MES pH 6.5 1.8 M Ammonium sulfate  
34 0.2 M K/Na tartrate  0.1 M tri-Sodium citrate pH 5.6 2.0 M Ammonium sulfate  
35   1.0 M Imidazole pH 7.0 
36   0.4 M K/Na tartrate 
37  0.1 M HEPES sodium salt pH 7.5 0.8 M K/Na tartrate 
38  0.1 M Imidazole pH 6.5 1.0 M Sodium acetate  
39 0.05 M Cadmium sulfate  0.1 M HEPES pH 7.5 1.0 M Sodium acetate  
40  0.1 M Sodium cacodylate pH 6.5 1.4 M Sodium acetate  
41  0.1 M Sodium acetate pH 4.6 2.0 M Sodium chloride 
42 
0.1 M Sodium phosphate 
0.1 M Potassium phosphate 0.1 M MES pH 6.5 2.0 M Sodium chloride 
43  0.1 M HEPES pH 7.5 4.3 M Sodium chloride 
44  0.1 M HEPES sodium salt pH 7.5 1.4 M tri-Sodium citrate 
45   
1.6 M tri-Sodium citrate 
pH 6.5 
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46  0.1 M HEPES sodium salt pH 7.5 
0.8 M Sodium phosphate 
0.8 M Potassium 
phosphate 
47  0.1 M Sodium acetate pH 4.6 2.0 M Sodium formate 
48   4.0 M Sodium formate 
49  0.1 M BICINE pH 9.0 
2 %(v/v) Dioxane, 10 
%(w/v) PEG 20000 
50  0.1 M MES pH 6.5 
10 %(v/v) Dioxane, 1.6 M 
Ammonium sulfate 
51   35 %(v/v) Dioxane 
52 0.5 M Sodium chloride  0.1 M tri-Sodium citrate pH 5.6 
2 %(v/v) Ethylene imine 
polymer 
53  0.1 M TRIS pH 8.5 
12 %(v/v) Glycerol1.5 M 
Ammonium sulphate 
54 
0.5 M Sodium chloride 
0.01 M Magnesium chloride  0.01 M CTAB 
55 0.01 M Ferric chloride  0.1 M tri-Sodium citrate pH 5.6 
10 %(v/v) Jeffamine M-
600 
56  0.1 M HEPES pH 7.5 
20 %(v/v) Jeffamine M-
600 
57 0.5 M Ammonium sulfate  0.1 M tri-Sodium citrate pH 5.6 1.0 M Lithium sulfate 
58 0.01 M Nickel chloride  0.1 M TRIS pH 8.5 1.0 M Lithium sulfate 
59  0.1 M HEPES sodium salt pH 7.5 1.5 M Lithium sulfate 
60  0.1 M BICINE pH 9.0 
2.0 M Magnesium 
chloride 
61   0.2 M Magnesium formate 
62  0.1 M MES pH 6.5 1.6 M Magnesium sulfate 
63  0.1 M TRIS.HCl pH 8.5 8 %(w/v) PEG 8000 
64  0.1 M HEPES pH 7.5 10 %(w/v) PEG 8000 
65 0.5 M Lithium sulfate   15 %(w/v) PEG 8000 
66 0.2 M Zinc acetate  0.1 M Sodium cacodylate pH 6.5 18 %(w/v) PEG 8000 
67 0.2 M Calcium acetate  0.1 M Sodium cacodylate pH 6.5 18 %(w/v) PEG 8000 
68 0.2 M Magnesium acetate  0.1 M Sodium cacodylate pH 6.5 20 %(w/v) PEG 8000 
69 0.05 M Potassium phosphate   20 %(w/v) PEG 8000 
70 0.2 M Ammonium sulfate  0.1 M Sodium cacodylate pH 6.5 30 %(w/v) PEG 8000 
71 0.2 M Sodium acetate  0.1 M Sodium cacodylate pH 6.5 30 %(w/v) PEG 8000 
72 0.2 M Ammonium sulfate   30 %(w/v) PEG 8000 
73  0.1 M HEPES sodium salt pH 7.5 
2 %(v/v) PEG 400, 2.0 M 
Ammonium sulfate 
74 0.2 M Calcium chloride 0.1 M HEPES sodium salt pH 7.5 28 %(v/v) PEG 400 
75 0.1 M Cadmium chloride 0.1 M Sodium acetate pH 4.6 30 %(v/v) PEG 400 
76 0.2 M Magnesium chloride 0.1 M HEPES sodium salt pH 7.5 30 %(v/v) PEG 400 
77 0.2 M tri-Sodium citrate 0.1 M TRIS.HCl pH 8.5 30 %(v/v) PEG 400 
78 0.1 M Sodium chloride 0.1 M BICINE pH 9.0 20 %(w/v) PEG 550 MME 
79 0.01 M Zinc sulfate 0.1 M MES pH 6.5 25 %(w/v) PEG 550 MME 
80   
10 %(w/v) PEG 1000, 10 
%(w/v) PEG 8000 
81   30 %(w/v) PEG 1500 
82 0.01 M Nickel chloride 0.1 M TRIS pH 8.5 
20 %(w/v) PEG 2000 
MME 
83 0.2 M Ammonium sulfate  0.1 M Sodium acetate pH 4.6 
30 %(w/v) PEG 2000 
MME 
84  0.1 M Sodium acetate pH 4.6 8 %(w/v) PEG 4000 
85 0.2 M Ammonium sulfate 0.1 M Sodium acetate pH 4.6 25 %(w/v) PEG 4000 
86 0.2 M Ammonium acetate 0.1 M Sodium acetate pH 4.6 30 %(w/v) PEG 4000 
87 0.2 M Ammonium acetate 0.1 M tri-Sodium citrate pH 5.6 30 %(w/v) PEG 4000 
88 0.2 M Magnesium chloride 0.1 M TRIS.HCl pH 8.5 30 %(w/v) PEG 4000 
89 0.2 M Lithium sulfate 0.1 M TRIS.HCl pH 8.5 30 %(w/v) PEG 4000 
90 0.2 M Sodium acetate  0.1 M TRIS.HCl pH 8.5 30 %(w/v) PEG 4000 
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91 0.2 M Ammonium sulfate  30 %(w/v) PEG 4000 
92 0.2 M Ammonium sulfate  0.1 M MES pH 6.5 
30 %(w/v) PEG 5000 
MME 
93  0.1 M HEPES pH 7.5 
10 %(w/v) PEG 6000, 5 
%(v/v) MPD 
94   
10 %(w/v) PEG 6000, 2.0 
M Sodium chloride 
95  0.1 M HEPES pH 7.5 
20 %(w/v) PEG 10000, 8 
%(v/v) Ethylene glycol 
96  0.1 M MES pH 6.5 12 %(w/v) PEG 20000 
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B3 The JCSG+ Suite™ (Qiagen) Composition Table 
Number Salt Buffer  Precipitant 
1 0.2 M Lithium sulfate 0.1 M Sodium acetate pH 4.5 50 %w/v PEG 400 
2    0.1 M tri-Sodium citrate pH 5.5 20 %w/v PEG 3000 
3 0.2 M di-Ammonium citrate pH 5.0  20 %w/v PEG 3350 
4 0.02 M Calcium chloride  0.1 M Sodium acetate pH 4.6 30 %v/v MPD 
5 0.2 M Magnesium formate pH 5.9  20 %w/v PEG 3350 
6 0.2 M Lithium sulfate 0.1 M Phosphate-citrate pH 4.2 20 %w/v PEG 1000 
7    0.1 M CHES pH 9.5 20 %w/v PEG 8000 
8 0.2 M Ammonium formate pH 6.6  20 %w/v PEG 3350 
9 0.2 M Ammonium chloride pH 6.3  20 %w/v PEG 3350 
10 0.2 M Potassium formate pH 7.3  20 %w/v PEG 3350 
11 0.2 M Ammonium phosphate 0.1 M TRIS pH 8.5 50 %v/v MPD 
12 0.2 M Potassium nitrate pH 6.9  20 %w/v PEG 3350 
13 0.8 M Ammonium sulfate 0.1 M Citric acid  pH 4    
14 0.2 M Sodium thiocyanate pH 6.9  20 %w/v PEG 3350 
15    0.1 M BICINE pH 9 20 %w/v PEG 6000 
16    0.1 M HEPES  pH 7.5 
10 %w/v PEG 8000, 8 %v/v 
Ethylene glycol 
17    0.1 M Sodium cacodylate pH 6.5 
40 %v/v MPD, 5 %w/v PEG 
8000 
18    0.1 M Phosphate-citrate pH 4.2 
40 %v/v Ethanol, 5 %w/v 
PEG 1000 
19    0.1 M Sodium acetate pH 4.6 8 %w/v PEG 4000 
20 0.2 M Magnesium chloride 0.1 M TRIS pH 7 10 %w/v PEG 8000 
21    0.1 M Citric acid pH 5 20 %w/v PEG 6000 
22 0.2 M Magnesium chloride 0.1 M Sodium cacodylate pH 6.5 50 %v/v PEG 200 
23 1.6 M tri-Sodium citrate     
24 0.2 M tri-Potassium citrate pH 8.3  20 %w/v PEG 3350 
25 0.2 M Sodium chloride 0.1 M Phosphate-citrate pH 4.2 20 %w/v PEG 8000 
26 1 M Lithium chloride 0.1 M Citric acid pH 4 20 %w/v PEG 6000 
27 0.2 M Ammonium nitrate pH 6.3  20 %w/v PEG 3350 
28    0.1 M HEPES  pH 7 10 %w/v PEG 6000 
29  0.1 M HEPES  pH 7.5 
0,8 M Sodium phosphate, 
0,8 M Potassium phosphate 
30    0.1 M Phosphate-citrate pH 4.2 40 %v/v PEG 300 
31 0.2 M Zinc acetate 0.1 M Sodium acetate pH 4.5 10 %w/v PEG 3000 
32    0.1 M TRIS pH 8.5 20 %v/v Ethanol 
33    0.1 M Na/K phosphate pH 6.2 
25 %v/v 1,2 propandiol, 10 
%v/v Glycerol 
34    0.1 M BICINE pH 9 
10 %w/v PEG 20000, 2 %v/v 
Dioxane 
35 2 M Ammonium sulfate 0.1 M Sodium acetate pH 4.6    
36     
10 %w/v PEG 1000, 10% 
w/v PEG 8000 
37     
24 %w/v PEG 1500, 20% 
w/v glycerol 
38 0.2 M Magnesium chloride 0.1 M HEPES pH 7.5 30 %v/v PEG 400 
39 0.2 M Sodium chloride 0.1 M Na/K phosphate pH 6.2 50 %v/v PEG 200 
40 0.2 M Lithium sulfate 0.1 M Sodium acetate pH 4.5 30 %w/v PEG 8000 
41  0.1 M HEPES pH 7.5 70 %v/v MPD 
42 0.2 M Magnesium chloride 0.1 M TRIS pH 8.5 20 %w/v PEG 8000 
43 0.2 M Lithium sulfate 0.1 M TRIS pH 8.5 40 %v/v PEG 400 
44    0.1 M TRIS pH 8 40 %v/v MPD 
45 0.17 M Ammonium sulfate  
25,5 %w/v PEG 4000, 15 
%v/v Glycerol 
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46 0.2 M Calcium acetate 0.1 M Sodium cacodylate pH 6.5 40 %v/v PEG 300 
47 0.14 M Calcium chloride 0.07 M Sodium acetate pH 4.6 
14 %v/v Isopropanol, 30 
%v/v Glycerol 
48 0.04 M Potassium phosphate  
16 %w/v PEG 8000, 20 %v/v 
Glycerol 
49 1 M tri-Sodium citrate 0.1 M Sodium cacodylate pH 6.5    
50 0.2 M Sodium chloride 0.1 M Sodium cacodylate pH 6.5 2 M Ammonium sulfate 
51 0.2 M Sodium chloride 0.1 M HEPES pH 7.5 10 %v/v Isopropanol 
52 0.2 M Lithium sulfate 0.1 M TRIS pH 8.5 1,26 M Ammonium sulfate 
53    0.1 M CAPS pH 10.5 40 %v/v MPD 
54 0.2 M Zinc acetate 0.1 M Imidazole pH 8 20 %w/v PEG 3000 
55 0.2 M Zinc acetate 0.1 M Sodium cacodylate pH 6.5 10 %v/v Isopropanol 
56 1 M di-Ammonium phosphate 0.1 M Sodium acetate pH 4.5    
57 1.6 M Magnesium sulfate 0.1 M MES pH 6.5    
58    0.1 M BICINE pH 9 10 %w/v PEG 6000 
59 0.16 M Calcium acetate 0.08 M Sodium cacodylate pH 6.5
14,4 %w/v PEG 8000, 20 
%v/v Glycerol 
60    0.1 M Imidazole pH 8 10 %w/v PEG 8000 
61 0.05 M Cesium chloride 0.1 M MES pH 6.5 30 %w/v Jeffamine M-600 
62 3.15 M Ammonium sulfate 0.1 M Citric acid pH 5    
63    0.1 M TRIS pH 8 20 %v/v MPD 
64    0.1 M HEPES pH 6.5 20 %w/v Jeffamine M-600 
65 0.2 M Magnesium chloride 0.1 M TRIS pH 8.5 50 %v/v Ethylene glycol 
66    0.1 M BICINE pH 9 10 %v/v MPD 
67 0.8 M Succinic acid pH 7.0     
68 2.1 M DL-Malic acid pH 7.0     
69 2.4 M Sodium malonate pH 7.0     
70 1.1 M Sodium malonate pH 7.0 0.1 M HEPES pH 7 
0,5 %v/v Jeffamine ED-2001 
pH 7.0 
71 1 M Succinic acid pH 7.0 0.1 M HEPES pH 7 1 %w/v PEG MME 2000 
72    0.1 M HEPES pH 7 
30 %v/v Jeffamine M-600 pH 
7.0 
73    0.1 M HEPES pH 7 
30 %v/v Jeffamine ED-2001 
pH 7.0 
74 0.02 M Magnesium chloride 0.1 M HEPES pH 7.5 
22 %w/v Polyacrylic acid 
5100 sodium salt 
75 0.1 M Cobalt chloride 0.1 M TRIS pH 8.5 
20 %w/v Polyvinylpyrrolidone 
K15 
76 0.2 M Trimethylamine N-oxide 0.1 M TRIS pH 8.5 20 %w/v PEG MME 2000 
77 
0.005 M Cobalt chloride  
0.005 M Cadmium chloride  
0.005 M Magnesium chloride 
0.005 M Nickel chloride 0.1 M HEPES pH 7.5 12 %w/v PEG 3350 
78 0.2 M Sodium malonate pH 7.0  20 %w/v PEG 3350 
79 0.1 M Succinic acid pH 7.0  15 %w/v PEG 3350 
80 0.15 M DL-Malic acid pH 7.0  20 %w/v PEG 3350 
81 0.1 M Potassium thiocyanate  30 %w/v PEG MME 2000 
82 0.15 M Potassium bromide  30 %w/v PEG MME 2000 
83 2 M Ammonium sulfate 0.1 M bis-TRIS pH 5.5    
84 3 M Sodium chloride 0.1 M bis-TRIS pH 5.5    
85 0.3 M Magnesium formate 0.1 M bis-TRIS pH 5.5    
86 1 M Ammonium sulfate 0.1 M bis-TRIS pH 5.5 1 %w/v PEG 3350 
87    0.1 M bis-TRIS pH 5.5 25 %w/v PEG 3350 
88 0.2 M Calcium chloride 0.1 M bis-TRIS pH 5.5 45 %v/v MPD 
89 0.2 M Ammonium acetate 0.1 M bis-TRIS pH 5.5 45 %v/v MPD 
90 0.1 M Ammonium acetate 0.1 M bis-TRIS pH 5.5 17 %w/v PEG 10,000 
91 0.2 M Ammonium sulfate 0.1 M bis-TRIS pH 5.5 25 %w/v PEG 3350 
92 0.2 M Sodium chloride 0.1 M bis-TRIS pH 5.5 25 %w/v PEG 3350 
93 0.2 M Lithium sulfate 0.1 M bis-TRIS pH 5.5 25 %w/v PEG 3350 
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94 0.2 M Ammonium acetate 0.1 M bis-TRIS pH 5.5 25 %w/v PEG 3350 
95 0.2 M Magnesium chloride 0.1 M bis-TRIS pH 5.5 25 %w/v PEG 3350 
96 0.2 M Ammonium acetate 0.1 M HEPES pH 7.5 45 %v/v MPD 
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B4 The PACT Suite™ (Qiagen) Composition Table 
Number Salt Buffer Precipitant 
1  0.1M SPG buffer pH 4 25% w/v PEG 1500 
2  0.1M SPG buffer pH 5 25% w/v PEG 1500 
3  0.1M SPG buffer pH 6 25% w/v PEG 1500 
4  0.1M SPG buffer pH 7 25% w/v PEG 1500 
5  0.1M SPG buffer pH 8 25% w/v PEG 1500 
6  0.1M SPG buffer pH 9 25% w/v PEG 1500 
7 0.2M Sodium chloride 0.1M Sodium acetate pH 5 20% w/v PEG 6000 
8 0.2M Ammonium chloride 0.1M Sodium acetate pH 5 20% w/v PEG 6000 
9 0.2M Lithium chloride 0.1M Sodium acetate pH 5 20% w/v PEG 6000 
10 0.2M Magnesium chloride 0.1M Sodium acetate pH 5 20% w/v PEG 6000 
11 0.2M Calcium chloride 0.1M Sodium acetate pH 5 20% w/v PEG 6000 
12 0.01M Zinc chloride 0.1M Sodium acetate pH 5 20% w/v PEG 6000 
13  0.1M MIB buffer pH 4 25% w/v PEG 1500 
14  0.1M MIB buffer pH 5 25% w/v PEG 1500 
15  0.1M MIB buffer pH 6 25% w/v PEG 1500 
16  0.1M MIB buffer pH 7 25% w/v PEG 1500 
17  0.1M MIB buffer pH 8 25% w/v PEG 1500 
18  0.1M MIB buffer pH 9 25% w/v PEG 1500 
19 0.2M Sodium chloride 0.1M MES pH 6 20% w/v PEG 6000 
20 0.2M Ammonium chloride 0.1M MES pH 6 20% w/v PEG 6000 
21 0.2M Lithium chloride 0.1M MES pH 6 20% w/v PEG 6000 
22 0.2M Magnesium chloride 0.1M MES pH 6 20% w/v PEG 6000 
23 0.2M Calcium chloride 0.1M MES pH 6 20% w/v PEG 6000 
24 0.01M Zinc chloride 0.1M MES pH 6 20% w/v PEG 6000 
25  0.1M PCB buffer pH 4 25% w/v PEG 1500 
26  0.1M PCB buffer pH 5 25% w/v PEG 1500 
27  0.1M PCB buffer pH 6 25% w/v PEG 1500 
28  0.1M PCB buffer pH 7 25% w/v PEG 1500 
29  0.1M PCB buffer pH 8 25% w/v PEG 1500 
30  0.1M PCB buffer pH 9 25% w/v PEG 1500 
31 0.2M Sodium chloride 0.1M Hepes pH 7 20% w/v PEG 6000 
32 0.2M Ammonium chloride 0.1M Hepes pH 7 20% w/v PEG 6000 
33 0.2M Lithium chloride 0.1M Hepes pH 7 20% w/v PEG 6000 
34 0.2M Magnesium chloride 0.1M Hepes pH 7 20% w/v PEG 6000 
35 0.2M Calcium chloride 0.1M Hepes pH 7 20% w/v PEG 6000 
36 0.01M Zinc chloride 0.1M Hepes pH 7 20% w/v PEG 6000 
37  0.1M MMT buffer pH 4 25% w/v PEG 1500 
38  0.1M MMT buffer pH 5 25% w/v PEG 1500 
39  0.1M MMT buffer pH 6 25% w/v PEG 1500 
40  0.1M MMT buffer pH 7 25% w/v PEG 1500 
41  0.1M MMT buffer pH 8 25% w/v PEG 1500 
42  0.1M MMT buffer pH 9 25% w/v PEG 1500 
43 0.2M Sodium chloride 0.1M Tris pH 8 20% w/v PEG 6000 
44 0.2M Ammonium chloride 0.1M Tris pH 8 20% w/v PEG 6000 
45 0.2M Lithium chloride 0.1M Tris pH 8 20% w/v PEG 6000 
46 0.2M Magnesium chloride 0.1M Tris pH 8 20% w/v PEG 6000 
47 0.2M Calcium chloride 0.1M Tris pH 8 20% w/v PEG 6000 
48 0.01M Zinc chloride 0.1M Tris pH 8 20% w/v PEG 6000 
49 0.2M Sodium fluoride  20% w/v PEG 3350 
50 0.2M Sodium bromide  20% w/v PEG 3350 
51 0.2M Sodium iodide  20% w/v PEG 3350 
52 0.2M Potassium thiocyanate  20% w/v PEG 3350 
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53 0.2M Sodium nitrate  20% w/v PEG 3350 
54 0.2M Sodium formate  20% w/v PEG 3350 
55 0.2M Sodium acetate  20% w/v PEG 3350 
56 0.2M Sodium sulphate  20% w/v PEG 3350 
57 0.2M Potassium/sodium tartrate  20% w/v PEG 3350 
58 0.2M Sodium/potassium phosphate  20% w/v PEG 3350 
59 0.2M Sodium citrate  20% w/v PEG 3350 
60 0.2M Sodium malonate  20% w/v PEG 3350 
61 0.2M Sodium fluoride 0.1M Bis Tris propane pH 6.5 20% w/v PEG 3350 
62 0.2M Sodium bromide 0.1M Bis Tris propane pH 6.5 20% w/v PEG 3350 
63 0.2M Sodium iodide 0.1M Bis Tris propane pH 6.5 20% w/v PEG 3350 
64 0.2M Potassium thiocyanate 0.1M Bis Tris propane pH 6.5 20% w/v PEG 3350 
65 0.2M Sodium nitrate 0.1M Bis Tris propane pH 6.5 20% w/v PEG 3350 
66 0.2M Sodium formate 0.1M Bis Tris propane pH 6.5 20% w/v PEG 3350 
67 0.2M Sodium acetate 0.1M Bis Tris propane pH 6.5 20% w/v PEG 3350 
68 0.2M Sodium sulphate 0.1M Bis Tris propane pH 6.5 20% w/v PEG 3350 
69 0.2M Potassium/sodium tartrate 0.1M Bis Tris propane pH 6.5 20% w/v PEG 3350 
70 0.2M Sodium/potassium phosphate 0.1M Bis Tris propane pH 6.5 20% w/v PEG 3350 
71 0.2M Sodium citrate 0.1M Bis Tris propane pH 6.5 20% w/v PEG 3350 
72 0.2M Sodium malonate 0.1M Bis Tris propane pH 6.5 20% w/v PEG 3350 
73 0.2M Sodium fluoride 0.1M Bis Tris propane pH 7.5 20% w/v PEG 3350 
74 0.2M Sodium bromide 0.1M Bis Tris propane pH 7.5 20% w/v PEG 3350 
75 0.2M Sodium iodide 0.1M Bis Tris propane pH 7.5 20% w/v PEG 3350 
76 0.2M Potassium thiocyanate 0.1M Bis Tris propane pH 7.5 20% w/v PEG 3350 
77 0.2M Sodium nitrate 0.1M Bis Tris propane pH 7.5 20% w/v PEG 3350 
78 0.2M Sodium formate 0.1M Bis Tris propane pH 7.5 20% w/v PEG 3350 
79 0.2M Sodium acetate 0.1M Bis Tris propane pH 7.5 20% w/v PEG 3350 
80 0.2M Sodium sulphate 0.1M Bis Tris propane pH 7.5 20% w/v PEG 3350 
81 0.2M Potassium/sodium tartarte 0.1M Bis Tris propane pH 7.5 20% w/v PEG 3350 
82 0.2M Sodium/potassium phosphate 0.1M Bis Tris propane pH 7.5 20% w/v PEG 3350 
83 0.2M Sodium citrate 0.1M Bis Tris propane pH 7.5 20% w/v PEG 3350 
84 0.2M Sodium malonate 0.1M Bis Tris propane pH 7.5 20% w/v PEG 3350 
85 0.2M Sodium fluoride 0.1M Bis Tris propane pH 8.5 20% w/v PEG 3350 
86 0.2M Sodium bromide 0.1M Bis Tris propane pH 8.5 20% w/v PEG 3350 
87 0.2M Sodium iodide 0.1M Bis Tris propane pH 8.5 20% w/v PEG 3350 
88 0.2M Potassium thiocyanate 0.1M Bis Tris propane pH 8.5 20% w/v PEG 3350 
89 0.2M Sodium nitrate 0.1M Bis Tris propane pH 8.5 20% w/v PEG 3350 
90 0.2M Sodium formate 0.1M Bis Tris propane pH 8.5 20% w/v PEG 3350 
91 0.2M Sodium acetate 0.1M Bis Tris propane pH 8.5 20% w/v PEG 3350 
92 0.2M Sodium sulphate 0.1M Bis Tris propane pH 8.5 20% w/v PEG 3350 
93 0.2M Potassium/sodium tartrate 0.1M Bis Tris propane pH 8.5 20% w/v PEG 3350 
94 0.2M Sodium/potassium phosphate 0.1M Bis Tris propane pH 8.5 20% w/v PEG 3350 
95 0.2M Sodium citrate 0.1M Bis Tris propane pH 8.5 20% w/v PEG 3350 
96 0.2M Sodium malonate 0.1M Bis Tris propane pH 8.5 20% w/v PEG 3350 
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B5 The AmSO4 Suite™ (Qiagen) Composition Table 
Number Salt Buffer  Precipitant 1 
1   2.2 M Ammonium sulfate 
2 0.2 M Ammonium acetate  2.2 M Ammonium sulfate 
3 0.2 M Ammonium chloride  2.2 M Ammonium sulfate 
4 0.2 M Ammonium phosphate  2.2 M Ammonium sulfate 
5 0.2 M Ammonium fluoride  2.2 M Ammonium sulfate 
6 0.2 M Ammonium formate  2.2 M Ammonium sulfate 
7 0.2 M di-Ammonium citrate  2.2 M Ammonium sulfate 
8 0.2 M di-Ammonium phosphate  2.2 M Ammonium sulfate 
9 0.2 M Ammonium iodide  2.2 M Ammonium sulfate 
10 0.2 M Ammonium nitrate  2.2 M Ammonium sulfate 
11 0.2 M di-Ammonium tartrate  2.2 M Ammonium sulfate 
12 0.2 M Cadmium chloride  2.2 M Ammonium sulfate 
13 0.2 M Cadmium sulfate  2.2 M Ammonium sulfate 
14 0.2 M Cesium chloride  2.2 M Ammonium sulfate 
15 0.2 M Cesium sulfate  2.2 M Ammonium sulfate 
16 0.2 M Ammonium bromide  2.2 M Ammonium sulfate 
17 0.2 M Lithium acetate  2.2 M Ammonium sulfate 
18 0.2 M Lithium chloride  2.2 M Ammonium sulfate 
19 0.2 M tri-Lithium citrate  2.2 M Ammonium sulfate 
20 0.2 M Lithium nitrate  2.2 M Ammonium sulfate 
21 0.2 M Lithium sulfate  2.2 M Ammonium sulfate 
22 0.2 M Potassium acetate  2.2 M Ammonium sulfate 
23 0.2 M Potassium bromide  2.2 M Ammonium sulfate 
24 0.2 M Potassium chloride  2.2 M Ammonium sulfate 
25 0.2 M tri-Potassium citrate  2.2 M Ammonium sulfate 
26 0.2 M Potassium phosphate  2.2 M Ammonium sulfate 
27 0.2 M Potassium fluoride  2.2 M Ammonium sulfate 
28 0.2 M Potassium formate  2.2 M Ammonium sulfate 
29 0.2 M di-Potassium phosphate  2.2 M Ammonium sulfate 
30 0.2 M Potassium iodide  2.2 M Ammonium sulfate 
31 0.2 M Potassium nitrate  2.2 M Ammonium sulfate 
32 0.2 M K/Na tartrate  2.2 M Ammonium sulfate 
33 0.2 M Potassium sulfate  2.2 M Ammonium sulfate 
34 0.2 M Potassium thiocyanate  2.2 M Ammonium sulfate 
35 0.2 M Sodium acetate   2.2 M Ammonium sulfate 
36 0.2 M Sodium bromide  2.2 M Ammonium sulfate 
37 0.2 M Sodium chloride  2.2 M Ammonium sulfate 
38 0.2 M tri-Sodium citrate  2.2 M Ammonium sulfate 
39 0.2 M Sodium phosphate   2.2 M Ammonium sulfate 
40 0.2 M Sodium fluoride  2.2 M Ammonium sulfate 
41 0.2 M Sodium formate  2.2 M Ammonium sulfate 
42 0.2 M di-Sodium phosphate  2.2 M Ammonium sulfate 
43 0.2 M Sodium iodide  2.2 M Ammonium sulfate 
44 0.2 M Sodium malonate  2.2 M Ammonium sulfate 
45 0.2 M Sodium nitrate  2.2 M Ammonium sulfate 
46 0.2 M Sodium sulfate  2.2 M Ammonium sulfate 
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47 0.2 M di-Sodium tartate  2.2 M Ammonium sulfate 
48 0.2 M Sodium thiocyanate  2.2 M Ammonium sulfate 
49  0.1 M Citric acid pH 4.0 0.8 M Ammonium sulfate 
50  0.1 M Citric acid pH 5.0 0.8 M Ammonium sulfate 
51  0.1 M MES pH 6.0 0.8 M Ammonium sulfate 
52  0.1 M HEPES pH 7.0 0.8 M Ammonium sulfate 
53  0.1 M TRIS pH 8.0 0.8 M Ammonium sulfate 
54  0.1 M BICINE pH 9.0 0.8 M Ammonium sulfate 
55  0.1 M Citric acid pH 4.0 1.6 M Ammonium sulfate 
56  0.1 M Citric acid pH 5.0 1.6 M Ammonium sulfate 
57  0.1 M MES pH 6.0 1.6 M Ammonium sulfate 
58  0.1 M HEPES pH 7.0 1.6 M Ammonium sulfate 
59  0.1 M TRIS pH 8.0 1.6 M Ammonium sulfate 
60  0.1 M BICINE pH 9.0 1.6 M Ammonium sulfate 
61  0.1 M Citric acid pH 4.0 2.4 M Ammonium sulfate 
62  0.1 M Citric acid pH 5.0 2.4 M Ammonium sulfate 
63  0.1 M MES pH 6.0 2.4 M Ammonium sulfate 
64  0.1 M HEPES pH 7.0 2.4 M Ammonium sulfate 
65  0.1 M TRIS pH 8.0 2.4 M Ammonium sulfate 
66  0.1 M BICINE pH 9.0 2.4 M Ammonium sulfate 
67  0.1 M Citric acid pH 4.0 3.2 M Ammonium sulfate 
68  0.1 M Citric acid pH 5.0 3.2 M Ammonium sulfate 
69  0.1 M MES pH 6.0 3.2 M Ammonium sulfate 
70  0.1 M HEPES pH 7.0 3.2 M Ammonium sulfate 
71  0.1 M TRIS pH 8.0 3.2 M Ammonium sulfate 
72  0.1 M BICINE pH 9.0 3.2 M Ammonium sulfate 
73 0.1 M tri-Sodium citrate  
0.5 M Ammonium sulfate 
1.0 M Lithium Sulfate 
74   1.0 M Ammonium sulfate 
75  
0.1 M Sodium acetate pH 
4.6 1.0 M Ammonium sulfate 
76  
0.1 M HEPES sodium salt 
pH 7.5 
1.0 M Ammonium sulfate 
2 %(w/v) PEG 400 
77  0.1 M TRIS.HCl pH 8.5 1.0 M Ammonium sulfate 
78 0.05 M tri-Sodium citrate  
1.2 M Ammonium sulfate 
3 %(w/v) Isopropanol 
79  0.1 M TRIS.HCl pH 8.5 15 %(w/v) Glycerol 
80 0.5 M Lithium chloride  1.6 M Ammonium sulfate 
81 1.0 M Lithium sulfate  1.6 M Ammonium sulfate 
82 0.2 M Sodium chloride 
0.1 M HEPES sodium salt 
pH 7.5 1.6 M Ammonium sulfate 
83  
0.1 M HEPES sodium salt 
pH 7.5 
1.6 M Ammonium sulfate 
2 %(w/v) PEG 1000 
84  
0.1 M MES sodium salt pH 
6.5 1.8 M Ammonium sulfate 
85 2.0 M Sodium chloride  2.0 M Ammonium sulfate 
86  
0.1 M Sodium acetate pH 
4.6 2.0 M Ammonium sulfate 
87  
0.1 M MES sodium salt pH 
6.5 
2.0 M Ammonium sulfate 
5 %(w/v) PEG 400 
88  0.1 M TRIS.HCl pH 8.5 2.0 M Ammonium sulfate 
89   2.2 M Ammonium sulfate 
90   
2.2 M Ammonium sulfate 
20 %(w/v) Glycerol 
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91 0.1 M tri-Sodium citrate  2.4 M Ammonium sulfate 
92   
3.0 M Ammonium sulfate 
1 %(w/v) MPD 
93   
3.0 M Ammonium sulfate 
10 %(w/v) Glycerol 
94  
0.1 M HEPES sodium salt 
pH 7.5 3.5 M Ammonium sulfate 
95  
0.1 M MES sodium salt pH 
6.5 
3.5 M Ammonium sulfate 
1 %(w/v) MPD 
96   3.5 M Ammonium sulfate 
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Appendix C: Vectors used in this Study 
C1 pET-21a 
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C2 pET-22b 
 
 252
C3 pET-28b 
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C4 pET-32b 
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C5 pET-39b 
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C6 pCR®-Blunt 
 
 256
C7 minipRSET-A 
 
 257
C8 minipRSET-Trx 
 
 258
C9 pGEX-6p-1 
  
 
 
 
 
